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Abstract
TASK channels, members of  the two-pore-domain potassium channel family, contribute 
towards the resting membrane potential and have been implicated in the mechanism of  
general anaesthesia. Previous work from our group with a TASK-3 channel knockout (T3KO) 
mouse showed a reduction in halothane sensitivity using a loss of  righting reflex (LORR) 
assay, and absence of  the theta brain oscillation induced in wild type (WT) mice by halothane 
anaesthesia.
  Two further strains of  knockout mice, the TASK-1 knockout (T1KO) and the double 
knockout (DKO: TASK-1 and -3 channels), were compared with WT using the LORR assay, 
cortical electroencephalogram recording in response to halothane and during sleep. The 
mechanistic basis for the diminished theta oscillation in T3KO mice was investigated by 
recording in CA1 pyramidal cells of  the hippocampus.
  The LORR assay revealed a decrease in halothane sensitivity in T1KO but not DKO 
compared with WT. The T1KO strain had a theta oscillation induced by exposure to 
halothane similar to that of  WT mice, whereas that observed in the DKO was intermediate 
between WT and T3KO. T1KO differed from other strains in that the distribution of  sleep 
and wake periods was uniform across the diurnal cycle. The resting membrane potential did 
not differ between strains during control or halothane exposure. During control there was no 
strain difference in action potential (AP). Halothane altered AP shape in WT but not the 
T3KO strain. WT had a greater ability to sustain AP firing than T3KO during halothane.
  These data show that T1KO mice have decreased anaesthetic sensitivity and altered sleep 
structure compared with WT, indicating a role for this channel in anaesthetic sensitivity and 
sleep.  The similar resting membrane potential and lack of  response to halothane in the 
T3KO makes pyramidal cells an unlikely source of  the theta ablation observed.
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1.0 Introduction
Since its introduction as an aid to surgery, the practice of  anaesthesia has grown into a 
specialty in its own right. The first public demonstration of  ether anaesthesia was at the 
Massachusetts General Hospital on the 16th October, 1846 by the dentist William Morton and 
the news was transmitted by a variety of  transportation to Great Britain (Ellis 1976). The first 
employment of  ether in Great Britain is controversial. A blue plaque in Gower Street, 
London, commemorates the first recorded use of  ether in England by another dentist, James 
Robinson, on 19th December, 1846. However, there is evidence that ether was administered by 
William Scott for a limb amputation on the same day at the Dumfries Royal Infirmary, 
Scotland (Baillie 1965). From humble beginnings, as a Faculty within the Royal College of  
Surgeons of  England, the growth of  anaesthesia resulted in the formation of  the College of  
Anaesthetists in 1988, which received its royal charter in 1992. Two pioneers of  anaesthesia 
in the UK, John Snow and Joseph Thomas Clover, are depicted on the College’s coat of  arms 
(Figure 1). John snow is renowned for administering chloroform to Queen Victoria during the 
birth of  two of  her children, thereby increasing acceptance of  the contentious issue of  pain 
relief  during labour, and ordering the removal of  a water pump handle in Soho resulting in 
the end of  a cholera epidemic (www.johnsnowsociety.org). Thomas Clover was a medical 
student at the time of  the introduction of  ether into the UK, and he also gained substantial 
experience in delivering chloroform, developing an apparatus its the safe administration.
13
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Figure 1. Blue plaque (left) commemorating the administration of  the first general 
anaesthetic in England by the dentist James Robinson. The plaque is situated at 52 Gower 
Street, London, the former home of  Francis Boott, friend of  James Robinson. The 
armorial bearings (right) of  the Royal College of  Anaesthetists depicting John Snow (left) 
and Joseph Thomas Clover (right). Plaque photo taken by the author. Armorial bearings 
from The Royal College of  Anaesthetists (www.rcoa.ac.uk). Accessed November, 2010.
Several million general anaesthetics are administered each year in the United Kingdom and 
volatile anaesthetic agents form part of  the anaesthetic protocol in 90% of  these cases 
(Campling et al. 1992). Despite widespread use the mechanism of  action of  the volatile agents 
remains elusive. Over eighty years after Meyer and Overton identified the relationship 
between oil solubility and potency (later known as the lipid theory of  anaesthetic action), 
Franks and Lieb shifted focus to a protein theory with their demonstration that clinically 
relevant concentrations of  inhalational anaesthetic agents do not perturb the lipid bilayer 
(Franks & Lieb 1978, 1982). A strong correlation between potency to inhibit the soluble 
enzyme luciferase and anesthetic potency was soon reported and followed by the 
demonstration that volatile anaesthetics (halothane, isoflurane, chloroform and ether) 
activated a potassium current (IK (An)) leading to the inhibition of  steady-state firing activity of  
a particular anaesthetic-sensitive neurone in the snail Lymnaea stagnalis (Figure 2) (Franks & 
Lieb 1984, 1988). Furthermore, IK (An) was shown to demonstrate open rectification and 
voltage independence, providing an early indicator for the role of  two-pore-domain 
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potassium channels (K2P) in anaesthetic sensitivity. Confirmation that IK (An) was a member of  
the K2P family was provided in 2007 (Andres-Enguix et al. 2007).  An intense period of  
research over the last 30 years has identified a range of  potential anaesthetic targets from the 
K2P family, with variable effects on anaesthetic sensitivity in vivo (Linden et al. 2006, 2007; 
Heurteaux et al. 2004).
Figure 2. A clinically relevant concentration of  halothane (0.0080 atm., period of  exposure 
indicated by open bar) reversibly blocks the activity of  an identified neurone in Lymnaea 
stagnalis. MAC is minimal alveolar concentration, the concentration of  anaesthetic agent 
required to prevent gross purposeful movement in response to a nociceptive stimulus. The 
human value for MAC was used as a guide in selecting a clinically relevant halothane 
concentration. Adapted from Franks and Lieb (Franks & Lieb 1988).
In the assessment of  any potential target as a site of  action for general anaesthetics, three 
criteria have been suggested by Franks (2006) (Franks 2006). These are:
• Plausibility - is the target expressed at a relevant site in the brain and are the known 
actions of  the target likely to promote a state of  unconsciousness?
• Sensitivity - the target should be sensitive to clinically relevant concentrations of  
anaesthetic agents. 
15
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• Effect on in vivo models - if  a transgenic animal is created with the putative target 
altered in some way and shown to have an altered sensitivity to an anaesthetic agent, 
this provides strong evidence for the importance of  the target. 
1.1 Two-pore-domain potassium channels (K2P)
The presence of  a background (leak) current in neurones was first proposed by Hodgkin and 
Huxley as a basis for the resting membrane potential (Hodgkin & Huxley 1952). The primary 
role of  a potassium current in setting the resting membrane potential was then suggested 
(Hille 1973), and around this time it was shown that various anaesthetics, including volatile 
agents, hyperpolarised neurones (Nicoll & Madison 1982) and that halothane exposure 
produced an “anaesthetic-induced” potassium current in Lymnaea stagnalis (Franks & Lieb 
1988). The molecular basis of  the potassium leak current was first described almost a decade 
later with the discovery of  K2P channels in Saccharomyces cerevisiae and Caenorhabditis elegans 
(Ketchum et al. 1995), followed shortly in Drosophilia melanogaster (Goldstein et al. 1996) and 
mammalian systems (Fink et al. 1996; Lesage et al. 1996). 
1.1.1 The potassium leak
The presence of  a “leak” current emerged from the seminal work of  Hodgkin, Huxley, 
Goldman and Katz and was used to explain the resting membrane potential (Goldman 1943; 
Hodgkin & Huxley 1952; Hodgkin & Katz 1949). The electrochemical gradient created by 
active transporters drives the flow of  potassium (K+) ions from the inside of  the cell (high 
potassium concentration) outwards. As K+ ions leave the cell, the intracellular charge becomes 
more negative thus opposing further K+ efflux. Eventually an equilibrium is attained which 
can be described by the Nernst potential, the membrane voltage at which equilibrium occurs 
for a given ion at a given transmembrane gradient. This value is approximately -97 mV for K
+. The final resting membrane potential is determined by the sum of  the effects of  all ions 
crossing the plasma membrane. As K2P channels are open at rest, potassium efflux pulls the 
16
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resting membrane potential towards the Nernst potential for potassium and any increases in 
efflux, such as K2P channel activation, will act to hyperpolarise a cell. 
1.1.2 K2P structure and electrophysiological properties
Two-pore-domain potassium channels vary in structure from other potassium channels with 
each subunit having two pore forming domains, with four transmembrane segments (2P/
4TM (Figure 3). In contrast, voltage-gated potassium channels (KV) have one pore domain 
and six transmembrane segments (1P/6TM) and inwardly rectifying potassium channels have 
one pore domain with two transmembrane segments (1P/2TM). K2P channels form dimers 
and display the following electrophysiological characteristics: (1) weak voltage dependence; (2) 
activation over a physiological range of  membrane potential; (3) exhibit open rectification as 
predicted by the Goldman-Hodgkin-Katz equation (Goldstein et al. 2001). Rectification is the 
preferential movement of  current in a single direction, and open rectification is the flow of  
ions down their electrochemical gradient resulting from unequal (physiologic) transmembrane 
potassium concentrations. In a symmetrical potassium gradient ion flow is linear as described 
by Ohm’s law. In contrast, inwardly rectifying potassium channels have a voltage-dependent 
block resulting in current flow only when the membrane potential is more hyperpolarised 
than the Nernst potential (Figure 3). As many K2P channels are open at rest there is minimal 
delay to current flow in response to a change in voltage. Channel regulation allows control 
over the resting membrane potential and hence cell excitability. Activation of  K2P channels 
results in hyperpolarisation of  the cell membrane and a reduced probability of  action 
potential firing. This regulation is brought about through G protein coupled receptors 
(GPCRs; see below) and physiological factors.
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Figure 3. Membrane structure (top) and current-voltage curves (bottom) for inwardly-
rectifying (Kir, left) and two-pore domain (K2P, right) potassium channels. Kir channels have 
one pore (P) domain and two transmembrane (M) segments whereas K2P have two pore 
domains and four transmembrane segments. Under both symmetrical (sym) and 
physiologic (phys) potassium concentrations Kir channels pass currents only when the pore 
is unblocked, a voltage-dependent event. In contrast, K2P channels exhibit open 
rectification with an outward current over a physiologic range of  membrane potentials. 
Modified from Goldstein et al. (2001) and Hibino et al. (2010).
1.1.4 Nomenclature 
The classification of  K2P channels is an area of  confusion. Initially based on physicochemical 
features, more recent nomenclature systems have been proposed by the Human Genome 
Organisation and the International Union of  Pharmacology (Figure 4)(Goldstein et al. 2005). 
For simplicity, the original physicochemical classification will be used here. The acronym 
TASK refers to “TWIK (“tandem of  P domains in a weak inwardly rectifying K+ channel”)-
related acid-sensitive K+ channel”).
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Figure 4. Cladogram for the 15 identified members of  the human K2P gene family. TASK-1 
and -3 are in red. Naming system is based on the Human Genome Organisation (HUGO) 
assignments (KCNK X, with “X” based on order of  discovery), International Union of  
Pharmacology (K2P X.X) and physicochemical attributes (e.g. TWIK, “Tandem of  P 
domains in a weak inwardly rectifying K+ channel”). Other names based on 
physicochemical attributes are: TASK, “TWIK-related acid-sensitive K+ channel”; 
TRAAK, TWIK-related arachidonic acid-stimulated K+ channel ; TREK, TWIK-related 
K+ channel; TALK, TWIK-related alkaline pH activated K+ channel ; TRESK, TWIK-
related spinal cord K+ channel; THIK, tandem pore domain halothane-inhibited K+ 
channel . Functional channels have not been identified for KCNK 7, 12 and 15. Re-drawn 
and adapted from Goldstein et al. (Goldstein et al. 2005).
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1.2 TWIK-related acid-sensitive K+ channel (TASK) 
channels
The electrophysiological characteristics of  the TASK channels TASK-1 (KCNK 3) and -3 
(KCNK 9) are well characterised by the general properties ascribed to the K2P family, showing 
weak rectification, activity across the physiologic range of  membrane voltages, and little time 
dependence. As their name implies, both channels are inhibited by reductions in pH, a 
property associated with a histidine residue in the first pore domain (Lopes et al. 2001). 
Unfortunately there are currently no known selective blockers of  these channels. As a result, 
identification of  native currents relies on examining electrophysiological and pharmacologic 
properties. Differentiating TASK-1 and -3 channels is based on differences in pH sensitivity, 
with the TASK-3 channel less sensitive to acidity having a pK value of  6.7 while the TASK-1 
channel has a pK value of  approximately 7.3 (Kim et al. 2000; Duprat et al. 1997). Both 
homo- and heterodimer formation has been identified in heterologous expression systems 
(Lopes et al. 2001; Berg et al. 2004). Heterodimer formation with both channels leads to an 
intermediate pH sensitivity, with increasing evidence for their existence in motoneurones 
(Berg et al. 2004; Lazarenko et al. 2010), and the presence of  co-expression (Talley et al. 
2001). Additionally, TASK-3 channels have a greater sensitivity to ruthenium red (Czirjak & 
Enyedi 2003).
TASK-1 and -3 channel regulation has been most studied in cerebellar granule neurones 
(CGNs) (Aller et al. 2005; Brickley et al. 2001b). Channel inhibition, induced by muscarine or 
acetylcholine application, results in cell membrane depolarisation and increased probability 
of  action potential firing (Watkins & Mathie 1996). And this inhibition has been shown to be 
mediated through Gαq (Czirjak et al. 2001; Talley & Bayliss 2002; Besana et al. 2004; Lopes 
et al. 2005). The steps following Gαq activation are the activation of  phospholipase C (PLC), 
which hydrolyses the phospholipid PIP2, generating diacylglycerol (DAG) and inositol 
triphosphate (IP3). In turn, IP3 and DAG stimulate intracellular calcium release and protein 
kinase C (PKC) respectively (Fink et al. 1996; Kim et al. 2000; Czirjak et al. 2001; Chemin et 
al. 2003). Although it is clear that Gαq activation ultimately results in TASK channel 
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inhibition, the relative importance of  the downstream pathways is unresolved. There are 
presently roles indicated for PKC ((Lopes et al. 2000), PIP2 ((Chemin et al. 2003; Lopes et al. 
2005)), and Gαq (via direct channel interaction; Chen et al. 2006; Veale et al. 2007).
In vitro anaesthetic sensitivity was demonstrated for TASK-1 and -3 channels with the volatile 
anaesthetic agent halothane, in addition to other commonly used inhalational anaesthetic 
agents (Meadows & Randall 2001; Patel et al. 1999; Sirois et al. 2000). The site of  this action 
is in the fourth transmembrane domain, substitution of  which abolishes anaesthetic sensitivity 
(Patel et al. 1999; Sirois et al. 2000; Talley & Bayliss 2002). Activation of  TASK-1 by 
halothane is greater (approximately double) than in TREK-1 at the same concentration (1 
mM), and effects are fully reversible (Patel et al. 1999). The same study identified, in the 
TASK-1 channel, a minimal response to chloroform and inhibition by diethyl ether. A very 
similar response to 1 mM halothane was also identified in TASK-3 (65% current potentiation 
at 10 mV; Meadows & Randall 2001).
From in situ hybridisation studies, TASK-1 and -3 channel expression is widespread, including 
the CNS, heart, carotid body and adrenal glands (Aller et al. 2005; Brickley et al. 2007; Talley 
et al. 2001). TASK-3 channels have a wider distribution in the CNS, with areas of  overlap 
with TASK-1 channels in cerebellar granule cells, motoneurones, locus coeruleus and 
thalamus. Interestingly, some of  these areas play roles in the regulation of  sleep and theta 
oscillation generation (see later). Some of  these sites of  expression have been validated with 
the identification of  TASK currents in slice preparations (Patel et al. 1999; Sirois et al. 2000; 
Washburn et al. 2002; Millar et al. 2000; Torborg et al. 2006). These include motoneurones, 
cerebellar granule cells, locus coeruleus, raphe neurones and hippocampal interneurones.
Other than in general anaesthesia, TASK channels have been implicated in oxygen sensing 
by carotid body glomus cells (Buckler et al. 2000; Trapp et al. 2008), and secretion of  the 
hormone aldosterone by the adrenal gland (Davies et al. 2008). Carotid body glomus cells, 
located at the bifurcation of  the carotid artery in the neck, function primarily as sensors of  
oxygen partial pressure and are responsible for hypoxic drive in the face of  hypoxia. TASK-1 
channels were implicated in this mechanism based on the identification of  TASK-like 
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currents in this cell population and recordings in TASK-1 knockout (T1KO), TASK-3 
knockout (T3KO) and TASK-1 and TASK-3 (“double”) knockout (DKO) mouse strains 
(Buckler et al. 2000; Trapp et al. 2008). The use of  TASK-channel knockout strains (male 
DKO and female T1KO) also enabled identification of  a murine model of  primary 
hyperaldosteronism. The steroid hormone aldosterone is produced in the adrenal cortex and 
contributes to systemic regulation of  sodium, potassium and water. Compared to WT, a 
TASK-like current present in WT zona glomerulosa cells (the site of  aldosterone synthesis) 
was absent in male DKO mice (Davies et al. 2008). The authors proposed that the relative 
depolarised state of  the zona glomerulosa cells promoted increased aldosterone production 
irrespective of  normal regulators. 
1.2.1 TASK channels and general anaesthesia
Several papers have been published in the last few years reporting the roles of  TASK-1 and -3 
channels in anaesthetic sensitivity, more specifically their role in loss of  consciousness (LOC), 
response to a nociceptive stimulus and immobilisation (Lazarenko et al. 2010; Linden et al. 
2006, 2007). A summary of  the results will be presented here with a more complete discussion 
in the Discussion chapter.
Using the same strains of  TASK knockout mice as employed in our study, Linden et al. 
reported the results of  a range of  tests including anaesthetic sensitivities in T1KO and T3KO 
animals (Linden et al. 2006, 2007). The T1KO strain was found to have minimal differences 
in basal behaviour compared with WT as assessed by non-interactive observation of  activity 
and subjection to the SHIRPA range of  tests, which include the assessment of  a range of  
reflexes and responses to physical handling. Exposure to halothane identified a reduced 
sensitivity in the knockout using a loss of  tail-clamp withdrawal reflex (LOTW) assay, whereby 
the halothane concentration at which a response (limb or head movement) to clamping of  the 
proximal tail with hemostats was recorded (Figure 5). In contrast, there was no change in the 
loss of  righting reflex (LORR; Figure 5). Assessment of  the effects of  the gene knockout on 
mRNA expression failed to show alterations in the expression of  other K2P members.
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Figure 5. A reduced sensitivity to halothane is displayed by TASK-1 knockout (T1KO) 
animals (-/-) in a loss of  tail-clamp withdrawal (LOTW) assay (p<0.01) compared with 
wild type (WT; +/+), but no strain difference was identified in a loss of  righting reflex 
(LORR) assay. Comparison performed with a Student’s t test. Adapted from Linden et al. 
(Linden et al. 2006).  
A second paper by Linden et al. investigated the anaesthetic sensitivity of  the T3KO strain 
(Linden et al. 2007). As with the T1KO strain, basal behaviour and reflexes did not differ 
greatly from WT. Differences in halothane sensitivity, nocturnal activity and memory were 
identified. Though LORR was not assessed, the LOTW assay revealed a reduced halothane 
sensitivity in the knockout (Figure 6) to a similar degree as that identified in T1KO animals. 
Nocturnal activity (during the lights off  period, the more active period in mice) was assessed 
with the use of  infrared beams to denote movement and T3KO animals exhibited  
significantly greater (38%) activity levels.
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Figure 6. TASK-3 knockout (T3KO) mice (-/-) are less sensitive to wild type (WT; +/+) in a 
loss of  tail-clamp withdrawal (LOTW) assay, requiring a greater halothane concentration 
to prevent movement in response to the application of  a tail clamp, a nociceptive stimulus. 
p<0.01, Student’s t test. Adapted from Linden et al. (Linden et al. 2007).
A recent paper from Lazarenko et al. examined the effects of  halothane on LORR and 
LOTW in 3 strains of  knockout mice; T1KO, T3KO and DKO. They also studied the effect 
of  the knockout strains on the electrophysiological properties of  hypoglossal motoneurones. A 
reduction in halothane sensitivity was identified in all knockout strains in both the LORR and 
LOTW assays. There were no differences between knockout strains (Figure 7). The knockout 
strains had a reduced resting membrane potential (more depolarised) compared with WT, 
though no significant change in input conductance. The application of  halothane also 
resulted in a reduction in membrane potential in all the knockout strains.
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Figure 7. Halothane sensitivity is reduced in TASK-1, TASK-3 and double (both TASK-1 
and TASK-3) knockout strains (T1KO, T3KO and T-KO, respectively) compared with 
wild type (BL/6) with a loss of  tail-clamp withdrawal assay (MAC) and loss of  righting 
reflex assay (LORR). Adapted from Lazarenko et al. (Lazarenko et al. 2010).
1.3 The electroencephalogram (EEG) and cortical EEG
The first record in the literature of  the EEG was as “electric currents of  the brain” by 
Caton in 1875 (Caton 1875) who reported his findings in rabbits and monkeys, including 
noting changes in the EEG resulting from behaviour such as mastication. The term 
“electroencephalogram” was coined by Hans Berger in 1929 (as cited by Haas ;Haas 2003). 
The monitoring of  schizophrenic patients in the 1930s using EEG provided early evidence of  
the effects of  sedative and anaesthetic agents (Lemere 1938). This alteration of  the conscious 
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EEG following drug administration represents a rapidly expanding and lucrative field in the 
application of  EEG-derived parameters for the monitoring of  sedated and anaesthetised 
patients (Anon 2006). There are currently at least six commercially available devices using 
various proprietary algorithms to generate a simple and user-friendly monitor for clinical use 
in humans (Jameson & Sloan 2006).
1.3.1 Oscillations and the EEG
The EEG is a measure of  macroscopic bioelectric currents some of  which are in the form of  
oscillations (Rampil 1998). At the simplest level an oscillation results from a phasic energy 
source providing positive feedback within a system cycling between opposing forces (Buzsaki 
2006) The generation of  current flow resulting from ion flux is a simple example of  this. 
These currents reflect the temporal summation of  electrical activity from individual neurones. 
Excitatory and inhibitory post-synaptic potentials (PSP) are the basis of  the EEG and the 
signal recorded reflects the multitude of  synchronised and asynchronised PSP activity. At the 
level of  individual neurones, their contribution to the local field potential stems from changes 
in transmembrane potential, which in turn depends on current flow across the cell membrane 
via channel opening. Currents can be viewed as sources or sinks depending on the direction 
of  ion flow e.g. the movement of  sodium ions into a cell from the extracellular space would be 
a current sink and vice versa for potassium ions. Passive neurones act as capacitive low pass 
filters, favouring the long-lasting PSPs over action potentials. The longer duration of  PSPs 
(tens of  milliseconds versus a few milliseconds for an AP) also favours the likelihood of  
temporal overlap. The cytoarchitecture of  pyramidal cells in particular favours significant 
PSP formation and temporal summation: the forest of  parallel neurones with distinct sites for 
excitatory and inhibitory inputs generates PSPs which, when combined with shared 
excitatory/ inhibitory sources, come together to favour temporal summation and generation 
of  measurable electrical signals of  sufficient magnitude to be measured at distant sites such as 
the scalp (Rampil 1998; Buzsaki 2006). The timecourse of  PSPs also allows the occurrence of  
synchrony, that is the overlapping of  events in time. This results from the time scale over 
which PSPs occur, favouring the emergence of  one (or more) PSP before the termination of  
the previous one. Of  course there are many factors potentially influencing this likelihood; 
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neurotransmitter release, receptor activity, states of  local channels. And the decay time of  
PSPs is a variable affected by the leakiness of  the cell membrane. Synchrony is favoured by 
inter-cell connectivity as first proposed in the cell assembly hypothesis of  Hebb (Buzsaki 
2006).
The source of  the measured signal reflects the spatial relationship between the measuring 
electrode and the neurones in the local area. Fine electrodes inserted into brain tissue may 
record the activity of  a few hundred neurones whilst measurements made at the level of  the 
scalp or dura will reflect that of  hundreds of  thousands. Furthermore, signal sources may not 
be the neuronal populations closest to the electrode. Cytoarchitecture (see above), the low 
resistance of  neuronal tissue, capacitive currents of  cell membranes and impact of  other 
structures (blood vessels, skull muscles, skin, connective tissue) will all leave an imprint on the 
final signal. The localisation of  EEG sources is a particular challenge in epilepsy and has been 
compared with earthquake epicentre location in seismology (Buzsaki 2006). 
Classification of  the EEG into frequency bands was initiated by Berger, who assigned the 
Greek letter alpha to the first frequency recorded. This nomenclature has been continued, 
with arbitrary delineations between frequency bands leading to some variation in the 
frequencies delimiting ranges (Table 1; Rampil 1998).
Table 1. Commonly used bands for defining EEG frequency ranges. The frequency ranges 
are not strictly defined and published ranges in the literature vary. Adapted from Rampil, 
Buzsaki and Steriade et al. (Rampil 1998; Buzsaki 2006; Steriade et al. 1990).
Interestingly, the theta range of  frequencies in rodents is described as ranging from 3 - 12 Hz, 
thus overlapping with alpha in man (Bland et al. 2003; Steriade et al. 1990). This is the range 
Band
Delta (δ)
Theta (θ)
Alpha (α)
Beta (β)
Beta2 (β2)/ Gamma (γ)
Range (Hz)
0.5 - 3.5
3.5 - 7
7 - 13
13 - 30
30 - 50+
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used for the work presented here.
It should be clarified that the term electroencephalogram is restricted to recordings made 
using scalp electrodes (Figure 8). Recordings made at a deeper level, such as extradural should 
be described as cortical EEG or electrocorticogram (ECoG).
Figure 8. The author having his EEG recorded as part of  a neurophysiology experiment. 
1.4 The Theta oscillation
1.4.1 History
First described in 1938 by Jung and Kornmuller (as cited by Bland; Bland 1986), the theta 
oscillation (sometimes referred to as “rhythmical slow wave”) has remained enigmatic in terms 
of  both formation and function. It is the largest extracellular oscillation of  the mammalian 
brain (Vertes et al. 2004) and has been defined in rodents as a “sinusoidal-like rhythmical slow 
waveform” occurring within the range of  3-12 Hz (Bland et al. 2003).
Two types of  theta oscillation were first described by Kramis et al.(Kramis et al. 1975) and 
designated type 1 and type 2 theta. This followed from earlier work describing behaviours and 
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conditions associated with each type of  theta oscillation (Vanderwolf  1969; Grastyan et al. 
1959). Type 1 theta is associated with voluntary motor movement such as walking, hopping, 
postural shifts, head movements and grooming (Buzsaki 2005). It is characterised by its 
location between 7 - 12 Hz.
Type 2 theta is associated with immobility in the presence of  sensory stimuli, so-called “alert 
immobility” (Vanderwolf  1969). It may be elicited by changes in the immediate environment 
of  the animal, which may be perceived as a threat. For example, sudden sounds, hand 
clapping, hand waving and stroking (Bland 1986). The frequency range at which type 2 theta 
occurs is 4 – 7 Hz. Two further characteristics help define type 2 theta. Firstly, it is unique in 
that it can be induced by exposure to the anaesthetic agents ether (Kramis et al. 1975), 
urethane (Kramis et al. 1975), and halothane (Bland et al. 2003; Robledo 2008), and the 
anticholinesterase eserine (physostigmine; Leung & Vanderwolf  1980; Tebano et al. 1999). 
Secondly, the systemic administration of  the anticholinergic (antimuscarinic) atropine 
sulphate ablates this response (Kramis et al. 1975).
Both theta types are also present during REM sleep (Vertes 1977, 1979; Robinson et al. 
1977).
In this study, our focus was on the theta oscillation based on previous work from our 
laboratory showing perturbation of  the theta oscillation in a T3KO mouse (Robledo 2008). 
Disruption of  this oscillation was fortuitous as it is the dominant oscillation of  the rodent 
brain, thus simplifying the methods necessary for its measurement (Vertes et al. 2004).
1.4.2 Generation
The exact mechanisms of  theta oscillation generation and control remain to be fully 
elucidated. However, a framework exists describing the current understanding of  
contributions from the principle brain areas involved. These are: the nucleus reticularis pontis 
oralis (RPO) of  the rostral pontine reticular formation,  the supramammillary nucleus (SUM) 
and posterior hypothalamus, the medial septum and diagonal band of  Broca (MS/DBB), and 
the hippocampus. Briefly, theta oscillation generation involves a pathway from the brainstem 
(RPO) to the pyramidal cells and interneurones of  the hippocampus, via the SUM and MS/
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DBB. An initially tonic discharge from the RPO is transformed to phasic one in the SUM, 
and the net effect of  excitatory (cholinergic) and inhibitory (GABAergic) projections from the 
MS/DBB to the hippocampus results in theta oscillations (Figure 10 and Figure 11). 
Early work identified a contribution by the reticular formation of  the brainstem, in the form 
of  a tonic discharge, which led to generation of  the theta oscillation (Green & Arduini 1954; 
Petsche et al. 1965, 1962). This was later corroborated by showing that electrical stimulation 
of  the RPO area alone resulted in theta oscillation generation (Vertes 1981; Macadar et al. 
1974). Further elucidation of  the pathways was performed by tracer studies and 
autoradiography, which revealed the RPO was connected with the MS/DBB via an 
intermediary nucleus, the SUM (Vertes 1988; Vertes & Martin 1988). Glutamatergic 
neurones from SUM were shown to project to cholinergic and GABAergic neurones of  the 
MS/DBB and hippocampus (Vertes 1992; Borhegyi et al. 1998; Haglund et al. 1984; Leranth 
et al. 1999; Kiss et al. 2000).
Neurones of  the SUM exhibit a firing pattern in synchrony with theta which remained if  
MS/DBB activity was reversibly depressed with local procaine injections (Kirk & 
McNaughton 1991). Activation of  SUM through electrical stimulation or carbachol (a 
cholinergic agonist) injection resulted in formation of  a theta oscillation (Bland et al. 1990; 
Colom et al. 1991) whereas suppression of  SUM with local procaine injection disrupts theta 
(Bland et al. 1994). Interestingly, the importance of  SUM in theta oscillation generation 
appears to vary with the animal model used: in urethane anaesthetised rats, procaine injection 
into SUM abolishes theta (Bland et al. 1994), whereas in awake rats, procaine injection into 
SUM reduces the frequency of  theta without eliminating it (Kirk & McNaughton 1993). 
Similarly, depression of  the MS/DBB in urethane-anaesthetised rats abolished theta 
oscillations (Yoder & Pang 2005; Steffensen 1995; Bland et al. 1996; Petsche et al. 1962), but 
only resulted in a reduction in theta oscillation amplitude in conscious rats (Kirk & 
McNaughton 1993). Data from our laboratory has shown a similar effect during halothane 
exposure in mice (Figure 9).  Hence there is some debate in the literature as to the relative 
importance of  inputs from SUM versus a sole pacemaker role for the MS/DBB.
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Figure 9. Lidocaine injection into the medial septum of  a wild type mouse (solid white 
arrow) abolishes the theta oscillation induced by halothane. Increasing warmth of  colour 
represents an increase in oscillation power. Adapted from a figure provided by David Carr.
From the MS/DBB cholinergic neurones project on to and excite pyramidal cells and 
interneurones of  the hippocampus (Dutar et al. 1995). GABAergic neurones of  the MS/DBB 
exclusively project on to and inhibit GABAergic interneurones of  the hippocampus (Freund & 
Antal 1988).
Within the hippocampus, recent evidence has shown that multiple dipoles (excitatory and 
inhibitory) from many layers of  the hippocampus summate to produce the local field potential 
which is recorded at the level of  the cortical EEG (Montgomery et al. 2009). The CA1 
pyramidal cell has often been used as the classic example to illustrate theta oscillation 
generation at a single level. They also provide an important contribution to the amplitude of  
the theta oscillation recorded as a local field potential. A large (approximately 40%) reduction 
in theta oscillation amplitude results from irreversible damage to CA1 pyramidal cells 
(Buzsaki et al. 1989). The major contribution of  CA1 pyramidal cells to theta oscillations 
31
32
33
results from various unique features. Their large dendritic trees (relative to CA3; Pyapali et al. 
1998), which receive excitatory input from the EC and CA3 (inhibitory inputs are confined to 
perisomatic regions and the axon initial segment), may help establish a larger current sink-
source gradient, they form the final link in a chain of  inhibition-excitation reflecting the 
activity of  downstream connections (MS/ DBB) and their sheer mass of  numbers ensures that 
the final output (local field potential) reflects synchronous activity. At the pyramidal cell, the 
balance of  inhibitory and excitatory inputs result in theta oscillation generation. Inhibitory 
inputs arise from the MS/DBB via inhibitory interneurones. GABAergic neurones of  the 
MS/DBB project on to inhibitory (GABAergic) interneurones resulting in disinhibition of  the 
pyramidal cell in the perisomatic region. Excitatory cholinergic (and glutamatergic) input 
arises from the MS/DBB and entorhinal cortex (EC). These dipoles modulate the incoming 
pacemaker rhythm, altering the amplitude of  the theta oscillation. Several lines of  evidence 
for this interplay of  dipoles in CA1 pyramidal cells exists, including current source density 
analysis (Buzsaki et al. 1986; Brankack et al. 1993) and intracellular recordings (Pyapali et al. 
1998; Kamondi et al. 1998).
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Figure 10.Overview of  structures and pathways involved in generation of  the theta oscillation 
in the brain. Tonic discharge from the nucleus reticularis pontis oralis (RPO) of  the rostral 
pontine reticular formation is converted to a rhythmic discharge by the supramammillary 
nucleus (SUM) which in turn projects on to the medial septum/ diagonal band of  Broca 
(MS/DBB). Cholinergic projections from the MS/DBB provide excitatory inputs to the 
pyramidal cells and interneurones of  the hippocampus. GABAergic projections provide 
inhibitory inputs to interneurones. Excitatory inputs also arrive from the entorhinal cortex 
(EC). See text for further details.
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Figure 11.Overview of  excitatory and inhibitory connections between the medial septum and 
diagonal band of  Broca (MS/DBB), entorhinal cortex (EC) and hippocampus. Excitatory 
cholinergic (ACh; solid red lines) projections from the MS/DBB project on to pyramidal 
cells and inhibitory interneurones of  the hippocampus. Pyramidal cells also receive 
excitatory (glutamatergic; interrupted red lines) input from the EC. Inhibitory GABAergic 
(GABA; solid black lines) inputs from the MS/DBB terminate on interneurones, and from 
interneurones on to pyramidal cells. The end result is the generation of  a theta oscillation. 
See text for further details.
1.4.3 Theta oscillation differentiation
As described above, the two types of  theta oscillation are classified according to associated 
behaviours and response to pharmacological agents. The type 1 theta oscillation (7 - 12 Hz) is 
associated with voluntary motor movement such as walking and grooming and is not 
disrupted by atropine sulphate administration (Buzsaki 2005). In contrast, the type 2 theta 
oscillation (4 – 7 Hz) is associated with alert immobility
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(Vanderwolf  1969). Furthermore, it is induced by the anaesthetic agent halothane (Bland et 
al. 2003; Robledo 2008), the anticholinesterase eserine (physostigmine) (Leung & Vanderwolf  
1980; Tebano et al. 1999), and is abolished by atropine sulphate administration (Kramis et al. 
1975).
Type 1 theta oscillation
The mechanisms underlying the generation of  this theta oscillation remain to be fully 
elucidated. Kamondi et al (Kamondi et al. 1998) showed that surgical removal of  the EC in 
rats resulted in the transformation of  a type 1 theta oscillation to one resembling type 2 in its 
amplitude and frequency profile, and in its sensitivity to atropine. These results indicated that 
EC inputs are necessary for type 1 theta oscillation generation and Buzsaki (Buzsaki 2002) 
postulated that the pathway generating type 1 theta oscillation was sensitive to perturbations 
by urethane. Work by Leranth et al. (Leranth et al. 1999) and Moroni et al. (Moroni et al. 
1981) showing that the EC contains glutamatergic neurones and that urethane interferes with 
presynaptic glutamate release, draw attention to a potential role for this neurotransmitter.
Type 2 theta oscillation
The mechanism(s) through which atropine sulphate ablates type 2 theta oscillations is unclear. 
Although muscarinic cholinergic receptors are widespread in the hippocampus and MS/DBB 
(Hasselmo & Fehlau 2001; Buzsaki 2002), there is no evidence that direct action of  
acetylcholine receptors on pyramidal cells within the hippocampus is responsible for the 
ablation of  type 2 theta oscillation. The time course of  onset and decay effects on synaptic 
field potentials was judged to be too slow to contribute to theta oscillation generation, with 
time constants at least double those in response to GABA application (Hasselmo & Fehlau 
2001). Furthermore, following surgical removal of  the EC and creation of  an atropine 
sensitive theta oscillation current source density analysis revealed that the dipoles responsible 
for this oscillation were not associated anatomically with known sites of  cholinergic receptors 
(Kamondi et al. 1998; Buzsaki 2002). Instead, atropine is likely to exert its effects through 
inhibitory interneurones of  the hippocampus (Buzsaki et al. 1983; Stewart & Fox 1990). This 
effect may be mediated through TASK channels, as channel inhibition resulted from 
muscarine administration (Watkins & Mathie 1996).
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1.4.4 Interneurones and the theta oscillation
The GABAergic interneurones of  the hippocampus perform the role of  regulating pyramidal 
cells through inhibition. The large number of  interneurones identified and their myriad 
connections, to each other in addition to pyramidal cells, provides a massive potential for 
encoding information through a temporal mechanism (O'Keefe & Recce 1993; Buzsaki 2002; 
Klausberger & Somogyi 2008).   
Increasingly, a central role for inhibitory interneurones has been identified in the control of  
the theta oscillation (Buzsaki et al. 1983; Klausberger & Somogyi 2008; Freund & Antal 
1988). Projections from the GABAergic neurones of  the MS/DBB target hippocampal 
interneurones exclusively (Freund & Antal 1988). These anatomical connections place them 
in a powerful position in terms of  affecting theta oscillation generation and modulation 
(Figure 12). The precise role of  these interneurones is a rapidly expanding field, with at least 
21 classes of  interneurones identified in the hippocampus (Klausberger 2009). Evidence of  
the contribution of  these interneurones to theta oscillations is that they discharge out of  phase 
with the pyramidal cell they innervate, reflecting the rhythm at the heart of  theta oscillations 
(Fox et al. 1986). Unlike pyramidal cells, their study is hindered by difficulties in identifying 
separate classes in the normal brain based on morphology. Their classification is based on 
their innervation patterns of  pyramidal cell components and molecular expression. Two 
particular classes of  interneurones, parvalbumin (PV)-expressing and cholecystokinin (CCK)-
expressing, have been identified of  interest  based on their interactions with CA1 pyramidal 
cells and phasic firing during the theta oscillation (Klausberger et al. 2004, 2003, 2005). The 
specific interaction between the timing of  firing and the location of  inputs on pyramidal cells 
allows interneurones to modulate pyramidal cell firing, and in turn, theta oscillations. These 
attributes have been described as a “spatiotemporal interaction” (Klausberger & Somogyi 
2008). For example, the firing of  PV-expressing basket cells during the descending phase of  
the theta cycle, combined with their perisomatic input on pyramidal cells  contributes to the 
inhibition of  the pyramidal cell innervated (Klausberger et al. 2003). Inhibition (GABAergic) 
through hyperpolarisation of  the pyramidal cells alters local theta formation with potential 
effects on the local field potential depending on the relative contribution of  the inhibited 
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pyramidal cell.
Another line of  evidence for the role of  inhibitory interneurones is the finding that 
simultaneous blocking of  excitatory and inhibitory inputs of  the hippocampus resulted in 
increased firing rates, suggesting that primary hippocampal modulation is through inhibition 
(Cohen & Miles 2000). 
Figure 12.Cartoon depicting the interaction between inhibitory GABAergic interneurones 
and a CA1 pyramidal cell of  the hippocampus. The variation in projection sites of  the 
interneurones promotes modulation of  pyramidal cell activity. PV is parvalbumin 
expressing. CCK is cholecystokinin expressing.
1.4.5 Halothane and type 2 theta oscillation
Bland et al. (Bland et al. 2003) showed that sub-anaesthetic doses of  halothane induced the 
formation of  a type 2 theta oscillation in rats. This effect of  halothane has since been 
37
38
39
observed in wild type mice in our laboratory (Robledo 2008). Halothane involvement in the 
generation of  a theta oscillation involves actions on both hippocampal interneurones and 
pyramidal cells of  CA1. Nishikawa and MacIver  (Nishikawa & MacIver 2000, 2001) showed 
that the application of  clinically relevant concentrations of  halothane resulted in 
enhancement of  GABAergic synaptic inhibition via depression of  evoked EPSCs. This action 
of  halothane is a potential mechanism for the generation of  type 2 theta in response to 
halothane exposure. An alternative mechanism for the action of  halothane could be through 
the activation of  TASK channels. The observation that the expected induction of  a type 2 
theta oscillation was absent in T3KO mice points to a central role of  TASK-3 channels in a 
halothane-induced type 2 theta oscillation (Robledo 2008). 
1.4.6 TASK channels and the theta oscillation
The contribution of  TASK channels to the resting membrane potential places them in an 
important position to alter membrane conductance and potentially affect the theta oscillation. 
The results of  in situ hybridisation studies have identified the presence of  TASK-3 mRNA in 
the brain areas implicated in the generation of  theta oscillations (hippocampus pyramidal cell 
layer, MS/DBB, RPO, SUM, hippocampal interneurones). In contrast, TASK-1 mRNA 
expression is more restricted, with lower levels of  expression in the hippocampus CA1 
pyramidal cell layer and interneurones (Brickley et al. 2007; Talley et al. 2001). Recently, 
TASK-like currents have been identified in interneurones populating the stratum oriens layer 
of  the hippocampal CA1 region (Torborg et al. 2006) and pyramidal cells (Taverna et al. 
2005). The location of  these cell populations at the end of  the theta oscillation generation 
pathway could explain some of  the observed in vivo differences between T3KO and WT mice 
during halothane exposure.
1.4.7 TASK channel expression and sleep
The uneven expression of  TASK mRNA in the structures associated with theta oscillation 
generation (see above) is continued in those structures associated with the onset of  sleep. 
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These include the pre-optic area of  the hypothalamus, reticular and thalamo-cortical relay 
neurones of  the thalamus, and components of  the ascending reticular acitvating system 
(tuberomammillary nucleus, lateral hypothalamus, locus coeruleus, dorsal raphe nucleus) 
(McCarley 2007). TASK-3 mRNA expression was found to be more pronounced in all of  
these areas, except for the lateral hypothalamus (similar expression levels) and pre-optic area 
(greater TASK-1 expression) (Talley et al. 2001). This differential expression may underlie 
previous findings in our laboratory that T3KO animals had a slower transition between wake 
and sleep periods (Robledo 2008) and warrants further investigation in the T1KO and DKO 
strains.
A detailed discussion of  the regulation of  sleep in the context of  the results is in the 
Discussion chapter.
1.5 Aims and hypothesis
As identified at the beginning of  this chapter, three criteria have been identified for the 
assessment of  putative anaesthetic targets: plausibility, sensitivity and the effect in in vivo 
models (Franks 2006). Previous studies have shown that TASK channels are a plausible 
anaesthetic target based on relevant expression within the brain and that they have in vitro 
sensitivity to halothane. The purpose of  this investigation is to explore the effect of  
anaesthesia in 3 transgenic mouse strains: TASK-1 knockout (T1KO), TASK-3 knockout 
(T3KO) and double knockout (DKO; TASK-1 and TASK-3 channels deleted).
The aims of  this study are two fold. Firstly to test the hypothesis that T1KO, T3KO and 
DKO animals have altered behavioural phenotypes compared with wild type animals. These 
phenotypes include differences in the response to halothane, as measured using a LORR 
assay and the cortical EEG, and differences in the regulation of  sleep. Secondly, significant 
differences will be further investigated by patch clamp recording in brain slices under control 
conditions and during exposure to halothane. 
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2.0 Materials and methods
All experiments were carried out in accordance with the United Kingdom Animals (Scientific 
Procedures) Act 1986 and were approved by the Ethical Review Process Committee of  
Imperial College. Procedures were performed under Home Office licence (PPL 70/6811). 
wild type mice were C57/Bl6 and provided by Harlan (UK). Unless stated otherwise, all 
animals were male and between 8 - 20 weeks old. All knockout animals were originally 
provided by Professor William Wisden (Cell Biology and Functional Genomics Section, 
Imperial College, London, UK). Animals were housed in standard plastic cages (33 x 14.5 x 
12 cm) in a humidity and temperature controlled room, under a 12:12 hr light-dark cycle with 
lights off  at 0800. Water and food were provided ad libitum. Cages were inspected twice daily 
and cleaned once weekly.  
2.0.1 Creation of  knockout mouse strains and genotyping
All knockout strains (T3KO, T1KO and DKO) were created by homologous and insertional 
recombination (Aller et al. 2005; Brickley et al. 2007) Data for DKO is unpublished. 
Confirmation of  targeted gene deletion was by in situ hybridisation and real-time PCR. Gene 
deletion did not affect the expression of  other K2P channels.
Animals were genotyped upon completion of  each set of  experiments.
To confirm the genetic identity of  experimental animals, template DNA was 
amplified by specific primers  using the polymerase chain reaction (PCR): 
T1KO
Forward: 5’-GACCCGGGAGGGACGATGAAG-3’ 
Reverse: 5’-GGTGATGACGGTGATGGCGAAGTA-3’ 
pIRES
Forward: 5’-TAAGGCCGGTGTGCGTTTGTCTAT-3’
Reverse: 5’-TGGGGTACCTTCTGGGCATCCTTC-3’
T3KO
Forward: 5’-TCTGTCCCGGCTACCGATCCTGC-3’ 
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Reverse: 5’-TTCCGTGGGCGCAGCGGGTTCCGC-3’ 
(Sigma, UK)
DKO
The 3 sets of  above primers used.
Samples of  ear (approximately 2 mm2) were digested with 10 μL of  5x buffer PCR, 1.25 μL 
proteinase K and made up to 50 μL with 38.75 mL miliQ water. Digestion was for 40 
minutes at 55 ◦C, then 10 minutes at 95 ◦C.
The PCR reaction was carried out using the “Go Taq Green Master Mix” kit (Promega, 
UK). 3 - 5 μL of  DNA was combined with 2.5 μL primer (10 μM), 12.5 μL Mastermix, 3.75 
μL miliQ water and 1.25 μL DMSO.
The following PCR steps were used: 
5 minutes at 95 ◦C, followed by 35 cycles of  1 minute at 95 ◦C, 1 minute at 60 ◦C and 1 
minute at 72 ◦C, then 5 minutes at 72 ◦C and held at 4 ◦C. 
Each sample was then run on a 1.3 % agarose gel using 1 x TAE running buffer and 
compared against a 1500 bp DNA ladder (Promega, UK). Gels were run for 1h at 90 V and 
visualised following 20 minutes ethidium bromide application, followed by a wash step with 
water. Controls of  miliQ water and the PCR ingredients without DNA were used to check for 
contamination.
2.1 In vivo experiments
2.1.1 Animal Instrumentation
A combination of  sterile (autoclaved) and disposable instruments were used for all surgeries. 
Each animal was weighed before surgery to allow accurate drug dosage. General anaesthesia 
was induced by placing the animal in a Bell jar with the fresh gas outlet tube from a precision 
vaporiser  (ForTec, Cyprane, UK) through which halothane (Sigma-Aldrich, MO, USA) was 
carried in oxygen (BOC, , UK). Gas flow rate was controlled by a flowmeter set to 1-2 L 
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min-1. This was reduced to 0.5 L min-1 once the animal was induced.  Once the animal had 
lost its righting reflex, periodically tested during induction, the animal was removed from the 
Bell jar and placed on the work surface with its nose in front of  the fresh gas outlet tube. 
Following clipping of  the fur overlying the skull, disinfection of  the skin with iodine solution, 
subcutaneous administration of  buprenorphine (0.03 mg kg-1, Vetergesic, Alstoe, UK) and 
0.9% normal saline (0.5 mL), the animal was transferred to the stereotaxic frame (Harvard 
Apparatus, UK). Topical lubricant (Lacrilube, Aller-Gan, UK) was applied to eyes. Within the 
frame, the animal’s body was supported by a battery-powered heat pad (Right Spot Far Infra-
Red, Small Pad, Equine Right Spot, UK) and the head securely held in place using a tooth 
bar and nose clamp (Harvard Apparatus, UK). Depth of  anaesthesia was assessed by 
pinching a hind foot prior to the initial incision and regularly assessed during the surgery. If  
there was no withdrawal reflex, surgery commenced with a skin incision. The skin incision 
extended along the midline from just rostral to the lateral canthi of  the eyes to the caudal 
border of  the ears. 
Skin was held clear of  the surgical field by placing stay sutures at each corner of  the incision. 
A scalpel blade was used to scrape away the periosteum of  the skull and the skull was 
prepared for later cementing by cleaning with 70% ethanol, applied using a cotton bud. 
Proposed sites for cortical electroencephalograph (ECoG) electrode placement were measured 
and marked with a marker pen prior to drilling. 
The following sites were identified (Figure 13):
-1.5 mm Bregma, +1.5 mm midline (recording electrode)
+1.5 mm Bregma, -1.5 mm midline (recording electrode)
-2 mm Lambda, 0 mm midline (reference electrode)
-1.5 mm Bregma, -2.0 mm midline (anchoring screw)
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Figure 13.Cartoon of  dorsal surface of  mouse skull showing recording electrode (x) and 
anchoring screw (o) sites. Recording and reference electrodes were placed using 
coordinates relative to Bregma (B; point of  convergence of  skull suture lines) and Lambda 
(L; point of  convergence of  skull suture lines). Recording electrodes: -1.5 mm Bregma, 
+1.5 mm midline and +1.5 mm Bregma, -1.5 mm midline. Anchoring screw: -1.5 mm 
Bregma, -2.0 mm midline Reference electrode: +2 mm Lambda, 0 mm midline. Dashed 
lines are suture lines.
Holes were drilled using a hand-held battery-powered drill (Dremel Model 800, Dremel 
Europe, NL) with a 1.0 mm drill bit (Figure 14). The recording electrodes were gold plated 
(Decolletage AG, Switzerland; 2 mm diameter and 2.6 mm length) and the anchoring screw 
stainless steel. The recording electrodes were soldered to insulated multi-strand stainless steel 
wire prior to surgery to minimise surgical duration and avoid soldering the electrodes once 
they were inserted in the skull. Three further electrodes were placed in the nuchal muscles to 
enable electromyographic (EMG) recording. These electrodes were fashioned from stainless 
steel insulated wire, with the plastic insulation removed from the last 4-5 mm of  each end and 
coated with solder. One end of  each EMG electrode was buried within three distinct sites in 
the neck musculature by forming the tip into a hook. The opposite ends were soldered to the 
Neurologger prior to surgery to reduce the surgical duration. The connecting wires were pre-
cut to 4-5 cm lengths prior to surgery. 
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Figure 14.Photos showing skull before (left) and after (right) placement of  skull electrodes. 
Prior to insertion of  the skull electrodes the periosteum overlying the bone was removed 
and the surface cleaned. The surgical field was maintained with stay sutures and the 
animal’s position fixed with a nose bar. Electrodes (3 gold-plated, recording; 1 stainless 
steel, anchoring) were positioned relative to bregma and lambda (see text for coordinates). 
General anaesthesia was maintained with halothane carried in oxygen.
Once all the skull electrodes had been placed, they were covered with an initial layer of  dental 
cement (Orthoresin, DugDent, Dentsply, Germany). As this dried (approximately 10 minutes), 
the remaining free ends (3 x ECoG electrodes) were soldered on to the connector board. After 
connection of  the electrodes to the connector board, the board was positioned at a slight 
upward angle (≃10◦) to the plane of  the dorsal surface of  the skull and held in place with the 
aid of  artery forceps whilst a second, final layer of  dental cement was laid. This second layer 
encased the wires and fixed the connector board in position. Care was taken to ensure that 
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the angle of  the connector board (and Neurologger once attached) would not impede the 
animal’s movement in its cage. Any gaps at either extremity of  the skin incision were sutured 
close and the animal allowed to recover from anaesthesia. Recovery took place in a standard 
mouse cage under a heat lamp. The animal was observed until it started to move, at which 
point food and water were placed in the cage. To allow for adequate post-operative 
observation, surgeries were performed early in the day. Haemorrhage was negligible during 
instrumentation surgeries. Post-operative analgesia and antibiosis consisted of  carprofen 
(Rimadyl, Pfizer, UK) and enrofloxacin (Baytril, Bayer, UK) respectively. Both were 
administered in drinking water at a concentration of  100 ppm, for 3 days in the case of  
carprofen and 5 days in the case of  enrofloxacin. During the first 2-3 days after surgery, food 
pellets and water were placed on the floor of  the cage to minimise the effort required to feed. 
2.1.2 Cortical EEG recording device: Neurologger 2
The Neurologger is a wireless electronic recording device developed by Dr Alexei Vyssotski 
(Institute of  Neuroinformatics, University of  Zurich, Switzerland). The memory capacity of  
the device we used was 256 Mb, though devices have recently been developed with larger 
capacities. Its dimensions are 22 x 15 x 5 mm (l x w x h) and total weight (including batteries; 
2 x 10ZA hearing-aid batteries) of  approximately 2 g (Figure 15). The greatest advantage 
conferred by the wireless design was the potential to record potentially normal behaviour, 
previously limited by the use of  tethered recording systems (Figure 16). The duration of  
recordings was limited by sampling frequency and battery capacity. The 400 Hz sampling 
frequency used allowed recordings of  up to 30 hours, enough to record a complete light-dark 
cycle. Data recording was activated by completing the electrical circuit between the batteries 
and the Neurologger board with male and female gold-plated connectors. Following 
completion of  an experiment the recording was stopped by disconnecting the batteries. Data 
was downloaded by connecting the Neurologger to a PC via a USB interface and using 
proprietary software (Downloader, A Vyssotski). This file could then be read by the software 
used for EEG analysis, Spike2 (v 5.14 Cambridge Electronic Design, UK). On-line filtering 
performed by the Neurologger was a bandpass filter between 1 and 70 Hz. Off-line filtering 
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performed with Spike2 consisted of  a bandpass filter for the EMG data of  5-45 Hz (-3 dB), 
and a low pass filter of  1.0 Hz (-3 dB) for EEG data.
Figure 15.The Neurologger with batteries fitted.
Figure 16.Mice before (left) and after (right) Neurologger fitting. The photograph on the left 
shows the connector cemented in place with connecting pins exposed ready to accept the 
Neurologger (right). The Neurologger is covered with masking tape to protect it from 
water damage. 
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2.1.3 Loss of  righting reflex (LORR) assay
The aim of  this experiment was to assess any changes in anaesthetic sensitivity visible as a 
phenotypic alteration in response to exposure to halothane.
The animal was placed in a glass chamber with a volume of  900 mL (Figure 17). The lid of  
the chamber had 3 separate ports: one for delivery of  gas, one for evacuation of  gas and one 
for gas sampling. The gas analyser (Capnomac II, Datex, Division of  Instrumentarium 
Corporation, Finland) was connected to a PC (Sony Vaio, PCG-141C, Sony Corp., Japan) 
running monitoring software (Monitor v4.08, Department of  Anaesthesia and Intensive Care, 
Chinese University of  Hong Kong). Following placement in the chamber, 100% oxygen was 
delivered from a cylinder and through a flowmeter and calibrated anaesthetic vaporiser 
(ForTec, Cyprane Ltd, UK) at a flow rate of  4 L min-1. After a baseline period of  10 minutes, 
administration of  halothane began. A step-wise increase in agent concentration was 
delivered, from low to high. Each concentration was maintained for 10 minutes (based on 
time constant calculation to ensure a change in the gas  contents of  the chamber) and the 
concentration recorded from the gas analyser and saved as a .xls file by Monitor software. 
Immediately prior to an increase in concentration, the loss of  righting reflex was assessed. 
This was done by manually rotating the glass jar in an attempt to roll the animal onto its 
dorsum. A positive response i.e. loss of  righting reflex was when all four feet were off  the 
ground for a minimum period of  30 seconds. Each animal was tested once at each 
concentration. Once LORR was achieved the agent concentration was increased by a single 
step and LORR re-assessed. Normothermia was maintained throughout with a heat lamp. 
Waste gas was actively scavenged using a Fluovac system (Harvard Instruments) or evacuated 
through a window. All experiments were performed during the dark (wake) period of  the 
animals’ day. The experimenter was blinded to the strain of  the animal and animals identified 
by ear notch identification.
The results of  the LORR assay were subjected to a Waud analysis (Zivin & Waud 1992) and 
the resultant values for EC50 and slope used to fit a sigmoidal dose response curve. Data were 
plotted with graphical software (GraphPad Prism v4.0c, GraphPad, CA, USA).
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Strains studied using LORR assay (and anaesthetic agents used):
Wild type (halothane and cyclopropane)
DKO (halothane and cyclopropane)
T1KO (halothane and cyclopropane)
T3KO (halothane and cyclopropane)
A potential effect of  gender was assessed by performing separate experiments with female 
animals.
For halothane, the following concentrations (% atm.) were delivered: 0.4, 0.5, 0.6, 0.7, 0.8, 
0.9, 1.0, 1.1. For cyclopropane, 8, 12, 16, 20 and 25% concentrations were used. As 
cyclopropane is a gas at room temperature it was mixed with oxygen via an agent specific 
flowmeter. The following step-wise increments of  cyclopropane were added to 500 mL min-1 
of  oxygen until one step beyond LORR: 40, 60, 80, 100, 125 mL min-1. These flow rates 
resulted in the following percentage concentrations of  cyclopropane when mixed with 0.5 L 
min-1 O2: 8, 12, 16, 20, 25% respectively.
Data were compared using a one-way ANOVA and Bonferroni's post hoc test and P < 0.05 was 
considered significant. The comparison between female animals was performed with an 
independent t-test. 
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Figure 17. Cartoon of  equipment used to assess loss of  righting reflex (LORR). The rotating 
chamber in which the mouse was placed sat on two metal rods (grey), allowing smooth 
rotation of  the chamber. The lid of  the chamber had ports for gas entry (oxygen + 
anaesthetic agent), gas sampling (to the gas analyser) and scavenging. A heat lamp was 
positioned at a fixed distance for all experiments to maintain normothermia. LORR was 
assessed once at baseline and at each concentration of  anaesthetic. A positive response 
(loss of  LORR) was recorded as the animal was rotated on to its dorsum with four feet off  
the ground for 30 seconds. Data was analysed with Waud analysis (Zivin & Waud 1992) 
and results used to fit a sigmoidal dose-response curve.
2.1.4 Halothane exposure assay
The aim of  this experiment was to record the variation in ECoG during exposure to 
increasing levels of  halothane on DKO, T1KO and T3KO mice compared with WT.
Each animal was placed in a clear perspex chamber (28 x 28 x 20 cm) which had a tight-
fitting lid and ports for oxygen and anaesthetic gas entry, gas sampling and scavenging. 
Following connection to the Neurologger and initiation of  the gas monitoring, a baseline 
period of  at least 5 minutes in room air occurred. After this, halothane carried in 8 L min-1 of  
oxygen was delivered through two ports in the lid of  the gas tight chamber. A step-wise 0.1% 
increase in halothane concentration was delivered, with an increase in concentration every 10 
minutes, from 0.4 – 1.0%. Two final concentrations of  1.2 and 1.5% were also administered. 
Halothane concentrations were monitored and recorded as described above for the LORR 
assay. Waste gas was collected by a gas scavenging system (Fluovac, Harvard Apparatus, UK). 
The last 5 minutes of  each concentration step, when halothane concentration had stabilised, 
was used for data analyses. Power spectra were drawn from 5 minute epochs of  ECoG data, 
following Fast Fourier Transformation (FFT). (Cooley & Tukey 1965) To allow quantitative 
analyses and comparisons of  power spectra between strains, a Lorentzian curve was fitted to 
peaks identified within the theta frequency band (4 – 12 Hz) using graphing software 
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(Microcal™ Origin™ v 5.0, MA, USA; Figure 18). Where more than one peak was identified 
within the theta frequency band, the Lorentzian curve was fitted to the highest identifiable 
peak. In all cases, there was an easily-identifiable, dominant peak. From fitting of  the 
Lorentzian curve the following parameters were generated or calculated:  peak frequency, full 
width at half  magnitude (FWHM) and Q value (peak frequency/ full width at half  
magnitude; Figure 19).  
Figure 18.Identifiable peaks in the power spectra within the theta frequency band (4 - 12 Hz) 
were fitted with a Lorentzian curve. Two examples of  power spectra from wild type (WT) 
and TASK 3 knockout (T3KO) animals during exposure to halothane, before (left column) 
and after (right column) fitting of  the Lorentzian curves (red).
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Figure 19. Cartoon depicting the parameters derived from the Lorentzian curve fit: peak 
frequency (Peak Fq), full width at half-magnitude (FWHM, Hz; the frequency range is 
depicted by two vertical black bars.) and Q value (= peak fq / FWHM).
Comparisons of  Lorentzian curve fit data between strains for peak frequency, full width at 
half-magnitude and Q value were tested with two-way ANOVA for repeated measures with 
Bonferroni post hoc tests.
2.1.5 Halothane and atropine sulphate assay
The peak induced by halothane has been classified as a type 2 theta oscillation (Bland et al. 
2003). A defining feature of  this oscillation is that it is ablated by the systemic administration 
of  atropine sulphate (Kramis et al. 1975). Following observations by Robledo that the 
halothane induced theta oscillation in T3KO animals was sensitive to atropine (Robledo 
2008), this sensitivity was tested in T1KO animals, compared to WT. Additionally, the 
comparison between T3KO and WT was repeated.
The assay was performed with the animal in the same 900 mL glass chamber as that used for 
the LORR assay. The Neurologger was fitted immediately prior to experimentation. Each 
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animal was exposed to 4 levels of  halothane: 0%, 0.8%, 1.0% and 1.2%. Halothane was 
carried in oxygen and each step was maintained for 10 minutes before progression to the 
higher concentration. Each animal acted as its own control in a cross-over design. A saline 
control of  equal volume to the required atropine dose was used. Drugs were 
administered intraperitoneally (IP). The order of  drug administration was randomised 
but the experimenter was not blind to the drug administered. A minimum of  one week was 
left between the control and the atropine sulphate (Sigma-Aldrich, UK)  injection experiment. 
The atropine dose was 50 mg kg-1. Drugs were administered at the end of  the baseline (0% 
halothane) period. 
Data from individual animals was used to draw power spectra (using epochs from the last 5  
minutes at each concentration). The peak power for an identifiable peak within the type 2  
theta oscillation range of  frequencies was normalised to control and the percentage change 
(relative to control) in the type 2 theta oscillation between control and atropine conditions 
calculated for each concentration of  halothane. The numbers of  animals used from each 
strain, were as follows: T1KO, n = 6; WT, n = 3; T3KO, n = 3. An identical experiment was 
performed with isoflurane in place of  halothane to assess the impact of  atropine on type 2 
theta oscillation (T1KO, n = 6; WT, n = 4; T3KO, n = 4). 
2.1.6 Intraperitoneal eserine (physostigmine) assay
The aim of  this experiment was to investigate if  the type 2 theta oscillation induced by 
halothane could also be induced by a second drug, eserine.
Eserine (also known as physostigmine) is an anticholinesterase which has been shown to 
induce Type 2 theta oscillations when administered in a rats and mice (Leung & Vanderwolf  
1980; Tebano et al. 1999). Its administration prevents the enzymatic breakdown of  
acetylcholine in the brain. A dose of  0.2 mg kg-1 of  eserine or the equivalent volume of  saline 
control was administered IP to mice (T3KO, n=3; WT, n=3) instrumented for the 
Neurologger. Following a baseline period of  10 minutes, the drug/ control was administered 
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and the cortical EEG recorded for 40 minutes. Data was downloaded from the Neurologger 
and a five minute epoch was analysed (as described above) and used to draw power spectra.
2.1.7 Sleep assay
Sleep recordings were performed with the animals in an isolated box which was fitted with 
foam padding to minimise the effects of  external noise. The light: dark cycle was maintained 
as usual. The external dimensions of  the box were 80 x 60 x 50 cm. In order to accustom 
animals to the weight and dimensions of  the Neurologger, each animal was fitted with a mock 
Neurologger for four days preceding the experiment. The mock Neurologger consisted of  a 
piece of  circuit board identical in size to the actual Neurologger and weighted with tape and 
dental cement to match the weight of  the actual Neurologger. At the same time, the animal’s 
home cage was modified to allow for the presence of  the Neurologger: the wire frame 
forming the lid, food hopper and water bottle support was turned upside down and taped in 
place, and a hole was drilled in the end wall of  the cage to receive the spout of  a drinking 
bottle. Food was distributed on the floor of  the cage rather than in the lid. This modification 
markedly reduced the risk of  the Neurologger catching on the wire of  the lid. Climbing 
behaviour was still observed.
On the day of  the experiment, the mock Neurologger was replaced with the real one 2 - 3 
hours before the start of  the light period. Access to the experimental room was closed to all 
personnel until termination of  the experiment. Each recording period lasted 30 hours.
2.1.7.1 Analysis of  sleep data
Following the downloading and filtering of  data (as previously described) the sleep data was 
scored using a script with the Spike2 software. This script was created for us by Geoff  
Horseman at Cambridge Electronic Design (CED) and based on the sleep score of  Costa-
Miserachs et al. (Costa-Miserachs et al. 2003). Using the recorded EMG and EEG data, the 
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score identified three states: awake (W), NREM sleep (N), and REM sleep (R). A fourth state, 
doubt (D), was produced if  data could not be defined as one of  the other three states.
The general basis for classification of  behaviour according to EEG and EMG data were: 
awake = high EMG and intermediate theta: delta ratio; NREM sleep = low EMG, low theta: 
delta ratio, high delta; REM sleep = low EMG, high theta: delta ratio.
The first step in generating the sleep score was the extraction of  delta and theta oscillations 
from the filtered EEG signal with bandpass filters and the creation of  new data channels 
within the Spike2 window for delta and the theta: delta ratio. Along with the EMG channel, 
this information was used as a basis for an initial score performed on consecutive 5 second 
epochs of  data (Figure 20), applied to the entire recording. Epochs not categorised as wake, 
NREM sleep or REM sleep were scored as doubt.
Figure 20.Logic rules applied for initial detection of  sleep-wake states. Xobs td, Xobs emg and Xobs 
delta are the mean observed values from 5 sec epochs for the theta:delta ratio, EMG and 
delta oscillation respectively. Xdelta, Xemg and sdemg are mean delta and EMG and standard 
deviation of  EMG for the entire recording. W, NREM and REM are wake, NREM sleep 
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and REM sleep respectively. Adapted from Costa-Miserachs et al. (Costa-Miserachs et al. 
2003)
The identified wake, NREM sleep and REM sleep periods resulting from the initial scoring 
were used as a template to score remaining epochs initially scored as doubt. Mean and SD 
values generated from the initial identification of  wake, NREM sleep and REM sleep periods 
were compared with observed mean values from each 5 sec epoch (Figure 21 below). Where 
there was close agreement, the observed epochs were scored accordingly. Additionally, the 
degree of  agreement could be modified to optimise the scoring by the changing coefficients 
controlling the size of  the SD.
Figure 21.Example logic rules for identification of  REM sleep. Xobs td and Xobs emg are the mean 
observed values from a 5 second epoch. XREM td, sdREM td, XREM emg, and sdREM emg are the mean 
and standard deviation of  theta: delta ratio and EMG from scored REM sleep periods. α 
and β are coefficients which can be modified to optimise scoring; this was done manually 
by dragging cursors within the scoring window of  Spike2 to alter the level of  sensitivity 
when detecting the theta: delta ratio and EMG (for REM detection). The aim was to 
maximise detecting REM periods whilst minimising the impact of  any artefacts, striking a 
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balance between REM (or other) period identification and generating doubt scores. 
Coefficients for EEG, delta and EMG sensitivity could be altered during NREM detection. 
Adapted from Costa-Miserachs et al. (Costa-Miserachs et al. 2003).  
The final step was the grouping of  four consecutive 5 sec epochs to generate a scored 20 sec 
epoch from the predominant state (the order of  the states was not considered). This 
“averaging” of  scores removed the fluctuation seen within periods of  consistent 5 second 
epochs e.g. when a muscle twitch during a period of  stable NREM sleep resulted in a score of  
awake being assigned for a 5 second epoch, even though such an epoch is surrounded by 
epochs scored as NREM sleep. This final step also reduced the number of  epochs scored as 
doubt.
The final percentage of  doubt scores was 10% or less for every animal scored. The reliability 
of  the scoring provided a useful tool in training others to use the sleep score script, as poorly 
scored data resulted in doubt percentages greater than 10%. The final score was exported as 
a .txt file and plotted with graphing software (GraphPad Prism 4.0c, GraphPad, CA, USA). 
Figure 22 shows examples of  EEG, EMG and theta: delta ratio data resulting in the 
assignation of  wake NREM and REM sleep scores.
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Figure 22.Examples of  cortical EEG and EMG data scored as wake (W, column A), NREM 
sleep (N, column B) and REM sleep (R, column C). Uppermost line shows filtered EMG 
with results of  sleep score, depicted as 5 second and final 20 second epochs. Middle line 
shows theta: delta (T:D) ratio, extracted from cortical EEG data and lowermost line shows 
filtered cortical EEG data. A wake score was assigned on the basis of  the high EMG 
activity and high T:D. A NREM sleep score was assigned partially on the basis of  the low 
T:D and low EMG activity. A REM score was assigned on the basis of  the low EMG 
activity and high T:D.
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2.2 In vitro experiments
This section describes the materials and methods used for the in vitro part of  this thesis, the 
preparation of, and recording from brain slices.
2.2.1 Preparation of  acute brain slices  
In vitro experiments were performed using two strains of  mice, T3KO and WT. All animals 
were male and between 8 and 16 weeks old at the time of  sacrifice.
Each animal was anaesthetised with halothane in a Bell jar and loss of  righting reflex assured 
prior to decapitation. The skull was exposed by making an incision through the skin with a 
scalpel blade along midline extending caudally from between the eyes, followed by an initial 
immersion of  the head in cold slicing solution (Table 2) for approximately 10 seconds before 
the top of  the skull was removed. This was done by inserting one blade of  a pair of  fine 
scissors into the foramen magnum and cutting the skull in a line running from the foramen 
magnum to the lateral canthus of  the eye, then medially to the midline. A pair of  forceps was 
used to peel away the cap of  skull, exposing the brain. The brain was removed by carefully 
lifting it off  the base of  the skull using a small spatula, severing rostral attachments (Figure 
23).
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Figure 23. The intact brain of  the mouse as it appears following removal from the skull. The 
positioned of  the left hippocampus is delineated in red. Re-drawn from O’Mara et al. 
(O'Mara et al. 2001).
It was immediately immersed in cold slicing solution which was bubbled with carbogen (95% 
CO2, 5% O2; BOC, UK). Removal of  the brain was performed as quickly as possible to 
maximise tissue viability and the time from decapitation to brain removal took less than a 
minute. To record from the CA1 region of  the hippocampus, the following tissue block was 
prepared. Keeping the excised brain immersed in the slicing solution, the cerebellum was 
removed with a transverse cut, the brain bisected along its midline, and placed on the (medial) 
cut surface in a sylgard coated petri dish. A “magic cut” (Bischofberger et al. 2006) of  
approximately 10 degrees from a line perpendicular to the petri dish was made (Figure 24). 
This created a flat surface which could then be glued on to the slicing stage of  the slicing 
machine. This tissue orientation allowed horizontal slices to be made through the 
hippocampus starting at the ventral surface of  the brain (now uppermost on the slicing stage). 
This method to produce the tissue block optimises preservation of  CA1 pyramidal cells 
(Bischofberger et al. 2006). The tissue block was glued onto the slicing stage of  the slicing 
machine using superglue (Loctite Superglue, UK). The slicing machine (Model 7000smz, 
Campden Instruments, UK) had been prepared earlier by filling the chamber surrounding 
the metal stage with a mix of  ice and water. This maintained the low temperature necessary 
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to optimise tissue viability. A few seconds after placing the tissue on the superglue, with the aid 
of  a large spatula, the slicing stage was filled with cold slicing solution immersing the tissue. 
Carbogen was bubbled continuously through the slicing solution via an inlet in the back of  
the stage.
Figure 24. View of  a brain hemisphere with medial surface placed on a petri dish, positioned 
for the “magic cut”. The cut surface forms the base of  the tissue block and is glued to the 
slicing stage of  the slicing machine. Horizontal slices are taken starting from the ventral 
surface, moving dorsally. This orientation optimises preservation of  CA1 pyramidal cells. 
Adapted from (Bischofberger et al. 2006).
The slicing blade was made of  stainless steel and was replaced with a new blade every 4-6 
experiments. The z deflection of  the blade was checked daily and corrected to less than 0.6 
μm if  necessary.
The slicing machine was programmed to cut 350 μm thick slices, at a slicing speed of  1.0 mm 
sec-1 with 2 mm of  lateral blade (amplitude) movement at 80 Hz. Slices were often partially 
attached to the tissue block by strands of  meninges. These connections were severed with the 
point of  a 23 G hypodermic needle and slices left in the the slicing chamber until all the slices 
had been taken. Identification of  the correct depth of  tissue at which to start keeping slices 
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was done by visual identification of  the hippocampus. Five usable slices were produced from 
each brain. At completion of  slicing, slices were transferred to a custom-made incubating 
chamber (Figure 25). Here, they were incubated at 34◦C in a beaker placed in a heating 
block.
The cold slicing solution in the beaker was gradually exchanged for external recording 
solution (Table 3) via a peristaltic exchange pump (Model 77120-62, Cole Parmer, 
MasterFlex, US). After 45 minutes the slices were allowed to cool to room temperature and 
the solution exchange continued for a further 40 minutes.
Figure 25. Cartoon of  slice incubation chamber. The incubation chamber consisted of  a 50 
mL glass beaker containing a mesh-bottomed plastic cylinder which housed the slices, a 
smaller plastic cylinder which braced the larger cylinder within the beaker, and two 
silicone tubes. One tube supplied fresh external recording solution and the other removed 
slicing (and recording) solution.
2.2.2 Whole cell patch clamping
The effects of  1% (vaporiser setting) halothane on CA1 pyramidal cells of  the hippocampus 
were investigated using a whole cell patch clamping technique. Wild type and T3KO mouse 
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strains were studied. Experiments were performed at room temperature (23◦C).
Halothane concentration
The concentration of  halothane chosen was based on the aqueous phase concentration (Caq) 
at room temperature (23◦C; Franks & Lieb 1993) within the range we found to provide 
LORR in both T3KO and WT strains, approximately 1%.
Using the following formula:
Caq (mM) = 121.86 x λ x P (%atm) / (273.15 + T (◦C))
where  λ is the Ostwald solubility coefficient, T is temperature and P is the gas phase 
concentration. A vaporiser setting of  1% at 23◦C results in an aqueous phase concentration 
of  0.5 mM, using a value of  1.20 for the Ostwald solubility coefficient. This calculation is 
based on an Ostwald solubility coefficient for pure water; a reduction in the solubility 
coefficient of  10 - 15% occurs in a physiological buffer, with a resultant decrease in calculated 
aqueous phase concentration (Franks & Lieb 1993).
Equipment
The electrophysiology “rig” was mechanically isolated with the use of  an air table (Intracel 
Isolate System 2000, Intracel, UK) cushioned with nitrogen gas regulated to 65 p.s.i. with a 
two stage regulator (BOC, UK). Electrical isolation was created by housing the microscope in 
a Faraday cage and the cage earthed to the amplifier earth. 
Slices were placed in a bath and held in place with a “harp” consisting of  a U-shaped 
platinum frame strung with nylon strands, which had been glued on to the frame with 
superglue (Figure 26). The frame surrounded the slice and the nylon strands pressed down on 
it, preventing movement. Use of  a frame also allowed manipulation of  the slice in the bath 
whilst avoiding direct contact with the slice. The bath was filled with a constantly exchanging 
external recording solution. The inflow was from a gravity driven system supplying 1-2 mL 
min-1 of  solution, and the outflow was through suction tubing connected to a peristaltic pump 
(Pump P-1, Pharmacia LKB, Sweden). The external recording solution was at room 
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temperature and continuously bubbled with carbogen. A silver chloride pellet immersed in 
the bath solution was connected to the headstage earth.
Slices were visualised with a microscope (Axioskop 2 FS Plus, Zeiss, Germany ) with infrared 
differential interference contrast optics (IR-DIC), and images were viewed with the aid of  a 
digital camera (Model C7500-51, Hamamatsu CCD Camera, Japan) mounted in place of  the 
eye pieces, with images transmitted to a monitor. Visual navigation within the slice was 
through a low power objective (Zeiss Neofluar 1.5x, Zeiss, Germany) initially, followed by a 
high power water immersion objective (Zeiss IR-Achroplan 63x, Zeiss, Germany). Further 
magnification (up to 3x) was provided by the digital camera. Contrast and brightness controls 
were located on the control box of  the digital camera. Once the pyramidal cells of  the CA1 
region had been identified, the image was optimised by adjusting the amount of  light 
transmitted to the slice and the angle of  the condenser. This provided an impression of  depth, 
aiding the approach with the patch pipette.
Patch pipette manufacture and manipulation
Patch pipettes were formed from thin-walled borosilicate glass (OD 1.5 mm, ID 0.86 mm) 
containing a filament (GC150-F10, Harvard Apparatus, US). Each piece of  glass was pulled 
into two pipettes in a two-stage vertical puller (Model PC-10 Puller, Narishige, Japan). The 
temperature of  the first and second stage pull was adjusted to optimise the shape and length 
of  the pipette tip. As there was minimal shielding around the heating filament of  the puller, it 
was susceptible to slight changes in environmental temperature and air flow, necessitating 
frequent adjustment. Pipette resistance, once filled with internal  solution, ranged from 3 - 8 
MΩ. Pipettes were driven through the bath solution and within the slice by a piezo-electric 
micromanipulator (MP-225, Sutter Instrument Company, UK).
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Figure 26. Cartoon of  slice in microscope bath, held in place by platinum “harp” with nylon 
strands (grey). Recording solution inflow (1 - 2 mL min-1) was gravity driven and outflow 
was matched by a peristaltic pump. The glass patch pipette was held in a holder driven by 
a piezo-electric micromanipulator. Positive pressure could be applied to the pipette through 
tubing connected to a 3-way tap.
Pipettes were secured in place by a pipette holder (DB-S Electrode Holder, G23 Instruments, 
UCL, UK). Stability and an airtight seal were provided by two rubber O-rings. This airtight 
seal allowed positive pressure to be delivered through the pipette, preventing obstruction of  
the fine pipette tip (approximately 2μm diameter) by debris as the pipette was driven down to 
the neurone of  interest. The pipette holder was attached to the headstage amplifier and an 
electrical connection between the pipette and headstage amplifier provided by a silver-
chloride coated stainless steel wire running from the internal solution within the pipette to the 
headstage amplifier. The headstage amplifier was connected to the patch clamp amplifier 
(Multiclamp 700B, Axon Instruments, CA, USA), which was located outside the Faraday 
cage. The amplifier filtered the analogue signal which was then digitised by a National 
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Instruments digitisation board (PCI-6052E). Stimulation and recording protocols were run 
using free software: WinWCP (v4.1.6, Strathclyde Institute of  Pharmacy and Biomedical 
Sciences; current clamp recordings) and WinEDR (v3.1.4, Strathclyde Institute of  Pharmacy 
and Biomedical Sciences; voltage clamp recordings).  
Whole cell recording
Neurones were recorded using the technique of  blind patching. Once an area within the 
pyramidal cell layer had been selected a pipette was pulled, filled with internal solution and 
loaded into the pipette holder. A constant positive pressure was applied with nitrogen gas 
through the pipette from a pico-spritzer (≃5 psi; Picospritzer II, General Valve Corporation, 
US) connected to the pipette holder via plastic tubing as the pipette was submerged in the 
bath solution. The pipette was manoeuvred until visible in the field of  view. It was then 
lowered in tandem with the objective until it was visible just above the cell layer. Current flow 
through the pipette was neutralised on the amplifier and pipette resistance calculated by 
applying a -10 mV square wave. The focus of  the field of  view was adjusted to the deepest 
layer that could be visualised, usually 4 - 5 cells below the surface of  the slice, and the pipette 
slowly lowered into focus. From this point the pipette continued to be lowered without direct 
visualisation. Instead, the -10 mV square wave was observed on the monitor. As a cell was 
contacted by the pipette tip, the square wave “jumped” suddenly to a more positive value, 
reflecting an increase in membrane resistance. The subjective evaluation of  the speed of  this 
jump gave an indication of  the relationship between the pipette and the cell. At this point, 
positive pressure was removed and a seal allowed to form, encouraged with gentle negative 
pressure applied by oral suction via a 1 mL syringe. The aim was the formation of  a gigaseal 
(> 1 GΩ). In a healthy cell a gigaseal would form in less than a minute. The capacitive 
transients were then corrected with the amplifier. Once a stable gigaseal was formed, further 
negative pressure was applied to the cell membrane to break through and achieve a whole cell 
configuration. Breaking through resulted in exposure of  the internal contents of  the cell to 
the internal solution of  the pipette. The slice was exposed to halothane by switching the 
gravity fed inflow tube from a bottle containing recording solution to one in which halothane 
carried in carbogen (1L min-1) was being bubbled. Halothane coming out of  solution was 
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scavenged into a charcoal cannister under the driving force of  the gas. Halothane was 
bubbled into the solution for a minimum of  10 minutes prior to exposing the slice to 
halothane and once the switch had been made to the halothane containing recording 
solution, a further 10 minutes were allowed for penetration of  the slice before the 
experimental protocols were started. Nishikawa and MacIver (Nishikawa & MacIver 2000) 
reported a slow onset (10 minutes)  in halothane effects on IPSCs, though they had a larger 
bath volume than our rig, with a similar fluid rate, resulting in a slower time constant for fluid 
exchange. Neurones that had stable series resistance and cell capacitance over the recording 
period were used for analysis.
Current clamp recordings
WinWCP software was used for the current clamp experiments. Under control conditions and 
in the presence of  1% halothane, the cell was subjected to a brief  pulse and a long pulse 
protocol. Both protocols were run with the cell at its natural resting membrane potential (0 
current injected) and at -60 mV (current injected to hold cell at -60 mV). The brief  pulse was 
an incremental increase in voltage, in steps of  1 mV, starting at 3 mV, with a  duration of  0.2 
ms. The aim of  the brief  pulse protocol was to elicit an action potential (AP). The long pulse 
protocol was an incremental increase in voltage steps of  0.2 mV, starting at -0.4 mV, with a  
duration of  160  ms.
Current clamp data analysis
The data recorded from the current clamp protocols was used to analyse the AP parameters 
of  each cell and generate current-frequency (I-f)  input-output curves. Graphing (GraphPad 
Prism v4.0c) and data handling (Microsoft Excel 2004 v 11.2, WA, USA) software were used. 
Action potential (AP) parameters
A time independent method, phase plane plots (PPP; Figure 27), was used to assess and 
compare AP parameters (Bean 2007).  A PPP is a plot of  the time derivative of  the voltage 
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(dmV/dt) versus the voltage (mV). The following parameters could be read from each phase 
plane plot: AP threshold, maximal rate of  rise, maximal rate of  decay and peak.
Figure 27. Phase plane plot. By plotting the time derivative of  the voltage (dmV/dt) versus 
the voltage (mV) the following parameters can be easily read from the plot: threshold, 
maximum rate of  rise, peak amplitude, maximum rate of  decay.
 
Current-frequency (I-f)  input-output curves
Plots of  frequency (Hz) against current (pA) were constructed from the long pulse data by 
manually counting the number of  APs fired in response to each step of  voltage injected.
Whole cell parameters
Whole cell parameters were calculated using the current response to a brief  pulse 
immediately prior to the firing of  an AP, under control conditions and in the presence of  
halothane.
The following equations were used:
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Input conductance (G; Siemens) = 1 / Ri
Where Ri is the input resistance (Ω) = τ / C 
with τ (seconds) being the time constant of  the decay phase of  the cell response to the brief  
pulse and C is the membrane capacitance (Farads) recorded from the amplifier.
The current injection required to achieve AP threshold was measured by reading off  the 
value displayed on the software (WinWCP; v4.1.6, Strathclyde Institute of  Pharmacy and 
Biomedical Sciences; current clamp recordings) for each recording. The averages under each 
recording condition were then calculated and compared between strains.
Voltage clamp recordings
In a separate set of  experiments, using WinEDR software, cells were held at -60 mV and 
sIPSCs recorded under control conditions and in the presence of  halothane 1%. Recording 
under each condition lasted 10 minutes with a wash-in period for halothane of  10 minutes. 
Halothane was applied in the same way as for the current clamp recordings.
Voltage clamp data analysis
Spontaneous IPSCs were detected in WinEDR by setting a threshold of  detection for the size 
of  sIPSC peaks. As a result of  the presence of  APs, and the high frequency of  sIPSCs 
present, the automated detection system was found to be inaccurate, and events were counted 
manually. A section of  data from the last five minutes under each condition was selected and 
400 events counted. This data was used to calculate the following parameters: sIPSC 
frequency, average IPSC decay (from a weighted time constant fitted to the exponential), area 
under the IPSC curve, and peak height. Average IPSC decay, area, and peak height were 
calculated from the average of  single events which were uncontaminated by synaptic events 
occurring during the rise or decay phases.
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Confocal microscopy
Though the pyramidal cell layer of  CA1 is well defined, cell identity and morphology were 
confirmed with confocal microscopy. A confocal microscope (Zeiss LSM 510, Zeiss, 
Germany) with a 40x oil immersion lens was used to obtain images in conjunction with ZEN 
software (ZEN, Zeiss, Germany). The optical source was an argon 458 laser passed through a 
475 nm long pass filter. Slice thickness (z interval) was 1 μm. Other settings were optimised for 
each sample and included pinhole aperture, detector gain, amplifier gain and offset.
Slices were first fixed in EDAC (1-Ethyl-3(3-dimethylamino-propyl)carbodiimide) buffer 
(Sigma E-7750, UK) with 1% N-hydroxysuccinimide (20 mg/10-20 mL; Sigma H-7377, UK) 
following the protocol of  Panula et al (Panula et al. 1984). Both constituents (EDAC, 800 mg; 
N-hydroxysuccinimide, 20 mg) were diluted in 20 mL of  phosphate buffer (0.1 M, pH 7.4). 
After immersion in the buffer for 24 hours, slices were  mounted in Vectashield Mounting 
Medium with DAPI (4’,6-diamidino-2-phenylindole; Vector Lab., Inc., CA, USA). 
2.2.3 Solutions
All chemicals were obtained from Sigma-Aldrich UK. Slicing and external recording solution 
was made up as a 10x stock in 1 and 2 L bottles respectively. Sucrose, glucose, calcium 
chloride and magnesium chloride were omitted from the concentrated stock solution and 
added on each experimental day to a 1x solution made up by dilution with MiliQ water. 
Internal recording solution was made up as a 25 mL batch without Mg-ATP or Na-GTP and 
stored at -20◦C in 1 mL aliquots. Aliquots were stored for 5-6 weeks. Mg-ATP and Na-GTP 
solutions were freshly made up each week, stored in 30 μL aliquots at -20◦C and added to the 
internal solution each day. All solutions were buffered to a pH of  7.3 - 7.4. Lucifer yellow (1 
mg; Sigma, US) was added to each aliquot of  internal solution immediately prior to use. Over 
the course of  the experimental day the internal solution was stored on ice to minimise 
degradation of  Mg-ATP and Na-GTP.
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Table 2. Composition of  slicing solution.
Table 3. Composition of  external recording solution.
Table 4. Composition of  internal recording solution.
Low potassium slicing solution 
NaCl
KCl
NaH2PO4.H2O
NaHCO3
Sucrose
CaCl2
MgCl2
Glucose
mM
85
2.5
1.25
26
75
1
4
25
Low potassium recording solution
NaCl
KCl
NaH2PO4.H2O
NaHCO3
CaCl2
MgCl2
Glucose
mM
125
2.5
1.25
26
2
1
25
Internal recording solution
KCH3SO4
NaCl
HEPES
EGTA
MgCl2
CaCl2
Mg-ATP
Na-GTP
KOH
mM
120
4
10
5
1
1
3
0.3
1M stock to pH solution to 7.3-7.4
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2.3 Statistics
The statistical tests used to make comparisons between treatment conditions (control and 
halothane) and between strains (WT and T3KO) for the in vivo experiments were ANOVA for 
repeated measures or 2-way ANOVA with the appropriate post hoc test depending on the 
number of  comparisons being made. The results of  the in vitro experiments were analysed 
with paired or unpaired t tests depending on the comparison being made. The choice of  test 
for each result is described in the each figure legend. For all comparison, a p-value < 0.05 was 
considered significant.  
2.4 Gentoyping
Animals used were genotyped following termination of  the experiments to confirm genetic 
identity (Figure 28, Figure 29, Figure 30). Ear tissue samples were used for template DNA and 
amplified using the PCR (see Methods).
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Figure 28.Results from genotyping tissue (ear) samples from T3KO and WT animals. The 
analysis was performed blind. T3KO animals (samples 1-6) show a band at 400 base pairs 
(bp), and WT at 350 bp. L is ladder and H is the DNA-free water sample.
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Figure 29.Results from genotyping tissue (ear) samples from T1KO and WT animals. The 
analysis was performed blind. T1KO animals (samples 1-6) show a band at 400 base pairs 
(bp), and WT at 300 bp. A multiplex PCR was performed with primers for both T1KO 
and pIRES. L is ladder and H is the DNA-free water sample.
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Figure 30. Results from genotyping tissue (ear) samples from DKO and WT animals. 
Primers for TASK-1 and TASK-3 genes were used in to identify DKO animals. The 
analysis was performed blind. DKO animals show a band at 400 base pairs (bp) for 
both TASK-1 (b) and TASK-3 (c) primers. WT show a band at 300 bp (a) and 350 
bp (c). L is ladder.
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3.0 Results
Some of  the in vivo data presented in this, and the following chapter have been published 
(Appendix; Pang et al. 2009).
3.1 Behavioural phenotypes I - the loss of  righting 
reflex (LORR) and sleep
3.1.1 LORR assay: is there a difference in anaesthetic 
sensitivity between T3KO, T1KO, DKO and WT strains of  
mice?
The origins of  one of  our earliest investigations, the LORR, were the findings of  Dr Alex 
Caley (a previous PhD student in our laboratory) that the T3KO animal was markedly less 
sensitive to halothane that WT. This initial work was consolidated and further comparisons 
made, with the anaesthetic agent cyclopropane, and between the T3KO, T1KO, DKO and 
WT strains. Other groups have made similar comparisons with variable results (Lazarenko et 
al. 2010; Linden et al. 2006, 2007). Potential reasons for these differences will be described in 
the discussion.
Full details of  the methodology are described in Chapter 2. Briefly, each animal was exposed 
to a step-wise increase in anaesthetic concentration following a baseline period with 100% 
oxygen. Experiments were performed in a rotatable glass chamber maintained a fixed 
distance from a heat lamp. The anaesthetics were delivered from a precision, temperature 
calibrated vaporiser (halothane), or by mixing directly with oxygen (cyclopropane).
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3.1.1.2 Halothane
Figure 31.Dose-response curve of  loss of  righting reflex data with halothane following Waud 
analysis for WT, DKO, T1KO and T3KO strains of  mice. The y-axis represents the 
response to halothane where 0 is consciousness and 1 is loss of  righting reflex and the x-
axis shows the range of  halothane concentrations used. Solid circles represent raw data for 
individual animals, plotted staggered for clarity. The EC50 ± SEM values, slopes ± SEM 
and group sizes for the strains tested are: WT, 0.68 ± 0.02, 12.8 ± 3.0, n=19; DKO, 0.70 ± 
0.01, 37.9 ± 18.0, n=8; T1KO, 0.78 ± 0.01, 18.6 ± 3.2, n=20; T3KO, 0.94 ± 0.02, 15.9 ± 
3.4, n=12. There was a significant difference between T1KO and WT (p<0.001), T3KO 
and WT (p<0.001), T1KO and T3KO (p<0.001), DKO and T1KO (p<0.05), DKO and 
T3KO (p<0.001). There was no significant difference between WT and DKO. WT data 
were pooled between Daniel Pang (n=11) and Alex Caley (n=8). Statistical differences 
were tested with one-way ANOVA and a Bonferroni post hoc test.
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Compared with WT and DKO strains, which did not have differing EC50 values (0.68 ± 0.02 
and 0.70 ± 0.01, respectively), the T3KO strain was markedly less sensitive to halothane (EC50 
= 0.94 ± 0.02) with a 38% decrease in sensitivity (Figure 31, above).  Halothane sensitivity of  
the T1KO strain ( EC50 = 0.78 ± 0.01) was intermediate between WT (and DKO) and 
T3KO. 
3.1.1.3 Sex
An early question that arose during the LORR experiments was whether a sex difference 
existed in the response to anaesthetics. To test this, female DKO, T3KO and WT animals 
were compared to males in the presence of  halothane (Figure 32).
Figure 32.A comparison between sexes for WT, T1KO, T3KO and DKO strains. Dose-
response curve of  loss of  righting reflex data with halothane following Waud analysis for 
WT, DKO, T1KO and T3KO strains of  mice. The y-axis represents the response to 
halothane where 0 is consciousness and 1 is loss of  righting reflex and the x-axis shows the 
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range of  halothane concentrations used. Error (SEM) bars have been omitted for clarity 
from the lines representing the female data. Solid circles represent raw data for individual 
male animals and crosses represent corresponding female data, plotted staggered for 
clarity. A rightward shift in halothane sensitivity was evident for the T1KO and DKO 
strains. The converse occurs with the T3KO strain. There was a significant difference 
between sexes for the DKO strain (p<0.001) and T1KO (p<0.01), but not for WT or 
T3KO. The EC50 ± SEM, slope ± SEM, and group sizes were as follows: WT male, 0.68 ± 
0.02, 12.8 ± 3.0, n=19; WT female, 0.73 ± 0.02, 20.2 ± 6.9, n=8; DKO male, 0.70 ± 
0.01, 37.9 ± 18.0, n=8; DKO female, 0.88 ± 0.04, 13.6 ± 5.2, n=5; T1KO male, 0.78 ± 
0.01, 18.6 ± 3.2, n=20; T1KO female, 0.87 ± 0.04, 13.4 ± 5.7, n=8; T3KO male, 0.94 ± 
0.02, 15.9 ± 3.4, n=12; T3KO female, 0.87 ± 0.04, 31.2 ± 12.1, n=9. Statistical 
differences were tested with unpaired t-tests.
This experiment was performed to investigate a potential bias from using mixed sex groups. 
The inconsistent nature of  the results, the significant differences between the sexes for DKO 
and T1KO strains but not WT or T3KO, serves to highlight the potential variability. 
Performing experiments without assessing the potential impact of  sex may serve to hide 
differences within a single sex group. Alternatively, large sample sizes may be required before  
a significant difference is achieved. 
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Figure 33.Comparison between experimenters for loss of  righting reflex (LORR) data. Dose-
response curve of  LORR data with halothane following Waud analysis for WT mice, 
where AC is data collected by Dr Alex Caley (EC50=0.70 ± 0.03, slope = 14.3 ± 5.0, n=8), 
and DP is data collected by Daniel Pang (EC50=0.66 ± 0.03, slope = 12.3 ± 3.9, n=11). 
The y-axis represents the response to halothane where 0 is consciousness and 1 is loss of  
righting reflex and the x-axis shows the range of  halothane concentrations used. Solid 
circles represent raw data for individual animals, plotted staggered for clarity. There is a no 
significant difference between the EC50 values obtained. Error bars represent SEM.
These data show the good inter-observer agreement for the method of  measuring LORR we 
used (Figure 33). This is important to demonstrate given the manual rotation technique 
employed and risk of  variability introduced by the effect of  different technique between 
experimenters. Additionally, our rigourous adherence to our definition of  LORR, that all four 
paws of  the animal must be off  the ground for at least 30 seconds in order to be classed as a 
LORR.
3.1.1.4 Cyclopropane
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Next, the effect of  exposure to cyclopropane was tested as it is an anaesthetic agent that does 
not affect TASK-3 channels in vitro (Gruss et al. 2004). As cyclopropane is a gas at room 
temperature, it was delivered by mixture with a known flow rate of  oxygen through an agent 
specific flowmeter. 
Figure 34.Dose-response curve of  loss of  righting reflex assay with cyclopropane following 
Waud analysis for WT, DKO, T1KO and T3KO strains of  mice. The y-axis represents the 
response to cyclopropane where 0 is consciousness and 1 is loss of  righting reflex and the 
x-axis shows the range of  cyclopropane flow rates used. Solid circles represent raw data for 
individual animals, plotted staggered for clarity. Raw data overlap as cyclopropane 
concentration was determined by the flowmeter. A gas analyser specific to cyclopropane 
was not available (unlike for the halothane LORR assay). Cyclopropane was mixed with 
500 mL min-1 oxygen and the following concentrations tested: 8, 12, 16, 20 and 25%. The 
EC50 ± SEM values (equivalent % cyclopropane concentrations), slopes ± SEM and group 
sizes for the strains tested are: WT, 0.95 ± 0.04 (19.0% ± 0.8), 13.8 ± 5.2, n=10; DKO, 
0.89 ± 0.06 (17.8% ± 1.2), 12.0 ± 5.8, n=4; T1KO, 0.76 ± 0.03 (15.2% ± 0.6), 9.5 ± 2.2, 
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n=18; T3KO, 0.98 ± 0.04 (19.6% ± 0.8), 12.9 ± 4.6, n=10. There was a significant 
difference between WT and T1KO (p<0.01) and between T1KO and T3KO (p<0.001). 
Data were tested for significance with a one-way ANOVA and a Bonferroni post hoc test.
With the exception of  the T1KO strain, there was no difference in the response to 
cyclopropane between the other strains tested (Figure 34, above). T1KO (EC50 = 15.2% ± 
0.6) showed greater sensitivity to cyclopropane than WT (EC50 = 19.0% ± 0.8) and T3KO 
(EC50 = 19.6% ± 0.8). The explanation for this is not apparent, though cyclopropane has 
effects at other putative anaesthetic targets, as discussed later.
3.1.2 Sleep: does an aspect of  normal behaviour differ 
between strains?
Having a non-tethered system for monitoring the cortical EEG with the Neurologger, it 
provided an ideal tool to study normal behaviour. Given the occurrence of  theta oscillations 
during REM sleep and the identification in previous work from our laboratory that the 
T3KO strain had a different sleep architecture compared with WT (Robledo 2008), and the 
demonstration that the T3KO strain have altered nocturnal activity (Linden et al. 2007), it 
was important to investigate any alterations in sleep in the T1KO and DKO strains.
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Figure 35.Percentage of  time spent awake per hour during a sleep recording over 29 hours 
with the mouse in its home cage. Red = T3KO (n=5), green = T1KO (n=3), blue = DKO 
(n=4), black = WT (n=5). Data for T3KO is from CR, data for WT is pooled from DP and 
CR. During the first hour there was a greater percentage of  time spent awake in the 
T3KO strain (88.6 ± 5.1%) than the DKO (p<0.01, 34.4 ± 7.7%), WT (p<0.05, 46.1 ± 
9.9%) and T1KO (p<0.05, 42.0 ± 6.0%) strains. During the second hour there was a 
greater percentage of  time spent awake in the T3KO (63.5 ± 14.4%) than the WT 
(p<0.01, 15.0 ± 4.6%), and in the T1KO (72.0 ± 6.5%) than the WT (p<0.01) strains. 
During the 25th hour there was a greater percentage of  the time spent awake in the 
T3KO (69.0 ± 10.3%) than the WT (p<0.05, 15.6 ± 9.2%) strains. Error bars represent 
SEM. These data were analysed with 2-way ANOVA for repeated measures with 
Bonferroni post hoc tests. Asterisk indicates significant (p < 0.05) difference from WT.
Sleep data has been presented as “quiet” and “active” periods rather than “light” and “dark” 
periods to avoid confusion with the nocturnal behaviour of  the mice. Similarly, the terms 
“wake” and “sleep” have been avoided as rodents do not have the well defined division of  
these behaviours exhibited in humans. Our data for wild type show that even during the quiet 
(or “sleep”) period, 30% of  each hour is spent awake. This doubles during the active (or 
“wake”) period (64%).
The percentage of  time spent awake during the active period is similar for WT, T3KO and 
DKO strains (WT 64.1 ± 3.4%, DKO 60.2 ± 2.7 %, T3KO 61.3 ± 2.8%; Figure 35). During 
the quiet period there is a clear difference between T3KO and the other strains, with a  
substantially greater time spent awake in the first hour (88.6 ± 5.1%) than the other strains 
(DKO 34.4 ± 7.7%, WT 46.1 ± 9.9%, T1KO 42.0 ± 6.0%). A similar situation persists in the 
second hour (with the exception of  T1KO, which does not differ from T3KO) before the time 
spent awake by T3KO falls into line with that of  the other strains. The general distribution of  
a lower percentage of  time spent awake in the quiet period and vice versa for the active 
period is displayed by all strains except T1KO. This strain has a near even distribution of  
time spent awake during both periods (quiet 47.3 ± 4.1%, active 47.6 ± 4.2%). The data 
beyond the 24 hour period (hours 25-29) were included to verify that any stress induced by 
handling prior to the experiment (when the mock Neurologger was replaced with the real 
83
84
85
Neurologger) did not affect the results. This was borne out by the similar relationship between 
strains observed in hour 25 as in hour 1 i.e. the T3KO strain spent a significantly greater 
period of  time awake than the WT strain. This would indicate that T3KO has a slower 
transition between the active and quiet periods compared with other strains. The time spent 
awake by the DKO strain was striking in its similarity to wild type, with no significant 
differences at any time point.
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Figure 36.Percentage of  time spent in NREM sleep per hour during a sleep recording over 29 
hours with the mouse in its home cage. Red = T3KO (n=5), green = T1KO (n=3), blue = 
DKO (n=4), black = WT (n=5). Data for T3KO is from CR, data for WT is pooled from 
DP and CR. During the first hour there was a greater percentage of  time spent in NREM 
sleep in the DKO (57.1 ± 7.8%) than the T3KO (p<0.01, 11.0 ± 5.0%), and the WT (48.7 
± 9.5%) than the T3KO (p<0.05) strains. In the second hour there was a greater 
percentage of  time spent in NREM sleep in the WT (72.2 ± 4.3%) than the T3KO 
(p<0.05, 32.5 ± 11.7%) and the WT than the T1KO (p<0.05, 24.7 ± 6.7%) strains. The 
WT strain (71.1 ± 8.0%) spent more time in NREM sleep compared with T3KO (p<0.01, 
27.6 ± 8.9%) during the 25th hour, and compared with T1KO (23.2 ± 14.7%; WT 79.1 ± 
5.7%) during the 29th hour (p<0.001). Error bars represent SEM. These data were 
analysed with 2-way ANOVA for repeated measures with Bonferroni post hoc tests. Asterisk 
indicates significant (p < 0.05) difference from WT. 
Like the data for percentage time spent awake, a similar pattern appears for NREM sleep. 
Again most strains behave similarly during the active period, spending around a third of  the 
time in NREM sleep (Figure 36). The exception, T1KO, spends a similar percentage of  time 
in NREM sleep during both periods (quiet period 44.8 ± 3.3%, active period 44.9 ± 3.6%). A 
notable strain difference becomes apparent during the first hour (quiet period), when T3KO 
(11.0 ± 5.0%) spends substantially less time in NREM sleep than DKO (57.1 ± 7.8%) and 
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WT (48.7 ± 9.5%) strains. This pattern continues into the second hour after which T3KO 
behaviour joins that of  the other strains. Again, T3KO displays a slower transition from 
active to quiet periods, lagging behind the other strains. Once more, the DKO strain shows a 
striking similarity to WT.
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Figure 37.Percentage of  time spent in REM sleep per hour during a sleep recording over 29 
hours with the mouse in its home cage. Red = T3KO (n=5), green = T1KO (n=3), blue = 
DKO (n=4), black = WT (n=5). Data for T3KO is from CR, data for WT is pooled from 
DP and CR. During the second hour WT (11.9 ± 0.8%) spent more time in REM sleep 
than the T3KO (p<0.05, 4.0 ± 1.8%) and T1KO (p<0.05, 2.9 ± 0.7) strains. Similarly WT 
(hour 25, 12.5 ± 1.6%; hour 29, 13.7 ± 2.7%) spent more time in REM sleep than the 
T3KO (p<0.01, 3.4 ± 1.8%) and T1KO (p<0.05, 4.9 ± 3.1%) strains during the 25th and 
29th hours respectively. Error bars represent SEM. These data were analysed with 2-way 
ANOVA for repeated measures with Bonferroni post hoc tests. Asterisk indicates significant 
(p < 0.05) difference from WT. Note the change in y-axis scale compared with Figure 35 
and Figure 36. 
During the quiet period the general pattern observed during NREM sleep is maintained; the 
T3KO strain sleeps less than WT at the beginning of  the period before following the same 
pattern for the rest of  the period. During the active period there is no difference between 
strains in the time spent in REM sleep. The distribution of  REM sleep between quiet and 
active periods is very similar for the T1KO strain (quiet 6.8 ± 0.7%, active 6.2 ± 0.7%), 
failing to show the cyclical pattern observed in the other strains. DKO and WT show a very 
similar distribution of  REM sleep throughout (Figure 37).
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Figure 38.Time spent as a percentage in wake, NREM sleep and REM sleep (top to bottom, 
respectively) during the quiet (light) period (12 hours) of  the circadian cycle. Less time was 
spent awake in WT (29.9 ± 2.8%) than each of  the other strains (p<0.05; DKO, 44.9 ± 
3.2%; T1KO, 47.3 ± 4.1%; T3KO 45.3 ± 4.9%), whereas more time is spent by WT (60.1 
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± 2.3%) in NREM sleep than each of  the other strains (p<0.05; DKO, 47.7 ± 2.7%; 
T1KO, 44.8 ± 3.3%; T3KO 46.8 ± 4.1%). During REM sleep, there was no difference 
between strains WT, 9.1 ± 0.7; DKO, 6.8 ± 0.6%; T1KO, 6.8 ± 0.7%; T3KO 8.0 ± 
1.0%). Data were subjected to unpaired t-tests. Error bars represent SEM.
Figure 39.Time spent as a percentage in wake, NREM sleep and REM sleep (top to bottom, 
respectively) during the active (dark) period (12 hours) of  the circadian cycle. The T1KO 
strain spent less time (47.6 ± 4.2%) awake than all other strains (p<0.05; WT, 64.1 ± 
3.4%; DKO, 60.2 ± 2.7; T3KO, 61.3 ± 2.8%), and more time in NREM sleep (T1KO, 
44.9 ± 3.6%) than WT (p<0.05, 33.1 ± 2.9%) or T3KO strains (p<0.05, 34.0 ± 2.4%). 
There was no difference compared with DKO (35.2 ± 2.2%). Compared to WT (2.3 ± 
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0.5%), T1KO spent more time in REM sleep (p<0.05, 6.2 ± 0.7%). There was no 
difference between T1KO and DKO (4.1 ± 0.6%) or T3KO (4.8 ± 0.5%) strains. Data 
were subjected to unpaired t-tests. Error bars represent SEM.
Analysis of  the data split into 12 hour periods (quiet and active) shows some interesting 
differences (Figure 38 and Figure 39). During the quiet period (Figure 38) WT spends 
substantially less time awake compared to all other strains, and the situation is reversed during 
NREM sleep. A different picture is apparent during the active period (Figure 39) when time 
spent awake is similar across strains with the exception of  T1KO, in which it is lower. Again, 
the situation is reversed during NREM sleep. T1KO also spends more time in REM sleep 
than WT. These results reflect the importance of  analysing the data in different ways. The 
hourly analyses (Figure 35, Figure 36, Figure 37) revealed the differences in transitional 
behaviour between T3KO and the other strains. Whereas, pooling the hourly data into 12 
hour periods showed that the WT strain spent less time awake during the quiet period than 
the knockout strains, with a concomitant increase in NREM sleep. A difference that was 
inapparent by displaying and analysing data hour by hour.
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Figure 40.Comparison of  quiet (clear bars) and active (black bars) periods for each strain 
during wake, NREM sleep and REM sleep states, expressed as percentage time. The WT 
(quiet 29.9 ± 2.8%; active 64.1 ± 3.4), T3KO (quiet 45.3 ± 4.9%; active 61.3 ± 2.8) and 
DKO (quiet 44.9 ± 3.2%; active 60.2 ± 2.7) strains showed the same patterns of  behaviour 
with less time spent awake during the quiet period (WT, p<0.0001; T3KO, p<0.05; DKO, 
p<0.05) and more time spent in NREM (WT, p<0.0001, [quiet 60.1 ± 2.3; active 33.1 ± 
2.9]; T3KO, p<0.05, [quiet 46.7 ± 4.1; active 34.0 ± 2.4]; DKO, p<0.05, [quiet 47.7 ± 
2.7; active 33.2 ± 2.2]) and REM (WT, p<0.0001, [quiet 9.1± 0.7; active 2.3 ± 0.5]; 
T3KO, p<0.05, [quiet 8.0 ± 1.0; active 4.8 ± 0.5]; DKO, p<0.05, [quiet 6.8 ± 0.6; active 
4.1 ± 0.6]) sleep. The T1KO strain showed a very different pattern, with no difference in 
time spent in each state during both active and quiet periods (awake [quiet 47.3 ± 4.1; 
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active 47.6 ± 4.2], NREM [quiet 44.8 ± 3.3; active 44.9 ± 3.6], REM [quiet 6.8 ± 0.7; 
active 6.2 ± 1.2] ). 
Figure 40 highlights the difference between T1KO and the other strains. The cyclical pattern 
of  wake versus sleep varying during the quiet and active periods, as shown by all other strains, 
is broken by the behaviour of  the T1KO strain, which shows a very stable distribution of  
wake and sleep behaviours throughout the circadian cycle.
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3.2 Behavioural phenotypes II - the theta oscillation 
and the response to halothane, atropine sulphate and 
eserine
3.2.1 Halothane
The TASK1 and TASK3 channels are activated by the volatile anaesthetic agents halothane 
and isoflurane (Berg et al. 2004; Talley & Bayliss 2002; Meadows & Randall 2001; Sirois et al. 
2000; Patel et al. 1999). The degree of  activation by halothane is greater for the TASK3 than 
TASK1 channel and the effects of  halothane are greater than isoflurane in either channel. 
Previous work by our group showed the induction of  a type 2 theta oscillation in T3KO mice 
exposed to halothane (Robledo 2008). This series of  experiments was performed to verify 
these findings and investigate the effects of  halothane in the T1KO and DKO strains. As 
expression of  TASK1 mRNA is absent in the hippocampus, one area involved in generation 
of  the theta oscillation, it was predicted that behaviour might be similar to WT (Aller et al. 
2005). The response of  each animal was measured individually by exposure to a step-wise 
increase in halothane concentration as the cortical EEG was recorded with the Neurologger 
(see Chapter 2 for detailed methods).
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Figure 41.Results of  exposure to an increasing concentration of  halothane in 4 strains of  
mice instrumented with a Neurologger. Each graph is a representative example of  one 
animal. The WT strain shows the induction of  a type 2 theta oscillation by exposure to a 
clinically relevant concentration of  halothane. The T1KO strain shows a similar response. 
The DKO and T3KO strains differ from WT and T1KO in the shape of  peak produced 
as a result of  halothane exposure. Quantification of  this response was performed by fitting 
a Lorentzian curve to identified peaks (see below).  
Exposure to halothane in each strain induces a change in the power spectrum derived from 
the cortical EEG. The induction of  a peak centred at approximately 5 Hz (within the theta 
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oscillation range) is visible for each strain studied, but the quality of  this peak varies. It is 
narrower and better defined (more “tuned”) in the WT and T1KO strains, becoming slightly 
broader in the DKO strain, and even more so in the T3KO strain (Figure 41). As the 
concentration of  halothane is increased to a supraclinical level the peak is reduced in size and 
frequency (WT and T1KO) or disappears entirely (DKO and T3KO). In order to quantify 
these observed responses to halothane, identifiable peaks in the power spectra were fitted with 
a Lorentzian curve. 
Figure 42.Type 2 theta oscillation peak frequency decreases in WT and T3KO as halothane 
concentration increases, with the highest frequency occurring at the lowest concentration 
of  halothane administered. Significant differences in peak frequency occurred at 0.6% and 
0.8% (p<0.05). Sample sizes were: WT, n=8; T3KO, n=4. Error bars represent SEM. A 
single exponential curve was fitted to discreet data points. Data were analysed with 2-way 
ANOVA with repeated measures followed by Bonferroni post hoc tests.
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Figure 43.Type 2 theta oscillation peak frequency decreases in WT and T1KO as halothane 
concentration increases, with the highest frequency occurring at the lowest concentration 
of  halothane administered. Significant differences in peak frequency occurred at 0.4%, 
1%, 1.2% (p<0.05) and 1.5% (p<0.001). Sample sizes were: WT, n=8; T1KO, n=6. Error 
bars represent SEM. A single exponential curve was fitted to discreet data points. Data 
were analysed with 2-way ANOVA with repeated measures followed by Bonferroni post hoc 
tests.
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Figure 44.Type 2 theta oscillation peak frequency decreases in WT and DKO as halothane 
concentration increases, with the highest frequency occurring at the lowest concentration 
of  halothane administered. Significant differences in peak frequency occurred at 1.5% 
(p<0.001). Sample sizes were: WT, n=8; DKO, n=3. Error bars represent SEM. A single 
exponential curve was fitted to discreet data points. Data were analysed with 2-way 
ANOVA with repeated measures followed by Bonferroni post hoc tests.
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Figure 45.Type 2 theta oscillation peak frequency decreases in WT, T3KO, T1KO and DKO 
as halothane concentration increases, with the highest frequency occurring at the lowest 
concentration of  halothane administered. Significant differences in peak frequency 
occurred between the following strains and concentrations (in addition to the differences 
listed in the previous 3 figures): T3KO vs. T1KO, all concentrations between 0.6 - 1.5% 
inclusive (p<0.001). T3KO vs. DKO, 0.9% and 1.0% (p<0.05), 1.2% (p<0.01) and 1.5% 
(p<0.001). Sample sizes were: WT, n=8; T1KO, n=6; DKO, n=3; T3KO, n=4. Error bars 
represent SEM. A single exponential curve was fitted to discreet data points. Data were 
analysed with 2-way ANOVA with repeated measures followed by Bonferroni post hoc tests.
The peak frequency data (Figures 42-45) show a progression in peak position from a sub-
anaesthetic (sub-LORR) concentration to a concentration greater than that required for 
LORR. The initial theta oscillation peak appeared at approximately 7 Hz in all strains, then 
differed in the rate of  decrease for each strain until exposure to the final, highest halothane 
concentration. The response in the T1KO and DKO strains were very similar, exhibiting the 
lowest peak frequency at the highest halothane concentration (3.1 ± 0.3 Hz and 2.6 ± 0.3 Hz, 
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respectively). WT and T3KO strains had the smallest changes in peak frequencies, both 
culminating in peak frequencies of  approximately 5 Hz.
Figure 46.Full width at half-magnitude (FWHM) decreases in WT and T3KO strains as 
halothane concentration increases, reflecting the narrowing of  the theta oscillation 
generated. Significant differences in FWHM occurred at 0.6% (p<0.001), 0.7% (p<0.05), 
0.8% (p<0.01), 0.9% and 1.0% (p<0.001), 1.2% (p<0.01). Sample sizes were: WT, n=8; 
T3KO, n=4. Error bars represent SEM. A single exponential curve was fitted to discreet 
data points. Data were analysed with 2-way ANOVA with repeated measures followed by 
Bonferroni post hoc tests.
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Figure 47.Full width at half-magnitude (FWHM) decreases in WT and T1KO strains as 
halothane concentration increases, reflecting the narrowing of  the theta oscillation 
generated. There were no significant differences in FWHM between WT and T1KO at 
any concentration. Sample sizes were: WT, n=8; T1KO, n=6. Error bars represent SEM. 
A single exponential curve was fitted to discreet data points. Data were analysed with 2-
way ANOVA with repeated measures followed by Bonferroni post hoc tests.
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Figure 48.Full width at half-magnitude (FWHM) decreases in WT and DKO strains as 
halothane concentration increases, reflecting the narrowing of  the theta oscillation 
generated. There were no significant differences in FWHM between WT and T1KO at 
any concentration. Sample sizes were: WT, n=8; DKO, n=3. Error bars represent SEM. A 
single exponential curve was fitted to discreet data points. Data were analysed with 2-way 
ANOVA with repeated measures followed by Bonferroni post hoc tests.
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Figure 49.Full width at half-magnitude (FWHM) decreases in each strain as halothane 
concentration increases, reflecting the narrowing of  the theta oscillation generated. The 
decrease in FWHM across the range of  halothane concentrations was least for T3KO 
(0.4%, 4.0 ± 0.6 Hz ;1.5%, 2.5 ± 0.7 Hz). The values of  FWHM for WT, DKO and 
T1KO at 0.4% and 1.5% halothane were: WT, 2.6 ± 0.4 and 0.6 ± 0.2 Hz; DKO, 2.6 ± 
0.5 and 1.3 ± 0.7 Hz; T1KO, 2.8 ± 0.6 and 0.6 ± 0.3 Hz. Sample sizes were: WT, n=8; 
T1KO, n=6; DKO, n=3; T3KO, n=4. Error bars represent SEM. A single exponential 
curve was fitted to discreet data points. Data were analysed with 2-way ANOVA with 
repeated measures followed by Bonferroni post hoc tests.
The basic pattern of  a narrowing peak was visible in all strains (Figures 46-49), with the WT 
and T1KO showing a near identical narrowing as the halothane concentration was increased. 
The T3KO strain showed the least change in shape of  the theta oscillation peak, with a 
FWHM value of  4 ± 0.6 Hz decreasing to 2.5 ± 0.7 Hz at the highest concentration of  
halothane. This 40% decrease is small compared to the approximately 80% decrease in 
T1KO and WT strains. Again, this reflects the pattern seen in the raw data (Figure 41), where 
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the theta oscillation peak remains broad in the T3KO strain. The DKO strain falls between 
these extremes, with a 50% decrease in FWHM over the range of  concentrations studied.
Figure 50.The Q value for WT and T3KO. It is calculated from peak frequency/ full width 
at half-magnitude, and reflects the “sharpness” of  the theta oscillation. Significant 
differences were identified between WT and T3KO strains at 0.8% (p<0.05), 0.9%, 1.0%, 
1.2% (p<0.001) and 1.5% (p<0.01). Sample sizes were: WT, n=8; T3KO, n=4. Error bars 
represent SEM. A Gaussian curve was fitted to discreet data points. Data were analysed 
with 2-way ANOVA with repeated measures followed by Bonferroni post hoc tests.
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Figure 51.The Q value for WT and T1KO. It is calculated from peak frequency/ full width 
at half-magnitude, and reflects the “sharpness” of  the theta oscillation. No significant 
differences were identified at any concentration between WT and T1KO strains. Sample 
sizes were: WT, n=8; T1KO, n=6. Error bars represent SEM. A Gaussian curve was fitted 
to discreet data points. Data were analysed with 2-way ANOVA with repeated measures 
followed by Bonferroni post hoc tests.
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Figure 52.The Q value for WT and DKO. It is calculated from peak frequency/ full width at 
half-magnitude, and reflects the “sharpness” of  the theta oscillation. Significant differences 
were identified between WT and DKO strains at 0.9% and 1.0 (p<0.01). Sample sizes 
were: WT, n=8; DKO, n=3. Error bars represent SEM. A Gaussian curve was fitted to 
discreet data points. Data were analysed with 2-way ANOVA with repeated measures 
followed by Bonferroni post hoc tests.
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Figure 53.  The Q value for all strains. The strains studied can be divided into two groups, 
those showing a gradual increase in Q value up to 1.2% halothane (WT and T1KO) and 
those showing a little change over the range of  halothane concentrations (DKO and 
T3KO). WT and T1KO strains had a three to four fold increase in Q value between 0.4 - 
1.2% (WT 0.4 - 1.2%, 3.5 ± 0.5 - 10.7 ± 2.0; T1KO 0.4 - 1.2%, 2.8 ± 0.5 - 12.1 ± 2.3). 
There was no significant change over the same range for DKO and T3KO strains. 
Significant differences were identified between the following strains and concentrations (in 
addition to the differences listed in the previous 3 figures): T3KO vs. T1KO 0.8%, 0.9%, 
1.0%, 1.2% (p<0.001), 1.5% (p<0.01). T1KO v DKO: 1.2% (p<0.05). There were no 
significant differences between T3KO and DKO strains. Sample sizes were: WT, n=8; 
T1KO, n=6; DKO, n=3; T3KO, n=4. Error bars represent SEM. A Gaussian curve was 
fitted to discreet data points. Data were analysed with 2-way ANOVA with repeated 
measures followed by Bonferroni post hoc tests.
The Q value result highlights the difference between strains, splitting them into two groups 
(Figures 50-53). The smallest change in Q value occurred with the T3KO and DKO strains, 
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and the greatest change with the WT and T1KO strains. This confirms the picture presented 
in the power spectra data (Figure 41), with WT and T1KO showing near identical changes 
over the range of  halothane concentrations, whereas T3KO, and to a lesser extent DKO, did 
not develop such a finely tuned theta oscillation peak. For these data, the Q value is 
particularly influenced by the marked difference in FWHM between T3KO and the other 
strains. The fitting of  a Lorentzian curve to the power spectra enabled an objective 
comparison of  the response to halothane exposure between strains. These data showed the 
near-identical type 2 theta oscillation induced by halothane in T1KO and WT strains, the 
marked absence of  a sharply tuned theta peak in the T3KO strain and an intermediate 
response in the DKO strain. Furthermore, the results of  the T3KO response repeat previous 
findings in our laboratory (Robledo 2008).
3.2.2 Atropine sulphate
The anticholinergic (muscarinic antagonist) agent atropine sulphate has been shown to block 
the generation of  type 2 theta oscillations and this effect was originally described as a defining 
feature of  the type 2 theta oscillation, “atropine-sensitive theta” (Kramis et al. 1975). This 
sensitivity to atropine sulphate distinguished type 2 from the atropine-resistant type 1 theta 
oscillation (Kramis et al. 1975). Furthermore, both cholinergic input from the MS/ DBB is an 
essential component in the generation of  the theta oscillation (Yoder & Pang 2005). Bland et 
al. have shown the abolishment of  a halothane-induced theta oscillation in rats (Bland et al. 
2003). The aim of  our experiment was to investigate the effect of  systemic atropine sulphate 
administration on the halothane-induced theta oscillation in WT and T1KO strains, which 
produce a theta oscillation upon exposure to halothane, and the effect on the cortical EEG in 
the T3KO strain. Abolishment of  the theta oscillation in WT and T1KO would provide 
further evidence that halothane-induced theta is a type 2 theta oscillation.  In this experiment, 
a 10 minute baseline period was followed by IP administration of  50 mg kg-1 atropine 
sulphate and exposure to an increasing concentration of  halothane. The peak power for an 
identifiable peak within the type 2  theta range of  frequencies was normalised to control 
(Figure 54) and the percentage change in the type 2 theta oscillation between control and 
atropine conditions calculated for each concentration of  halothane. 
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Figure 54.The effect of  atropine sulphate (50 mg kg-1, IP) on WT, T1KO and T3KO strains 
with and without 1% halothane; representative data. The data were normalised to the 
control condition in the absence of  atropine. The characteristic halothane-induced peak, 
centred around 5 Hz, is visible in the WT and T1KO strains and absent in the T3KO 
strain. During the baseline period (no halothane), there was no theta oscillation and no 
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effect of  atropine administration on the cortical EEG. In contrast, the presence of  atropine 
sulphate prevented induction of  the theta oscillation in the WT and T1KO strains.  n=4 
for each strain.
The type 2 theta oscillation is clearly visible as a peak centred around 5 Hz in the power 
spectrum of  WT and T1KO strains. In these strains it was abolished by the administration of  
50 mg kg-1 atropine. In T3KO, there is no clear Type 2 theta oscillation in the presence of  
halothane and the administration of  atropine does not significantly change the appearance of  
the power spectrum. These findings are similar to those of  Bland et al. in the rat (Bland et al. 
2003).
To quantify the effects of  atropine sulphate administration in the presence and absence of  
anesthetic agent for each strain studied, the peak power following atropine sulphate 
administration was compared with the corresponding control period (Table 5).
Table 5. Changes in peak power following atropine administration with and without 
halothane. Values are the mean percentage change (n=4 for each strain) relative to control 
condition (for each strain with and without halothane), following atropine administration. 
During exposure to 1% halothane, there is a large decrease of  approximately 60% in the 
peak power following atropine sulphate administration compared with control conditions 
for WT and T1KO strains. There is no change associated with atropine administration in 
the T3KO strain.
These data illustrate the changes observed in the power spectra (Figure 54), quantifying the 
large reduction in theta oscillation in the WT and T1KO strains, and absence of  effect on the 
T3KO power spectrum.
Baseline + atropine
halothane 1% + 
atropine
WT
84.89
16.79
T1KO
70.74
14.17
T3KO
83.94
82.43
109
110
111
3.2.3 Eserine
The anticholinesterase agent eserine, also known as physostigmine, has been shown to induce 
type 2 theta oscillations in the rat and mouse (Leung & Vanderwolf  1980; Tebano et al. 
1999). Its mechanism of  action, prevention of  the breakdown of  ACh, provides an alternative 
means of  investigating the role of  cholinergic input in generation of  the type 2 theta 
oscillation. Although it has been reported that eserine does not effect the generation of  the 
type 1 theta oscillation, it administration is associated with immobility, reducing the likelihood 
of  observing type 1 theta in the spontaneously moving animal (Leung & Vanderwolf  1980). 
Eserine (0.2 mg kg-1, IP) or an equal volume of  saline was administered systemically to mice 
(WT and T3KO) instrumented with the Neurologger (Figure 55).
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Figure 55.Power spectra with normalised power for WT and T3KO strains (n=3 for each 
strain) with and without eserine (0.2 mgkg-1, IP ). The traces in bold represent the mean 
and the fainter traces, the standard error for each strain. The administration of  eserine to 
WT animals induced a theta oscillation peak centred around 4.5Hz. In this strain, eserine 
administration resulted in a 270 ± 60% increase in theta power (p<0.05). In contrast, in 
the T3KO strain there was no definable theta oscillation peak induced compared to the 
control condition.
These data provide further evidence of  the role of  cholinergic inputs in the generation of  the 
type 2 theta oscillation, and that this pathway is non-functional in the T3KO strain. 
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3.3 Mechanistic phenotypes - characterisation of  the 
TASK3 knockout (T3KO) action potential in 
hippocampal CA1 pyramidal cells
Following the results of  the in vivo work, showing the difference in cortical EEG between 
mouse strains in response to exposure to halothane, it was logical to begin the pursuit of  the 
underlying mechanisms of  this difference. The decision to compare T3KO and WT strains 
was based on several factors: the greatest difference in type 2 theta oscillation was between the 
T3KO strain and WT, TASK3 mRNA is normally expressed  in the CA1 area of  the 
hippocampus in WT animals and absent in the T3KO strain (Brickley et al. 2007), there is a 
large body of  evidence that the  septohippocampal formation is crucial for theta oscillation 
generation and that CA1 pyramidal cells form the major contribution to the recorded cortical 
EEG (Buzsaki 2002; Vertes et al. 2004). 
The distinctive anatomy of  the hippocampus and clearly defined stratum pyramidale 
containing the soma of  pyramidal neurones made identification of  the appropriate region 
relatively straightforward (Figure 56).   
Figure 56.Brightfield low power image of  a brain slice with pertinent structures labelled: EC, 
entorhinal cortex; DG, dentate gyrus; CA 1 and 3, cornu ammonis areas 1 and 3 
respectively.
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3.3.1 Resting membrane potential
Figure 57.Scatter plots showing the resting membrane potential (RMP; the horizontal black 
bar is the mean, and filled circles represent individual data points) for WT (n=13) and 
T3KO (n=11) strains under control conditions and during exposure to 1% halothane 
(HAL). No current is being injected into the cell. There was no significant difference in 
resting membrane potential between strains or conditions. Values of  RMP were: WT 
control -56.5 ± 1.3 mV; WT halothane -57.4 ± 1.1 mV; T3KO control -57.2 ± 1.6 mV; 
T3KO halothane -55.0 ± 2.1 mV.
The lack of  change in resting membrane potential (RMP) during halothane exposure, 
compared with control conditions (Figure 57) was similar to the findings of  Nishikawa and 
MacIver (Nishikawa & MacIver 2000). They did not record a significant change in rat CA1 
pyramidal cells upon exposure to 0.35 mM halothane. The lack of  difference in the T3KO 
strain was surprising given the potential contribution of  the TASK3 channel to setting the 
RMP, and in contrast to the findings of  Lazarenko et al. (Lazarenko et al. 2010) who found 
T3KO cells to be approximately 4% more depolarised, albeit in motoneurones. 
Whole cell parameters
Capacitance
There was no difference between strains under control conditions. The mean ± SEM 
capacitance for WT was 132.9 ± 17.1 pF, and for T3KO it was 128.0 ± 17.2 pF. 
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Membrane time constant
There was no difference in the sub-threshold membrane time constant (Figure 58) between 
strains or within a strain under control conditions or during halothane application.
Figure 58.Membrane time constant for the sub-threshold response to a brief  current 
injection. There was no difference between strains or conditions. Shaded bars are results 
of  halothane application. Control conditions: WT 7.9 ± 1.1 ms (n=14), T3KO 8.8 ± 1.3 
ms (n=9). Halothane: WT 7.4 ± 0.7 ms (n=12), T3KO 8.0± 1.8 ms (n=5). Data were 
subjected to an unpaired t test. Error bars represent SEM.
Current required to attain AP threshold
The current required to achieve AP threshold increased with exposure to halothane in the 
WT (Figure 59). There was no change between control or halothane conditions in the T3KO 
strain. Interestingly, Brickley et al., examining the electrophysiological characteristics in 
cerebellar granule cells using the same knockout strain, reported that the T3KO strain fired 
APs at a significantly lower current injection than WT, a reflection of  the more depolarised 
resting membrane potential in the T3KO strain (Brickley et al. 2007). The lack of  difference 
in the current injection required to achieve AP threshold between strains in this study 
probably reflects the similar resting membrane potential. We did identify an increase in the 
current required to achieve AP threshold during halothane exposure in WT but not in T3KO 
which may reflect an increased input conductance associated with halothane activation of  
TASK-3 channels in the WT.
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Figure 59.Current required to achieve threshold was significantly greater in WT upon 
exposure to 1% halothane (p = 0.014). The addition of  halothane did not affect the 
current required to achieve threshold in the T3KO strain (p = 0.35). There was no 
difference between strains under control conditions (p = 0.33). Data were compared with 
paired (pre- and post-halothane) and unpaired (WT versus T3KO control) t tests. Sample 
sizes were n = 11 for WT and n = 8 for T3KO. Error bars represent SEM.
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3.3.2 Action potential
Figure 60.Examples of  phase plane plots from T3KO and WT animals constructed from 
action potentials during current clamp. In each case, the black curve represents control 
and the red curve exposure to 1% halothane. Action potentials were elicited with a brief  
pulse. The brief  pulse was a depolarising incremental increase in voltage, in steps of  1 mV, 
starting at 3 mV, with a  duration of  0.2 ms.
The phase plane plots (Figure 60) show at a glance that there is no difference in the AP 
stimulated under control or halothane conditions for the T3KO strain, whereas there is a 
clear difference for WT. 
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Figure 61.The effect of  exposure to 1% halothane (approximately 0.40 mM) on the 
maximum rate of  rise, maximum rate of  decay and action potential peak height in acute 
brain slices from WT animals (n=8). There are significant decreases in each parameter 
following exposure to halothane. The maximum rate of  rise decreased from 98.9 ± 12.7 to 
72.5 ± 5.2 mV ms-1 (p<0.05), the maximum rate of  decay decreased from 34.5 ± 3.0 to 
29.5 ± 2.3 mV ms-1 (p<0.05), and the action potential peak decreased from 32.9 ± 4.2 to 
22.3 ± 2.0 mV (p<0.05). Data were compared with a paired t test.
The application of  halothane resulted in a reduction in the maximal rate of  rise, rate of  
decay and peak action potential height in the WT strain (Figure 61). The decrease in these 
parameters was 27%, 15% and 32% respectively. Halothane application did not result in a 
change in these parameters in the T3KO strain (Figure 62).
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Figure 62.The effect of  exposure to 1% halothane (approximately 0.40 mM) on the 
maximum rate of  rise, maximum rate of  decay and action potential peak height in acute 
brain slices from T3KO animals (n=7, control; n=6, halothane). There are no significant 
decreases in each parameter following exposure to halothane. The maximum rate of  rise 
was 104.5 ± 15.6 and 106.5 ± 15.6 mV ms-1 during control and halothane conditions, 
respectively. The maximum rate of  decay was 32.5 ± 2.4 and 31.3 ± 2.3 mV ms-1 during 
control and halothane conditions, respectively. The action potential peak was 35.5 ± 3.2 
and 35.4 ± 3.8 mV, respectively.
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Figure 63.A comparison of  maximum rate of  rise, maximum rate of  decay and action 
potential peak between WT (black bars) and T3KO (red bars) under control conditions 
(left column) and exposure to 1% halothane (right column). The mean ± SEM values are 
as reported in the previous two figures. During exposure to halothane, WT slices exhibited 
a significantly slower maximum rate of  rise (p<0.05) and action potential peak (p<0.01) 
compared with T3KO slices.
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Under control conditions there was no difference between strains in maximum rate of  rise, 
maximum rate of  decay or the action potential peak (Figure 63, left column). In contrast, 
exposure to 1% halothane (Figure 63, right column) resulted in a lower maximum rate of  rise 
(WT 72.5 ± 5.2 mV ms-1, T3KO 106.5 ± 15.6 mV ms-1) and action potential peak (WT 22.3 
± 2.0 mV, T3KO 35.4 ± 3.8 mV) in WT compared with T3KO. There was no difference 
between strains in the maximum rate of  decay achieved (WT 29.5 ± 2.3 mV ms-1, T3KO 
31.3 ± 2.3 mV ms-1). 
3.3.3 Sustained AP firing
Current-frequency curves (Figure 64 and Figure 65) were drawn for each strain under control 
and halothane conditions with the cells allowed to sit at their resting membrane potential and 
whilst held at -60 mV. A similar pattern was visible for each condition; in each case the WT 
strain was able to sustain AP firing at a greater current injection than the T3KO strain. This 
difference was more pronounced during exposure to halothane, when the T3KO strain 
exhibited a deterioration in APs beyond approximately 400 pA of  current, whilst WT was 
able to sustain AP firing until over 550 pA of  current injection. 
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Figure 64.Current - frequency (I-f) curves constructed for WT and T3KO pyramidal cells at 
rest, during control conditions and exposure to 1% halothane. The frequency count 
included action potentials up to the point at which action potential height deteriorated to 
less than 75% of  the height of  the first action potential in a train. During exposure to 1% 
halothane, WT pyramidal cells were able to sustain AP firing at a higher level of  current 
injection. The rate of  firing did not differ between strains at the equal levels of  current 
injection and there was no strain difference at the point of  initial AP firing. WT, n=11. 
T3KO, n=8. Inset graphs show example data for control (black) and halothane (red) 
conditions. The ability of  the WT to sustain APs is noticeable from the greater number of  
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current steps tolerated. The long pulse protocol was an incremental increase in current 
steps of  20 pA, starting at -40 pA, with a  duration of  160  ms.
Figure 65.Current - frequency (I-f) curves constructed for WT and T3KO pyramidal cells 
held at -60 mV (row B), during control conditions and exposure to 1% halothane. The 
frequency count included action potentials up to the point at which action potential height 
deteriorated to less than 75% of  the height of  the first action potential in a train. During 
exposure to 1% halothane, WT pyramidal cells were able to sustain AP firing at a higher 
level of  current injection. The rate of  firing did not differ between strains at the equal 
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levels of  current injection and there was no strain difference at the point of  initial AP 
firing. WT, n=11. T3KO, n=8. Inset graphs show example data for control (black) and 
halothane (red) conditions. The ability of  the WT to sustain APs is noticeable from the 
greater number of  current steps tolerated. The long pulse protocol was an incremental 
increase in current steps of  20 pA, starting at -40 pA, with a  duration of  160  ms.
These data are similar to findings by Brickley et al. who reported a decreased ability to fire 
sustained APs by cerebellar granule cells in a T3KO strain compared with WT (Brickley et al. 
2007). They postulated that the reduced input conductance associated with the TASK-3 
channel knockout resulted in greater inactivation of  voltage gated sodium channels, limiting 
the ability to sustain AP firing. Nishikawa and MacIver did not find an increase in AP firing 
upon exposure to halothane, though their protocol used a single current injection step unlike 
the depolarising steps we employed (Nishikawa & MacIver 2000).
3.3.4 sIPSC decay time and area are increased, and 
frequency decreased by halothane
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Figure 66.Typical examples of  sIPSCs from WT and T3KO strains under control conditions 
and during halothane application. 
The following data result from the average of  400 sIPSCs manually identified for each 
experiment. Typical individual examples are shown in Figure 66. The application of  
halothane significantly slowed the IPSC decay for each strain (Figure 67). The increase in 
time constant was 15% for WT and 32% for T3KO. There was no difference between strains 
during control or halothane conditions. Similarly, with application of  a similar halothane 
concentration in rat CA1 pyramidal cells, Nishikawa and MacIver (2000) reported that the 
recorded stimulus evoked (at the Schaffer collateral pathway) mIPSCs  showed an increase in 
the decay time constant (Nishikawa & MacIver 2000).
Figure 67.Bar graph of  sIPSC decay time constant for WT and T3KO. Shaded bars are 
results for 1% halothane application. There was a significantly slower time constant under 
control conditions for both strains (p<0.05).  Control conditions: WT 40.3 ± 4.9 ms, 
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T3KO 32.2 ± 7.0 ms. Halothane: WT 55.5 ± 4.7 ms, T3KO 42.7 ± 13.0 ms. Data were 
subjected to a paired t test. Error bars represent SEM.  
The area under the sIPSC curve did not differ between strains (Figure 68). The application of  
halothane resulted in a 40% increased area under the curve in the WT strain. A similar 
change in the mean values (58% increase) occurred in the T3KO strain though this did not 
achieve significance.
Figure 68.Bar graph of  sIPSC area under the curve for WT and T3KO. Shaded bars are 
results for 1% halothane application. There was a significantly smaller area under the 
curve under control conditions for WT (p<0.05).  Control conditions: WT 1317.0 ± 138.0, 
T3KO 1469.0 ± 340.0. Halothane: WT 1897.0 ± 202.0, T3KO 2333.0 ± 251.1. Data 
were subjected to a paired t test. Error bars represent SEM. 
The frequency of  sIPSCs did not differ between strains under control or halothane conditions 
(Figure 69). However there was an effect of  halothane in each strain. In the WT halothane 
application resulted in a 40% decrease in IPSC frequency, and in the T3KO strain a similar 
(30%) change in mean values occurred though this did not achieve significance. In contrast, 
Nishikawa and MacIver (2000) reported an increase in mIPSC frequency with the application 
of  halothane (Nishikawa & MacIver 2000). That study included AMPA and NMDA receptor 
127
128
129
antagonists and a sodium channel blocker in the internal solution which may have 
contributed to the difference in findings. 
Figure 69.Bar graph of  sIPSC frequency for WT and T3KO. Shaded bars are results for 1% 
halothane application. There was a significantly lower frequency during halothane 
application for WT (p<0.05).  Control conditions: WT 8.6 ± 2.0 Hz, T3KO 8.7 ± 3.0 Hz. 
Halothane: WT 5.2 ± 0.3 Hz, T3KO 6.3 ± 3.3 Hz. Data were subjected to a paired t test. 
Error bars represent SEM.
There was no difference in sIPSC peak height (Figure 70) between strains or within a strain 
under control conditions or during halothane application. An equipotent halothane 
concentration applied to CA1 pyramidal cells of  the rat did not alter IPSC amplitude 
(Lukatch & MacIver 1997).
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Figure 70.Bar graph of  sIPSC peak height for WT and T3KO. Shaded bars are results for 
1% halothane application. There is no difference between strains or treatment conditions. 
WT n=6, T3KO n=4. Control conditions: WT 33.3 ± 1.5 pA, T3KO 30.2 ± 7.0 pA. 
Halothane: WT 34.3 ± 2.5 ms, T3KO 34.8 ± 6.2 ms. Data were subjected to a paired t 
test. Error bars represent SEM.
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4.0 Discussion
This study was broadly divided into two sections. The first, covering the in vivo work, 
investigated the anaesthetic sensitivity, cortical EEG response and sleep behaviours of  three 
strains of  transgenic mice. We have shown that the TASK1 and 3 channels are targets for the 
volatile anaesthetic halothane, the cortical EEG response to halothane exposure is markedly 
altered in the T3KO strain, and the structure of  sleep is changed in terms of  transitions 
between the active and quiet periods (T3KO) and distribution of  activity between these 
periods (T1KO). Additionally, our results with the DKO strain highlight the possibility of  
compensation occurring when global knockout animals are created.
The second section, examining the underlying mechanism of  the theta oscillation through 
acute brain slice preparations, showed there was no difference in the RMP between WT or 
T3KO strains, confirmed the effect of  halothane in WT hippocampal CA1 pyramidal cells 
and the contribution of  the TASK3 channel to input conductance, and  identified a role for 
TASK3 channels in sustaining action potential firing. 
4.1 Loss of  righting reflex (LORR)
4.1.2 Loss of  consciousness (LOC) versus LORR
General anaesthesia has been traditionally defined as a triad of  loss of  consciousness, 
analgesia and muscle relaxation. This definition originated from a sentence at the end of  a 
paper examining the properties of  methyl-N-propyl ether in the 1950s (Rees & Gray 1950) 
and was rapidly accepted (Gray & Rees 1952). It simply described the the desirable outcomes 
of  a general anaesthetic when delivered to facilitate surgery. Though this definition suits its 
intended purpose, it brings a degree of  confusion to the investigation of  general anaesthesia 
as anaesthetic agents have variable efficacy in each component of  the triad. For example, 
ketamine (in humans) given alone can induce loss of  consciousness and analgesia but provides 
poor muscle relaxation. From the standpoint of  research into mechanisms of  action, a simpler 
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definition has been recently proposed, the “reversible, drug-induced loss of  
consciousness”(Franks 2006). This clear endpoint eliminates confusion, provided loss of  
consciousness can be clearly identified. Comparing the effects of  increasing concentrations of  
anaesthetics would involve measurable end-points. Loss of  consciousness in humans is 
typically identified by the failure to respond to a verbal command such as “open your 
eyes”(Bonhomme et al. 2000). Loss of  righting reflex in rodents is used as a surrogate measure 
of  loss of  consciousness and a positive correlation has been shown between these measures 
(Figure 71; Franks 2008). 
Figure 71.The relationship in EC50 between loss of  consciousness (LOC) in humans (defined 
as failure to respond to a verbal command) and loss of  righting reflex (LORR) in rats and 
mice. There is a clear correlation between LOC in humans and LORR in rodents for both 
injectable and inhalational anaesthetic agents. Concentrations are for aqueous solution at 
37◦C. Graph re-drawn from data provided in Franks (2008) (Franks 2008). 
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4.1.3 LORR and TASK channel knockout mice
Linden et al (Linden et al. 2006) tested LORR in a T1KO mouse with halothane (Figure 72). 
Contrary to our findings, they reported no significant difference between the T1KO (mean 
approximately 0.85% atm.) and wild type (mean approximately 0.9% atm. Figure 5). 
Comparisons of  LORR data should be done carefully as there is no standardised 
methodology or definition of  LORR. The definition used in our laboratory is that all 4 feet 
are off  the ground for a period of  at least 30 seconds. Some of  the methodological differences 
may explain the differing results in LORR in T1KO reported by Linden et al. (2006). 
Compared to our methodology for testing LORR, Linden et al. (2006) tested the righting 
reflex every 2 minutes (versus every 10 minutes) with each test consisting of  placing the mouse 
in a supine position on 3 consecutive occasions. If  the animal was unable to right itself  during 
each trial it was scored as a loss of  righting reflex and the anaesthetic concentration recorded. 
It is not stated if  the manipulation of  the animal was performed by rotating the chamber (as 
in our studies) or picking up the mouse directly. It is also unclear what duration the animal 
had to remain in a supine position for the result to be scored as a LORR, or if  all four feet 
had to be off  the ground. Such differences in methodology could explain the observed 
differences in anaesthetic sensitivity between studies. 
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Figure 72.Halothane sensitivity measured with a loss of  righting reflex assay (LORR) in 
T1KO (n=14-20) and wild type (n=14-20) mice. There was no significant difference 
between strains. These data differ from ours in that we found a significantly higher 
concentration of  halothane is required to achieve LORR in T1KO mice (Figure 31). Re-
drawn from Linden et al. (Linden et al. 2006).
A separate paper by Linden et al. (2007) investigated the anaesthetic sensitivity of  the T3KO 
strain (Linden et al. 2007). A LORR assay was not performed but results for a loss of  tail 
withdrawal (LOTW) assay were reported. A significantly higher concentration of  halothane 
was required (p<0.01) for LOTW in knockout (approximately 1.5% atm.) compared with wild 
type (approximately 1.3% atm.) mice. It is difficult to infer effects on LORR from these data 
as LOTW requires a nociceptive response, and it is not therefore possible to separate potential 
alterations in LORR from the response to a nociceptive stimulus.
Another group, investigating the sensitivity of  T1KO, T3KO and DKO to halothane (and 
isoflurane) described slightly different results from our findings (Lazarenko et al. 2010; Table 
6).
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Table 6. EC50 values (mean ± SEM) for halothane (% atm.) reported by Lazarenko et al. 
(Lazarenko et al. 2010) compared with those of  our study using a loss of  righting reflex 
assay. *Represents a significant difference compared to wild type (p<0.05). Lazarenko et 
al. (2010) found a decreased sensitivity to halothane in all knockout strains. This is in 
contrast to our findings, of  a decrease in halothane sensitivity in T1KO and T3KO 
compared with WT, but no difference for DKO. Furthermore, we found a significant 
difference between T1KO and T3KO, with T3KO requiring a higher concentration of  
halothane to achieve LORR. n>6 was used for each strain by Lazarenko et al. (2010).
They reported that all strains of  knockout animals were less sensitive to halothane than wild 
type, but without differences between strains. The most striking differences compared with 
our results was the difference in halothane sensitivity identified in T3KO and DKO. In 
T3KO, whilst we found an EC50 of  0.94% atm., they reported 0.83% atm., a value similar to 
T1KO. Their findings in the DKO strain (EC50= 0.81% atm.) did not differ from the other 
knockout strains, whereas we found an EC50 of  0.70% atm., no different from wild type. 
There are two key differences in the study of  Lazarenko et al. (2010) compared with ours. 
Firstly, the methodology employed by Lazarenko et al. (2010) was based on that of  Quinlan et 
al. (Quinlan et al. 1998). This methodology differed from ours in that mice were exposed to a 
single concentration of  anaesthetic agent and allowed to recover before being subjected to the 
next concentration. Information is not provided regarding the nature of  loss of  righting reflex 
assessment, particularly the number of  tests at each concentration, the definition of  loss of  
righting reflex and whether the test chamber was rotated manually or motor-driven and 
whether this was performed intermittently or continuously. Despite these methodological 
differences, the similar halothane sensitivity reported for the wild type strains used would 
suggest that the explanation for differing results lies elsewhere. Secondly, the generation of  the 
knockout animals differs. In creating the mouse employed by Lazarenko et al., exon 2 of  the 
Wild type
T1KO
T3KO
DKO
Our study
0.68 ± 0.02
0.78 ± 0.01*
0.94 ± 0.02*
0.70 ± 0.01
Lazarenko et al. (2010)
0.70 ± 0.01
0.84 ± 0.01*
0.83 ± 0.01*
0.81 ± 0.02*
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TASK3 gene was removed (by flanking with LoxP), leaving behind exon 1 (Mulkey et al. 
2007; Lazarenko et al. 2010). Though both exons are required to code a fully functioning 
channel, there is recent evidence that partial transcription of  a two-pore domain potassium 
channel (TREK1 was used) can interact with and affect intact subunits (Veale et al. 2010). 
Such a truncated protein reduced the native wild type channel activity and expression, an 
example of  a dominant negative. In TASK1 and TASK3 channels, exon 1 codes for the first 
transmembrane domain and part of  the P1 loop and exon 2 codes the remaining channel 
components (Vega-Saenz de Miera et al. 2001; Kim et al. 2000). Therefore, it is possible that 
the remaining exon 1 in the mouse of  Lazarenko et al. (2010) successfully coded a truncated 
protein which may have affected the function of  the remaining non-targeted TASK channel 
(TASK1 or 3 depending on the knockout). The creation of  truncated proteins also raises the 
intriguing possibility that such proteins formed dimers with remaining K2P channels in the 
DKO strain, negatively affecting their function. 
In contrast, our animals (and those of  Linden et al. (Linden et al. 2006, 2007)) were created 
with multiple inverted insertions of  exon 1 at the TASK3 locus in the T3KO strain, and 
disruption of  exon 1 at the TASK1 locus in the T1KO strain. This approach entirely prevents 
channel transcription. These differences in the creation of  the knockout strains offer an 
explanation for the differing results between our studies.
4.1.4 LORR and cyclopropane
Following the results of  the halothane LORR assay, it was logical to assess the T3KO strain 
against an anaesthetic agent known to not have an effect on the TASK3 channel. On this 
basis, cyclopropane was chosen (Gruss et al. 2004). Intriguingly, the T1KO strain was more 
sensitive to cyclopropane than the other strains tested (T3KO, DKO, WT; Figure 34).  
These results indicate an effect of  cyclopropane on the TASK1 channel. This mechanism is 
unlikely to be mediated through GABAA receptors, which are upregulated in the T1KO 
(Linden et al. 2008), as cyclopropane does not act at this site either via potentiation of  GABA 
or directly at the receptor (Raines et al. 2003). As predicted, there was no increase in 
alteration in sensitivity compared with WT in the T3KO strain.
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4.1.5 LORR and sex
Our data clearly showed a significant effect of  sex for the DKO and T1KO strains (Figure 32) 
with female mice (DKO 0.88 ± 0.04 % atm, T1KO 0.87 ± 0.04 % atm) showing a lesser 
sensitivity to halothane than male mice (DKO 0.70 ± 0.01 % atm, T1KO 0.78 ± 0.01 % 
atm). Linden et al. (Linden et al. 2006) did not find a significant sex effect in the T1KO strain 
with a LORR assay. As the genetic background of  our strains is identical, this difference is 
likely due to methodological differences. Sex differences in anaesthetic sensitivity have been 
reported for injectable agents such as the neurosteroid alphaxalone (Fink et al. 1982) and 
these differences have been ascribed to a combination of  pharmacokinetic and 
pharmacodynamic differences. The evidence for sex differences in sensitivity to volatile agents 
is less clear, largely as a result of  underpowered clinical studies (Pleym et al. 2003). One 
mechanism through which sex could have an effect on volatile agent sensitivity is through 
cyclic regulation of  GABAA receptor populations during the oestrus cycle (Maguire et al. 
2005). In order to explore this source of  potential bias further, the oestrus cycle of  mice would 
have to be monitored and data analysed according to the stage of  oestrus.
4.1.6 LORR and inter-observer variability
Finally, given the variation in methodology used to assess LORR, and that our method 
involved manual rotation of  the container containing the animal, it was important to assess 
inter-observer variability. Using data previously collected by AC in wild type animals, a 
comparison with data collected by DP showed near identical results (Figure 33). This 
demonstrates the repeatability of  our technique, contributing to the consistency of  data. 
An alternative measure of  LOC
A recent, alternative measure in rodents, the forced walking test has been proposed, with the 
purported advantage of  identifying the moment of  loss of  consciousness as reflected in the 
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surrogate marker of  loss of  motion (Hwang et al. 2010). This loss of  motion is measured 
using a triaxial accelerometer attached to a headstage. For the anaesthetic agents studied, 
propofol and a xylazine/ ketamine combination, the point of  LORR did not differ 
statistically from the loss of  motion. 
4.2 TASK and sleep
Several automated sleep scoring systems are now available for use in mice (Brankack et al. 
2010; Pack et al. 2007; Veasey et al. 2000). Most recently, a system also based on data from 
the Neurologger has been published (Brankack et al. 2010). This system used a supervised 
classifier technique (versus the threshold algorithms used in our study) and reported good 
agreement with manually scored cortical EEG and EMG data. An alternative approach is an 
interesting system scoring activity as sleep or wake based on the breaking of  infra-red beams 
(Pack et al. 2007). The advantages of  such a system are that there is no requirement for 
surgery and animal instrumentation and that it provides a quick method to screen animals for 
gross differences. The disadvantage is that it is non-specific and unable to identify different 
sleep states.
4.2.1 Sleep and handling stress
Great effort was made to ensure that animals were not disturbed during the sleep experiments 
as there is evidence that disruption to light: dark cycles effects the distribution of  NREM and 
REM sleep (Deboer et al. 2007). Additionally, the recording period we used exceeded the 
12:12h light: dark cycle in order to assess the possibility of  handling stress affecting the initial 
period of  recording. This became particularly important with the differences we observed in 
the transition between active and quiet periods between T3KO and the other strains. 
The effect of  brief  (5 minutes) periods of  manual restraint on the ensuing light: dark cycle in 
rats showed an increase in total sleep over both periods, comprising of  increased NREM sleep 
during both periods and increased REM sleep during the active (dark) period (Tang et al. 
2007). Though the greatest difference appeared in the first hour after handling, the 
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differences were maintained over the remaining time. A study performed with C57BL/6 mice 
showed that 1 hour of  manual restraint (in the middle of  the quiet period) resulted in 
increased NREM and REM sleep during the following active period (Meerlo et al. 2001).
In our study, the transition into the second circadian cycle approximated that of  the first most 
closely in the WT, followed by the DKO and T3KO strains. The behaviour of  the TIKO 
animals differed in hours 25 - 29, compared with hours 1 - 5 (corresponding phases of  the 
circadian cycle). It is not clear if  the the greatest contributing factor is the effect of  handling 
stress on the initial recording period, or the small number of  animals studied.
The similar pattern of  behaviour in the WT, DKO and T3KO animals may have resulted 
from our effort to perform the Neurologger switch several hours before the onset of  the quiet 
period, that the restraint was brief  (less than one minute), and recordings were always 
performed in each animal’s home environment.
4.2.2 Sleep in the WT
The percentage time spent awake or in each sleep state during the active or quiet periods in 
WT mice were very similar to the findings of  Brankack et al. (Brankack et al. 2010), who used 
an automated system based on Neurologger recordings, and Huber et al. (Huber et al. 2000), 
using manual scoring with a  tethered system. Our data for WT during wake, NREM and 
REM sleep in the active and quiet periods were: active period; 64.1 ± 3.4% (wake), 33.1 ± 
2.9% (NREM), 2.3 ± 0.5% (REM). Quiet period; 29.9 ± 2.8% (wake), 60.1 ± 2.3% (NREM), 
9.1 ± 0.7% (REM). Those of  Huber et al. (Huber et al. 2000) were: active period; 66.9 ± 
1.9% (wake), 29.4 ± 1.6% (NREM), 3.6 ± 0.4% (REM). Quiet period; 35.9 ± 1.0% (wake), 
54.4 ± 0.7% (NREM), 9.7 ± 0.5% (REM).
4.2.3 Sleep in the knockout strains
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Other than T1KO, there was no difference for sleep or wake between strains during the active 
(dark) period (Figure 39). In contrast, the knockout strains spent more time awake and less 
time in NREM sleep than WT during the quiet (light) period (Figure 38). 
Linden et al. studied the circadian rhythm of  T3KO mice (Linden et al. 2007). Their findings 
differ significantly from ours in that T3KO mice exhibited a greater degree of  activity during 
the active period compared with wild type animals, and there was no identifiable difference 
between groups (T3KO vs. WT) during the quiet period. It is difficult to directly compare 
findings between their study and ours as different methods were used to identify activity/ 
wake. Whilst we used sleep scoring based on EMG and cortical EEG data, Linden et al. 
(Linden et al. 2007) used a photobeam system, with breaks of  the photobeams indicating 
movement. Thus, as they describe it, this is a measure of  locomotor activity rather than sleep. 
The other major difference was that the start of  the recording period was at the beginning of  
the active period, opposite to our recording timing, which started towards the end of  the 
active period. Though not commented on by the authors, similar to our findings, there was a 
greater mean activity in the T3KO strain, albeit non significant, at the transition between 
active and quiet periods (Figure 73).
Figure 73.Circadian activity in T3KO (open squares, -/-) and wild type (closed squares, +/+) 
mice over a 24 hour period, beginning in the active (dark) period. Activity was classified 
using a photobeam system, generating counts as the photobeams were broken by animal 
movement. The red oval encircles the transition from active to quiet period. Similar to our 
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study, these data show the T3KO strain taking longer to reduce its activity levels (a 
surrogate marker for wakefulness) compared with WT. Modified from Linden et al. 
(Linden et al. 2007).
The near equal distribution of  wakefulness and sleep states across the active and quiet periods 
in the T1KO strain was an interesting finding (Figure 40). The balance between wake and 
sleep is seated in the hypothalamus, as first postulated by von Economo (von Economo 1930). 
Current thinking regarding the initiation of  sleep is that it is a combination of  passive and 
active processes. A passive entry into sleep results from the gradual accumulation of  activity-
dependent metabolites such as adenosine, (Liu & Gao 2007; Porkka-Heiskanen et al. 1997), 
the synthesis of  which is associated with the increased metabolic rate of  wakefulness, with 
accumulation dampening the activity of  wake-promoting neurones of  arousal centres (see 
below). These neurones project on to and inhibit thalamic reticular neurones. The resultant 
disinhibition frees thalamic reticular neurones to inhibit thalamo-cortical relay neurones, 
severing communication of  sensory information between the thalamus and cortex (cortical 
deafferentation) and resulting in sleep. This view of  the onset of  sleep as a passive process, 
following the obstruction of  wakefulness, was proposed in the first half  of  the 19th century 
(Moruzzi 1964). Evidence of  an active component to entry into sleep came from work 
showing activity of  pre-optic area (POA) neurones (“sleep-active”) of  the rostral 
hypothalamus during sleep (Kaitin 1984; Szymusiak & McGinty 1989), with a central role 
played by GABA (Gaus et al. 2002; Gong et al. 2004). These neurones provide inhibitory 
projections on arousal areas of  the posterior hypothalamus and brainstem (including the 
ascending reticular activating system(Moruzzi & Magoun 1949): comprising the 
tuberomammillary nucleus [histaminergic], lateral hypothalamus [hypocretinergic], locus 
coeruleus [noradrenergic], dorsal raphe nucleus [serotonergic], pedunculopontine tegmentum 
[cholinergic] and laterodorsal tegmentum [cholinergic]).(Sherin et al. 1996, 1998; Steininger 
et al. 2001; Yoshida et al. 2006; Uschakov et al. 2007; Zardetto-Smith & Johnson 1995). In 
turn, these arousal centres promote wakefulness via inhibitory projections on to orexin 
neurones of  the lateral and posterior hypothalamus (Sakurai et al. 2005; Muraki et al. 2004). 
The complexity of  sleep-wake homeostasis makes it difficult to pinpoint a cause for the sleep 
behaviour identified in the T1KO strain. The data presented (particularly Figure 40) show the 
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striking loss of  a circadian rhythm in this strain, with no difference between time spent in any 
stage of  sleep or wakefulness, between the quiet and active periods. Given the small number 
of  animals studied (n = 3), more work is required to confirm this finding. It is possible that the 
compensation described by Linden et al. (2008) by upregulation of  GABA receptors is enough 
to alter the balance of  the normal sleep-wake cycle (Linden et al. 2008). The alteration in 
TASK channel expression levels in the brain could have a profound effect on the control of  
sleep and wake periods. Variable brain expression of  these channels may provide clues to the 
pathways underlying the observed changes (section 1.2). The data on the T3KO strain, 
provided by Dr Christian Robledo has been discussed in more detail elsewhere (Robledo 
2008; Pang et al. 2009; see Appendix).
The striking similarity between the DKO strain and wild type was unexpected, though 
perhaps not surprising. The occurrence of  developmental compensation in lines of  knockout 
mice has been appreciated since the early days of  the introduction of  the technology 
(Picciotto & Wickman 1998; Routtenberg 1995) and the mechanisms underlying 
compensation are increasingly appreciated (Greenspan 2001; Brickley et al. 2001b; Swensen 
& Bean 2005; Marder & Goaillard 2006). The maintenance of  a phenotype despite network 
alterations such as gene knockout is “degeneracy”, the ability of  a network to produce the 
same result through different strategies (Greenspan 2001; Figure 74). Compensatory 
functional upregulation of  certain GABAA receptor subtypes has been shown in the T1KO 
strain, exhibited as increased sensitivity to the injectable anaesthetic agents propofol and 
pentobarbital (Linden et al. 2008). It could be argued that compensation is more likely to 
occur when channels of  particular importance have been removed. Therefore the difficulty 
lies in assessing the true importance of  the knocked out gene in the face of  compensation. 
141
142
143
Figure 74.A network functioning under normal circumstances (A) results in an identifiable 
phenotype. Following perturbation (B), such as knockout of  a gene (red cross), 
compensatory connections (green lines) may result. The overall effect is to produce a 
phenotype, which may appear identical to that of  the normal situation (“degeneracy”). 
Identifying differences between phenotypes will depend upon the sensitivity of  the 
investigation performed. Closed circles are elements of  a network (such as genes). 
Continuous black lines are intact connections. Dashed black lines are interrupted 
connections. Adapted from Greenspan (Greenspan 2001).
4.3 Type 2 theta oscillation is variably altered in KO 
animals
The technique of  EEG recording employed in this study provided unique advantages over 
traditional tethered systems, namely the opportunity to express normal behaviour. The 
placement of  the skull electrodes overlying the dura mater resulted in the recording of  a 
cortical EEG. The advantage of  this technique was the ease and speed of  placement of  
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electrodes and low failure rate. The primary disadvantage is that the information recorded 
reflects local field potentials and is not specific to a single neurone or group of  neurones. 
However, the dominance of  the theta oscillation in the mammalian brain and its well-
characterised localisation to the hippocampus ensured that this recording technique was not a 
barrier to generating meaningful data.
The most striking finding of  the series of  experiments exposing each strain of  mouse to 
halothane was the difference in response in the T3KO compared with the other strains. This 
difference was first observed by Dr Christian Robledo (Robledo 2008). The T3KO strain 
failed to generate the classic finely tuned peak within the theta range of  frequencies that is 
elicited in WT animals in response to halothane exposure. Characterisation of  this difference 
by fitting a Lorentzian curve to the theta oscillation provided a quantitative measure of  the 
peak characteristics. Compared to WT, the peak generated in T3KO was considerably 
broader, with a  FWHM value of  approximately 3.5 Hz, versus 1.5 Hz in WT at a halothane 
concentration corresponding with the population LORR. This difference was reflected in the 
resultant Q value (peak frequency/ FWHM), where T3KO failed to demonstrate the 
increased sharpness of  the theta oscillation peak observed in WT as the halothane 
concentration increased. Instead, the Q values of  the two strains diverged, with the T3KO 
strain maintaining a non-changing Q value over the range of  halothane concentrations 
studied. These objective measures reflects the power spectra observed (Figure 41).
Of  the remaining strains, T1KO and DKO, their cortical EEG response to halothane is split 
between resembling the WT and the T3KO. The T1KO closely resembled the WT response 
across the range of  halothane concentrations used. Functional compensation, with the 
upregulation of  GABAA receptors in the T1KO strain has recently been reported (Linden et 
al. 2008). As GABAA is a target of  halothane (section 4.4.4), and GABAergic projections are 
essential for the generation of  the theta oscillation (section 1.4.2),  this compensation is a 
possible explanation for the ability of  the T1KO strain to generate a type 2 theta oscillation. 
The alteration in type 2 theta oscillation observed in the DKO (similar in Q value to T3KO) 
may reflect a degree of  compensation occurring to enable type 2 theta generation, but not 
sufficient to return the oscillation to a shape equivalent to that recorded in the WT. Despite 
the DKO strain showing an identical sleep pattern to WT, its cortical EEG response to 
halothane differs from WT. In contrast, the T1KO strain differed markedly from WT (and 
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the other knockout strains) in sleep structure, but showed a near identical cortical EEG 
response to halothane as WT. These opposing effects indicate that the pathways involved in 
type 2 theta oscillation generation differ from those involved in sleep.
Though not tested directly, there is indirect evidence that the type 2 theta oscillation is 
unrelated to the loss of  righting reflex (or loss of  consciousness). From Figure 41, it is clear 
that the type 2 theta oscillation begins to appear at sub-anaesthetic (sub-LORR) 
concentrations of  halothane. This is true for all the strains studied. Whilst it was an initially 
attractive idea that the two were related, this dies not appear to be the case.
4.3.1 Abolishment of  the theta oscillation by atropine 
sulphate confirms the theta oscillation induced by halothane 
is type 2
The administration of  systemic atropine sulphate during type 2 theta oscillation abolishes the 
oscillation, and this response is a defining characteristic of  this oscillation, also known as 
“atropine-sensitive theta” (Kramis et al. 1975). Previous observations in rats identified that the 
halothane-induced theta oscillation was type 2 theta based on this response to atropine 
administration during exposure to halothane (Bland et al. 2003; Figure 75). We were 
interested in confirming the type of  theta oscillation we had observed in the WT and T1KO 
strains, which generated a well-defined oscillation during halothane exposure, and observing 
what changes might occur in the T3KO strain, which failed to generate a clear oscillation in 
response to halothane. 
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Figure 75.Power spectra from a rat during exposure to 1% halothane alone (top, peak 
frequency of  5.2 Hz) or after administration of  systemic atropine sulphate (ATSO4, 50 mg 
kg-1, IP, bottom). The theta oscillation induced by halothane is abolished following atropine 
sulphate administration. The x axis depicts the frequency (Hz) and the y axis the power 
(V2). Note change in y axis scale between plots. Adapted from Bland et al. (Bland et al. 
2003).
Our findings in the WT and T1KO mirrored that of  Bland et al. (Bland et al. 2003). This 
provided further evidence, in addition to the frequency and induction by halothane, that the 
oscillation observed was type 2 theta. In the T3KO strain, there was no change in the 
appearance of  the power spectrum, confirming the involvement of  acetylcholine in type 2 
theta oscillation generation. The effect of  atropine sulphate reflects the essential contribution 
of  the cholinergic system in the generation of  the type 2 theta oscillation (Yoder & Pang 2005) 
(section 1.4.2).
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4.3.2 Eserine administration fails to induce type 2 theta 
oscillation in the T3KO strain
The administration of  eserine, an anticholinesterase, induces the type 2 theta oscillation 
(Leung & Vanderwolf  1980; Loizzo et al. 1996). Therefore a further confirmation of  the 
identity of  the oscillation (halothane-induced, atropine sulphate ablated) was provided by 
eserine administration. This resulted in the induction of  a type 2 theta oscillation in the WT. 
As expected, following the results from atropine sulphate administration, eserine 
administration in the T3KO strain did not induce a type 2 theta oscillation (Figure 55).
4.3.3 Differential brain expression of  TASK1 and TASK3 may 
explain the difference in cortical EEG and sleep observed in 
T3KO and T1KO strains
As described in the introduction (section 1.2) there are marked differences in brain expression 
of  mRNA between TASK1 and TASK3 channels and some of  these sites are central to 
generation of  the theta oscillation and sleep (Brickley et al. 2007; Talley et al. 2001). In terms 
of  type 2 theta oscillation generation apparatus TASK3 mRNA expression was very high in 
the supramammillary nuclei and dentate gyrus, high in the RPO and moderate in the CA1 
and CA3 pyramidal cell layers, and medial septum. TASK1 mRNA expression was moderate 
in the supramammillary nuclei and dentate gyrus, high in the RPO and low-to-moderate in 
the CA1 and CA3 pyramidal cell layers, and medial septum (Talley et al. 2001). Similar 
findings were reported by Brickley et al. who showed a greater difference in TASK3 versus 
TASK1 mRNA expression in the hippocampus (Brickley et al. 2007).
Perhaps crucially, Talley et al. reported TASK3 expression in regions of  the hippocampus 
distinct from the pyramidal cell layers and postulated the location within the interneurone 
population (Figure 76; Talley et al. 2001). The role of  interneurones is integral to the 
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generation of  the theta oscillation and it may be the absence of  expression in the T3KO 
strain within this population that underlies the lack of  type 2 theta oscillation observed.
Figure 76.TASK3 mRNA expression in a coronal section of  the hippocampus from in-situ 
hybridisation. The white arrow indicates areas of  expression outwith the pyramidal cell 
layer, possibly indicating expression within interneurones. CA1 and CA3 are the cornu 
ammonis areas 1 and 3 respectively. DG is dentate gyrus. Modified from Talley et al. 
(Talley et al. 2001).
These variations in expression between TASK1 and 3 across regions involved in type 2 theta 
generation provides insight into our results. The greater degree of  TASK3 expression, which 
would be maintained in the T1KO strain, would explain the ability of  this strain to generate a 
type 2 theta oscillation. In contrast, in the T3KO, missing critical channel expression 
rendered it unable to generate the oscillation. 
The anatomic locations implicated in the regulation of  sleep (section 4.2.3) also show unequal 
expression patterns between TASK3 and TASK1 mRNA, with substantially greater TASK3 
expression in the brainstem nuclei (dorsal raphe nuclei, locus coeruleus) and thalamic relay 
nuclei, and greater TASK1 expression in the thalamic reticular nucleus. The change in 
balance in expression levels within various nuclei provides a potential mechanism which may 
begin to explain our findings (and those of  Linden et al. (2007)). For example, the increase in 
the time spent awake in the T3KO strain (compared to WT) may be a result of  the loss of  
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TASK3 expression in the pre-optic nuclei (sleep promoting) of  the hypothalamus. And the 
equal division of  sleep and wake across quiet and active periods in the T1KO strain may 
result from loss of  TASK1 expression in the sleep promoting thalamic reticular nucleus 
combined with maintained TASK3 expression in the thalamic relay nuclei. Despite the 
complex interplay of  sleep pathways, this differential expression provides an appealing 
explanation for the variation in sleep patterns observed between strains. 
 
4.4 Halothane acts through both GABAA receptors and 
TASK3 channels in CA1 pyramidal cells
Blind patching
The decision to employ the technique of  blind patching was based on optimising neuronal 
health as recorded cells were situated within a deeper level of  the slice thereby minimising 
dendritic damage from slicing, and providing an unbiased sample population (Castaneda-
Castellanos et al. 2006). The density and homogeneity of  pyramidal cells within the easily 
identifiable stratum pyramidale also supported use of  this technique. Absolute confirmation 
of  the identity of  the cells studied was planned with the use of  confocal microscopy to identify 
(and measure) cells which had been patched. This analysis is currently in progress. 
4.4.1 Action potential (AP) characteristics
The AP properties of  the WT CA1 pyramidal cells was similar to those reported in the 
literature for C57BL/6 mice (McColl et al. 2006; Routh et al. 2009; Biscoe & Duchen 1985). 
It is interesting to note that significant differences in electrophysiological properties of  CA1 
pyramidal cells have been identified between mouse strains and between mice and rats (Routh 
et al. 2009). These differences include the resting membrane potential, action potential 
amplitude, input resistance and cell morphology. Compared with Sprague-Dawley rats, 
C57BL/6 mice had a more hyperpolarised resting membrane potential, slower action 
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potential upstroke and smaller amplitude, whereas 129/SvEv mice had a smaller dendritic 
surface area, greater input resistance, action potential threshold and amplitude. These 
differences highlight the importance of  appropriate comparisons when comparing data 
between studies. 
Halothane and the AP
Under control conditions there was no difference in RMP between WT or T3KO mouse 
strains. This is at odds with the findings of  Lazarenko et al. (2010) in motoneurones, who 
reported that their T3KO strain had a resting membrane potential 5 mV more depolarised  
compared with WT (Lazarenko et al. 2010). Our finding is surprising as removal of  the 
T3KO channel would be expected to lead to membrane depolarisation as the contribution to 
the potassium leak is removed. A possible explanation for the lack of  change in RMP between 
the strains studied may be due to other sources of  leak  contributing to the RMP. In this case 
the removal of  TASK-3 channels alone may not be sufficient to result in an alteration of  
RMP. Though this explanation is at odds with the findings of  Lazarenko et al. (2010) and 
Brickley et al. (2007), this may reflect the different cell populations studied; motoneurones and 
cerebellar granule cells respectively (Brickley et al. 2007; Lazarenko et al. 2010).
The application of  1% atm. halothane to the slices did not result in a change in RMP in 
either WT or T3KO strains. The lack of  effect in WT is the same as reported by Nishikawa 
and MacIver in rat CA1 pyramidal cells, using a slightly higher concentration of  halothane 
(approximately 1.2% atm.) (Nishikawa & MacIver 2000). However, the lack of  difference 
between strains is surprising as the expected effect of  halothane would be to activate TASK 
channels, thus hyperpolarising the cell membrane, and accentuating a difference between the 
T3KO and WT strains. A change in RMP (more depolarised) was reported by Lazarenko et 
al. (Lazarenko et al. 2010) in motoneurones of  T3KO mice at a significantly higher 
concentration of  halothane (0.8 mM) than used in this study. And the change in RMP was 
relatively small (approximately 3 mV). The application of  supraclinical concentrations of  
halothane (3 - 12 x MAC) to rat CA1 pyramidal cells only resulted in a 5 mV 
hyperpolarisation (Nicoll & Madison 1982). The differences between our findings and those 
of  Lazarenko et al. (2010) may lie in the different cell population studied (motoneurones vs. 
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CA1 pyramidal cells) or potential compensation by other K2P channels in setting the RMP, or 
differences in construction of  the KO animals used (section 4.1.3).
We found that AP properties were altered by the application of  halothane only in the WT, 
where the maximum rate of  rise, rate of  decay and AP peak were decreased (Figure 61). This 
confirmed that halothane was penetrating the slice in the face of  the lack of  RMP change. 
There was no effect of  halothane in the T3KO strain and the AP did not differ between 
strains under control conditions. Although we did not observe changes in RMP in the T3KO 
strain, the lack of  AP change in response to halothane application, when an alteration was 
observed in the WT, indicates a mechanism of  action via the TASK3 channel.
4.4.2 Whole cell parameters and halothane
In response to a train of  depolarising current steps during current clamp recording we found 
that halothane application had little effect on the ability of  T3KO to produce APs. In 
contrast, WT were able to continue to produce APs until a substantially greater current 
injection, a reduction in accommodation. This ability of  the WT strain was not identified by 
Nishikawa and MacIver in rat CA1 pyramidal cells (Nishikawa & MacIver 2000), who 
reported no change in discharge activity in with halothane application. A possible explanation 
for this difference is that a single pulse of  current was used (120 pA, 300 ms), rather than the 
series of  pulses reported here. We injected over 500 pA of  current at the end of  our stimulus 
protocol, at which point a difference in the response to halothane was discernible (Figure 64 
and Figure 65). At the lower current injection employed by Nishikawa and MacIver (2000) 
there was no difference between halothane and control in our data. Our results indicate that 
the TASK3 channel is necessary for sustained AP firing. Similar findings were reported by 
Brickley et al. who reported the inability of  cerebellar granule neurones to sustain AP firing in 
T3KO mice (Brickley et al. 2007). They proposed that the difference resulted from an indirect 
effect of  the potassium conductance provided by TASK3 channels to reduce the steady-state 
inactivation of  voltage-gated sodium channels (via membrane hyperpolarisation). 
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In our study we did not find a change in RMP between the T3KO or WT, a difference 
identified by Brickley et al. (the T3KO strain had a more depolarised RMP) which was 
associated with the lower current injection reported to reach AP threshold. In keeping with 
our findings (no difference in RMP), there was no difference in the current required to reach 
AP threshold under control conditions between strains. In spite of  the similar RMP values 
during halothane exposure, our data showed that there was an increase in the current 
required to achieve AP threshold in the WT but not the T3KO strain (Figure 59). The greater 
current required to achieve AP threshold in the WT strain during halothane exposure, 
compared with the control period, likely reflects the increased input conductance associated 
with halothane activation of  TASK-3 channels. This is supported by the absence of  effect of  
halothane on the current to reach AP threshold in the T3KO strain.
4.4.3 Halothane and spontaneous inhibitory post synaptic 
currents (sIPSCs)
Similar to the findings of  Nishikawa and MacIver (2000), and Banks and Pearce (1999), we 
also identified an increase in the sIPSC decay time, indicating a role for halothane in GABAA 
mediated synaptic inhibition (Nishikawa & MacIver 2000; Banks & Pearce 1999). The size of  
this increase in IPSC decay time was less than that reported by Nishikawa and MacIver 
(2000) and may reflect the lower concentration of  halothane used in our study (Nishikawa & 
MacIver 2000). The percentage change in decay time for an equipotent anaesthetic 
concentration appears to be related to the individual volatile agent and is also concentration 
dependent, with enflurane and isoflurane having a greater effect on decay time than 
halothane (Figure 77; Jones & Harrison 1993; Gage & Robertson 1985; Banks & Pearce 
1999). 
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Figure 77.The percentage increase in IPSC decay half  life is a function of  volatile agent and 
concentration (compared with control conditions). Enflurane and isoflurane application 
resulted in a marked prolongation in IPSCs compared to the increase resulting from 
halothane application. As anaesthetic concentration of  each agent increased, a further 
IPSC prolongation is observed. Note change in y-axis scales. Adapted from Jones and 
Harrison (Jones & Harrison 1993).
The area under the sIPSC curve (AUC) did not differ between strains under control or 
halothane exposure conditions. The effect of  halothane exposure was a significant increase in 
the AUC in the WT and a non-significant increase in mean values in the T3KO strain. These 
changes reflect the IPSC prolongation observed as a result of  halothane exposure in both 
strains, and the absence of  strain difference reflects the GABAA mediated action of  halothane.
Changes in IPSC amplitude reflect postsynaptic effects of  anaesthetic agents. The lack of  
effect of  halothane on IPSC amplitude is in keeping with the literature (Mody et al. 1991; 
Gage & Robertson 1985; Banks & Pearce 1999). Although Nishikawa and MacIver (2000) 
reported a modest change in stimulus-evoked IPSC amplitude, these results differed from an 
earlier study from the same group when no change in amplitude was identified (Nishikawa & 
MacIver 2000; Lukatch & MacIver 1997). Banks and Pearce (1999) reported a significantly 
greater dose dependent decrease in mIPSC amplitude with isoflurane (and enflurane) 
indicating an inter-agent difference (Banks & Pearce 1999). Interestingly, Banks and Pearce 
(1999) showed that the effects of  isoflurane and enflurane on mIPSC amplitude and decay 
time constant were not equal for a given concentration between or within agents. This could 
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explain why we did not observe an effect of  halothane on sIPSC amplitude, but did observe 
an increase on IPSC decay.
Changes in IPSC frequency reflect presynaptic effects of  anaesthetic agents by their actions 
on the release of  GABA from presynaptic terminals. Nishikawa and MacIver (Nishikawa & 
MacIver 2000) reported a significant increase (2-3 fold) in mIPSC frequency following the 
application of  halothane (0.35 mM). In contrast, Banks and Pearce  identified a much smaller 
(less than 1 Hz) increase in mIPSC frequency at 0.6 mM halothane (Banks & Pearce 1999). It 
is unclear why such different results were observed in these studies despite similar 
experimental methodology. Our results showed a 30 - 40% decrease in sIPSC frequency in 
both strains in response to halothane. Two important differences between our study and those 
of  Nishikawa and MacIver (2000) and Banks and Pearce (1999) may explain this difference. 
Firstly, both cited studies included bath application of  6-cyano-7-nitro-quinoxaline-2,3-dione 
(CNQX, approximately 20 μM) during IPSC recording. CNQX has been shown to increase 
IPSC frequency 2 - 4 fold at concentrations four times lower than used in these studies 
(Brickley et al. 2001a; McBain et al. 1992). Secondly, the animals (rats) used ranged from 2 - 6 
weeks old, spanning the time at which GABAA receptor subtypes undergo dramatic changes, 
specifically an increase in alpha1 expression, a subunit involved in halothane’s effects on 
GABAA (Nishikawa et al. 2002; Fritschy et al. 1994). These differences may account for the 
different findings of  our study.
These data indicate a postsynaptic (increase in decay time constant) mode of  action for 
halothane. Evidence for a presynaptic effect is less clear for the reasons outlined above. These 
effects were similar in both strains studied reflecting either minimal contribution from the 
TASK3 channel or a degree of  compensation masking potential effects.  
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4.4.4 Anaesthetic targets
A complicating factor in the investigation of  anaesthetic action is that the volatile general 
anaesthetics have multiple targets. Therefore the results of  studies in global knockout models 
require careful interpretation for this reason and the possibility of  compensatory central 
nervous system changes (Linden et al. 2008; Brickley et al. 2001b).
Halothane has been shown to have effects in a range of  receptors at clinically relevant 
concentrations. Indeed, within the K2P family alone, halothane activates TASK1 (Sirois et al. 
2000; Putzke et al. 2007; Patel et al. 1999; Berg et al. 2004; Linden et al. 2006), TASK3 
(Meadows & Randall 2001; Lazarenko et al. 2010; Berg et al. 2004; Linden et al. 2007), 
TREK1 (Heurteaux et al. 2004) and TRESK (Liu et al. 2004) channels. A TREK1 knockout 
mouse showed a decreased sensitivity to halothane with both LORR and MAC testing, 
though not to the same degree as reported here with the T3KO strain (Heurteaux et al. 
2004). The recently identified K2P TRESK appears particularly sensitive to halothane in vitro 
(Liu et al. 2004). 
Our work concentrated on halothane as this has the greatest effect (compared with isoflurane) 
on TASK1 and TASK3 channels (Patel et al. 1999; Andres-Enguix et al. 2007).
It is this in vitro evidence coupled with expression of  TASK, and K2P channels as a family, that 
makes them such attractive targets for the mechanism of  action volatile anaesthetic agents.
4.5 Conclusions
Our findings show roles for the TASK1 and 3 channels in anaesthetic sensitivity, generation 
of  the type 2 theta oscillation and the sleep-wake cycle. 
The T3KO strain was markedly less sensitive to the volatile anaesthetic than the T1KO 
strain, whilst there was no significant difference between the DKO and WT. A type 2 theta 
oscillation, induced by halothane and eserine and blocked by atropine sulphate in the WT, 
was completely disrupted in the T3KO strain. The shape of  the type 2 theta oscillation was 
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minimally altered in the T1KO strain and the effect on the DKO strain was intermediate 
between that of  the WT and T3KO strains. All knockout strains spent more time awake and 
less time asleep during the quiet period compared with WT. Additionally, the T3KO strain 
exhibited slow transition periods between active and quiet periods (Robledo 2008), and the 
T1KO strain showed similar amounts of  sleep and wake throughout the sleep-wake cycle.
A comparison of  hippocampal CA1 pyramidal cells between WT and T3KO strains reflected 
the action of  halothane through the TASK3 channel and GABAA receptor.
Halothane application slowed the action potential and reduced accommodation in the WT 
but had no effect in the T3KO strain. This indicates that TASK3 channels in CA1 pyramidal 
cells may contribute to the difference in type 2 theta oscillation observed between strains. 
Actions on the GABAA receptor were reflected by an increase in sIPSC decay times and 
decrease in frequency upon exposure to halothane in both strains.
Much of  the in vivo data presented in this thesis was recently published (Appendix; Pang et al. 
2009).
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4.5.1 Future directions
In vivo 
Further exploration of  the sleep phenotype exhibited by the T1KO strain is warranted. This 
could involve repetition of  the experiment to verify the results and increase the sample size. 
As the type 2 theta oscillation is also associated with certain behaviours such as immobility, it 
would be interesting to verify if  the phenotype exhibited by the T3KO is preserved. 
The theta oscillation also has roles in navigation and memory consolidation, therefore natural 
avenues to pursue would be to investigate these functions in the knockout strains.
In vitro
Further investigation of  the mechanistic framework underlying the difference in type 2 theta 
oscillation observed in the T3KO strain could be focused on the role of  inhibitory 
interneurones in the generation of  type 2 theta. Parvalbumin positive (parv-positive) 
interneurones exhibit TASK-like currents (Torborg et al. 2006) and could be a promising 
target. The difficulty in patching interneurones is that it is not possible to distinguish classes 
based anatomic location or morphology and parv-positive interneurones only represent 
approximately 20% of  all interneurones. Therefore to increase the likelihood of  patching an 
interneurone of  the desired class, aid identification and reduce animal numbers, generation 
of  a mouse line with a means of  identifying the desired class of  interneurones (such as with 
GFP) and selective TASK channel deletion in these cells.
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TASK channels are acid-sensitive and anesthetic-activated mem-
bers of the family of two-pore-domain potassium channels. We
have made the surprising discovery that the genetic ablation of
TASK-3 channels eliminates a specific type of theta oscillation in
the cortical electroencephalogram (EEG) resembling type II theta
(4–9 Hz), which is thought to be important in processing sensory
stimuli before initiating motor activity. In contrast, ablation of
TASK-1 channels has no effect on theta oscillations. Despite the
absence of type II theta oscillations in the TASK-3 knockout (KO)
mice, the related type I theta, which has certain neuronal pathways
in common and is involved in exploratory behavior, is unaffected.
In addition to the absence of type II theta oscillations, the TASK-3
KO animals show marked alterations in both anesthetic sensitivity
and natural sleep behavior. Their sensitivity to halothane, a potent
activator of TASK channels, is greatly reduced, whereas their
sensitivity to cyclopropane, which does not activate TASK-3 chan-
nels, is unchanged. The TASK-3 KO animals exhibit a slower
progression from their waking to sleeping states and, during their
sleeping period, their sleep episodes as well as their REM theta
oscillations are more fragmented. These results imply a previously
unexpected role for TASK-3 channels in the cellular mechanisms
underlying these behaviors and suggest that endogenous modu-
lators of these channels may regulate theta oscillations.
EEG ! knockout ! REM ! theta ! wavelet
I f a sufficient number of neurons participate in network oscil-lations, then the local field potentials summate, and measur-
able voltage oscillations can be recorded in the electroenceph-
alogram (EEG). These oscillations are observed over a wide
range of frequencies and reflect the synchronous neuronal
activity that occurs during a variety of different behaviors. For
example, as animals explore their environments, as they learn
and lay down memories, as they process sensory input, and as
they sleep, characteristic oscillations occur in the ‘‘theta’’ range
of frequencies (4–12 Hz) (1). These theta oscillations are often
divided into two types (1–5): Type I, which occurs at slightly
higher frequencies (6–12 Hz), and type II (also known as arousal
theta), which occurs at the lower end of the range (4–9 Hz). Type
I theta is associated with exploratory behavior, walking, running,
and rearing, whereas type II theta is associated with immobility
during the processing of sensory stimuli relevant to initiating, or
intending to initiate, motor activity.
The neuronal networks that generate these theta oscillations
involve ascending pathways from the brainstem that project to
the hypothalamus and then to the medial septum/diagonal band
of Broca and the hippocampus (6–9). Where the true pacemaker
is located is unclear, but the basic requirements for a neuron to
oscillate are a depolarizing drive (such as a sodium current)
together with a restoring drive, such as a repolarizing potassium
current. Most computational models (10–12) include several
different ionic currents, some of which are well-characterized
and attributed to known ion channels (e.g., HCN channels
underlying Ih), whereas others are only defined operationally
(e.g., slow potassium currents).
We have been studying the role TASK-3 potassium channels
might play in general anesthesia. This channel is a member of a
family of 15 ‘‘background’’ or ‘‘leak’’ potassium channels (13)
that is directly inhibited by acid and activated by certain inha-
lational anesthetics (14, 15). During our initial experiments, we
monitored the cortical EEG as a function of anesthetic concen-
tration and made a striking observation. In wild-type mice, a
highly-tuned anesthetic-induced peak in the theta band of fre-
quencies (4–9 Hz), which appeared at around the concentrations
that induced a loss of righting reflex, was absent in the TASK-3
knockout (KO) animals. TASK-1 KO mice, on the other hand,
appeared identical to wild-type animals.
In this paper we show that the ablation of TASK-3 potassium
channels removes type II theta oscillations, but leaves type I
theta oscillations and exploratory behavior unaffected. More-
over, the TASK-3 KO mice show altered anesthetic sensitivity,
disrupted sleep behavior, and a fragmentation of both sleep
episodes and theta oscillations during REM sleep. These results
suggest that TASK-3 channels play key roles in anesthetic
sensitivity and the regulation of sleep.
Results
Anesthetic-Induced Loss of Righting Reflex. To assess any differ-
ences in anesthetic sensitivity between wild-type, TASK-1 KO,
and TASK-3 KO animals, we used the loss of righting reflex
(LORR) as an assay. In rodents, LORR is observed at the same
concentrations as loss of consciousness in humans (16), with a
comparably steep concentration-response curve reflecting a
sharp transition between the awake and anesthetized states. We
first investigated halothane because of its great efficacy in
activating TASK channels (14, 15, 17–19). We found that the
TASK-3 KO mice were significantly (P ! 0.001) less sensitive to
halothane, with an EC50 of 0.94" 0.02% atm (n# 12) compared
with 0.68 " 0.02% atm (n # 19) for wild-type animals (Fig. 1A).
In contrast, TASK-1 KO mice showed only a small change in
anesthetic sensitivity with an EC50 of 0.78 " 0.01% atm; n # 20.
To help assess if the difference between wild-type and TASK-3
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KO animals was specifically due to the absence of TASK-3
channels, we next investigated the effects of cyclopropane, an
anesthetic gas that, even at the highest concentrations, does not
significantly activate TASK-3 channels (20). We found that for
cyclopropane, the EC50 for LORR was identical (P ! 0.5) for
wild-type and TASK-3 KO animals, being 19.6" 0.8% atm (n#
10) and 19.0 " 0.8% atm (n # 12), respectively (Fig. 1B).
An Atropine-Sensitive Theta Oscillation Is Absent in TASK-3 KO Mice.
In parallel with our LORR measurements, we recorded the
cortical EEG as a function of anesthetic concentration. In
wild-type animals, we observed the striking appearance of a
highly tuned peak in the theta range of frequencies ($4–9 Hz)
in the power spectrum when the mice were exposed to halothane
at and above the concentrations that caused a LORR (Fig. 1C).
In contrast, this peak was absent in TASK-3 KO animals (Fig.
1D). We obtained the same results with another inhalational
general anesthetic, isoflurane (n # 4). In wild-type animals, this
halothane-induced theta oscillation could be greatly ($85%)
inhibited (n # 3) by systemic atropine (50 mg/kg i.p.), a
nonselective antagonist of muscarinic acetylcholine receptors
(inset to Fig. 1C). The same dose of atropine had no significant
effect (n # 6) on the power spectra from TASK-3 KO mice in
the presence of halothane (Fig. 1D) or on the power spectra from
wild-type (n # 3) or TASK-3 KO (n # 7) mice in the absence of
halothane. We also performed the above experiments using
TASK-1 KO mice and found identical results (n # 4) to those
using wild-type animals (e.g., see Fig. 1E).
Atropine-sensitive theta oscillations (sometimes called type II
theta oscillations) that are resistant to the presence of anesthet-
ics aremediated byGABAergic and cholinergic projections from
the medial septum to the hippocampus (21, 22). To confirm that
this septohippocampal pathway was involved, we injected (n #
3) the local anesthetic lidocaine into the medial septum in
wild-type mice exposed to a concentration of halothane suffi-
cient to induce the sharply tuned theta oscillation. Lidocaine
injection caused an abrupt and almost complete elimination of
the theta peak; the effect reversed after about 20 min. This is
illustrated by the data of Fig. 1F, which shows theWavelet power
spectrum (see Materials and Methods) of the EEG as a function
of time, just before, and following, lidocaine injection in the
presence of halothane. The involvement of cholinergic pathways
is also suggested by the fact that anticholinesterase drugs such as
physostigmine produce slow type II theta oscillations in many
species, including mice (23–25). We confirmed this in wild-type
mice (n # 3) and found that an i.p. injection of 0.2 mg/kg
produced a 270 " 60% increase (P % 0.05) in peak theta power
centered at 4.5 Hz. In TASK-3 KO animals, in contrast, this dose
of physostigmine had no significant effect (n # 3; P ! 0.1).
We next examined how the theta oscillation was influenced by
halothane concentration. For all three genotypes (wild-type,
TASK-1 KO, and TASK-3 KO), a peak in the theta range was
observed at low halothane concentrations (typically between 7–8
Hz), but this gradually shifted to lower frequencies as the
concentration of halothane increased (Fig. 2 A–C). With both
wild-type (n # 8) and TASK-1 KO (n # 6) mice, the peak
sharpened and the peak power greatly increased, reaching a
maximum at around 1% halothane. This is shown in Fig. 2D and
E where the ‘‘Quality’’-factor Q (defined as the peak frequency/
peak width) is plotted against anesthetic concentration. The
Q-factor is a measure of the ‘‘tuning’’ of the oscillation. For
TASK-3 KO mice (n # 11), this tuned, atropine-sensitive, theta
oscillation was absent (Fig. 2F).
Cyclopropane, which is inactive on TASK-3 channels, caused
no significant increase in theta power for either wild-type (n #
7) or TASK-3 KO animals (n # 8) over the range of concen-
trations tested (8–25% atm).
Exploratory Theta Oscillations in Wild-Type and TASK-3 KO Animals
Are Identical. Theta oscillations occur when animals explore their
environments (1, 5, 26), and we next investigated how this
‘‘exploratory’’ or type I theta was affected by the TASK-3
potassium channel ablation and the absence of type II theta.
Mice were placed in an activity monitor so that their walking
speed could be recorded at the same time as their EEG. The FFT
power spectra were essentially identical for the wild-type and
TASK-3 KO animals (Fig. 3A). However, because it has been
reported (27–30) that the frequency of the exploratory theta
oscillations increases with the speed of the animal, we investi-
gated whether or not this occurred in our mice. Because of the
limitations of conventional power spectra in terms of time/
frequency resolution, we calculated theWavelet power spectrum
(31) as a function of time (Fig. 3B) and, using the coordinates
provided by the activity monitor, calculated the frequency at
Fig. 1. The ablation of TASK-3 potassium channels alters anesthetic sensi-
tivity and eliminates an atropine-sensitive theta oscillation. (A) TASK-3 KO
mice are significantly (P% 0.001) less sensitive tohalothane, an anesthetic that
potently activates TASK channels (14, 17–19). (B) In contrast, the loss of
righting reflex caused by cyclopropane, an anesthetic that has no effect on
TASK-3 channels (20), was unchanged (P! 0.5). (C) At around loss of righting
reflex concentrations, halothane induced a tunedoscillation in the EEGpower
spectrum in the theta band of frequencies in wild-type animals that was
sensitive to atropine (Inset). (D) TASK-3 KO mice had a strikingly different
phenotype. Halothane did not induce a tuned theta oscillation at any con-
centration. (E) TASK-1 KO mice displayed an identical behavior to wild-type
animals, with halothane also inducing a tuned theta oscillation sensitive to
atropine (see inset). The power spectra shown in panels C–Ewere all obtained
in the presence of 1% halothane. (F) Injection of lidocaine into the medial
septum reversibly inhibited the halothane-induced theta oscillation in wild-
type mice. The Wavelet power spectrum shows the appearance of a theta
oscillation during halothane exposure and its abrupt elimination, and then
recovery, following lidocaine injection. Lidocaine injectionsweremadeon the
midline at a depth from the surface of the skull of 5 mm and 0.8 mm from the
Bregma.
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maximum theta power as a function of the speed of the mouse.
The data confirmed that the theta frequency does, indeed,
increase with the speed of the animal, but the data for wild-type
(n! 5) and TASK-3 KO (n! 5) animals were virtually identical
(Fig. 3C). These data also serve to emphasize that the absence
of TASK-3 channels has selectively ablated one specific type of
theta oscillation.
Natural Sleep and Theta Oscillations During REM Are Fragmented in
TASK-3 KO Animals.Given that network oscillations feature prom-
inently in sleep and that TASK-3 KOmice aremore active during
the nocturnal period (32), we next investigated if the natural
sleep behavior of the mice had been affected. By using miniature
data-logging devices, we recorded the EEG and EMG of mice in
their ‘‘natural’’ home-cage environments over the full sleep-
wake cycle. There was a clear distinction in sleep behavior
between the genotypes (Fig. 4A). As expected, wild-type animals
(black lines in Fig. 4A, n ! 5) showed a large difference (n ! 5)
in the levels of wakefulness, non-REM and REM sleep during
the ‘‘lights on’’ 12-h period (natural sleep period) compared with
the ‘‘lights off’’ period (natural wake period). Moreover, the
progression between these different behavioral states was rather
abrupt. The TASK-3 KO animals (n ! 5), on the other hand,
showed a much slower progression when moving from the
natural wake period to the sleep period. During the first 2 h after
‘‘lights on,’’ the TASK-3 KO animals spent significantly (P "
0.05) more time awake, and significantly (P " 0.05) less time in
REM or non-REM, than wild-type mice, but this difference
progressively reduced over time.
When the distributions of sleep episodes were analyzed, we
found that, during the natural wake period, the number and
average length of sleep episodes was not significantly different
(P# 0.1 and P# 0.5, respectively) for wild-type and TASK-3 KO
mice (Fig. 4B, top graph). In contrast, there was an obvious
difference between the genotypes during the natural sleep
period. Here, the number of sleep episodes for the TASK-3 KO
mice was significantly (P " 0.001) larger than for the wild-type
(36.0 $ 3.5 compared with 19.3 $ 2.5), but their durations were
significantly (P " 0.005) shorter (655 $ 52 s compared with
1452 $ 180 s). In other words, the sleep episodes were
fragmented.
Fig. 2. Characteristics of theta oscillations in the presence of halothane for
wild-type, TASK-1, and TASK-3 KO animals. Halothane caused a concentra-
tion-dependent decrease in theta frequency in (A) wild-type mice, (B) TASK-1
KO mice, and (C) TASK-3 KO mice. For both (D) wild-type and (E) TASK-1 KO
animals, however, this was accompanied by a marked increase in peak theta
power and the sharpness of the theta peak at and above the concentrations
that induce a loss of righting reflex. This is shown by the plots of the Q-factor
vs. halothane concentration. The Q-factor of a tuned oscillator is defined as
the frequency divided by the full width at half maximum. (F) With TASK-3 KO
mice, halothane did not increase theta power, and the Q-factor did not
change significantly with halothane concentration.
Fig. 3. The theta oscillations that occur when mice explore their environ-
ments, ‘‘exploratory theta,’’ were identical in wild-type and TASK-3 KOmice.
(A) The Fast Fourier Transform (FFT) power spectrum of the EEG for mice
movingat#2.5 cm/s showeda clear peakat around8Hz,whichwas essentially
identical in wild-type and TASK-3 KO mice. On the left are typical traces
showing the movement of the different genotypes over a 30-min period—as
with the FFT power spectra, nodifferenceswere evident in the activities of the
mice. (B) The top traces show a typical segment of the EEG for a wild-type
mouse with the corresponding speed of the animal averaged over 0.5-s
epochs. The Wavelet power spectrum (see Material and Methods) beneath
showshowthe frequency content of the EEG changeswith timeand illustrates
how trains of theta oscillations (at %8 Hz) are often interrupted when the
animal stops moving. (C) A more detailed analysis reveals that the frequency
at peak theta power shows a significant increase (P" 0.05, repeatedmeasures
ANOVA) as a function of the speed of the animal.
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Because the most striking phenotypic difference between the
wild-type and TASK-3 KO animals was the loss of the type II
theta oscillations (Fig. 1 C andD), and because natural sleep had
been disrupted, we next investigated whether the theta oscilla-
tions that occur during REM sleep were also affected. We
calculated the Wavelet power spectrum as a function of time
during periods of sustained REM sleep that occurred during the
natural sleep period (‘‘lights on’’). Increased fragmentation of
the theta oscillations was evident in the Wavelet power spectra
of the TASK-3 KO mice. Fig. 4C shows representative examples
of Wavelet power spectra for the two genotypes, where it can be
seen that in wild-type animals, theta oscillations tend to be less
interrupted. This is shown quantitatively by the autocorrelation
functions shown below (Fig. 4D) calculated on 120-s segments of
data from both wild-type (left graph; n ! 5) and TASK-3 KO
animals (right graph; n ! 5). A test between the peak heights in
the autocorrelation functions show a significant difference (P "
0.05) between the wild-type and KO animals.
Discussion
The TASK-3 KO mice were significantly less sensitive to the
general anesthetic halothane. Indeed, they showed the greatest
genetically-engineered decrease in sensitivity to an inhalational
anesthetic yet reported for anesthetic-induced hypnosis (16, 33).
This decrease in halothane sensitivity is comparable with that
observed with TREK-1 KO mice in response to a painful
stimulus (33). The fact that the TASK-3 KO mice displayed an
unchanged sensitivity to cyclopropane, an agent that does not
measurably activate TASK-3 channels (20), supports the idea
that the decrease in halothane sensitivity was a direct conse-
quence of their absence. Thus, involvement of TASK-3 channels
in anesthetic-induced LORR seems likely. A possible role for
anesthetic-activated potassium channels was suggested many
years ago (34). The first such channel that was characterized was
discovered in the pond snail Lymnaea stagnalis (18), and when
recently cloned (17), found to be closely related to mammalian
TASK channels that have been shown to be activated by a variety
of volatile general anesthetics (14, 15). Nonetheless, other
channels, such as GABAA receptors and other two-pore-domain
potassium channels are almost certain to be involved (16, 35, 36),
because at only 40% higher concentrations, the TASK-3 KO
mice are also anesthetized.
The loss of type II theta oscillations in the TASK-3 KO mice
was completely unexpected. This theta oscillation has been
widely studied, using a variety of different anesthetics (4, 6, 8,
37). The increased tuning of the oscillation under halothane
anesthesia implies that the opening of TASK-3 channels pro-
motes neuronal synchronicity. The oscillation is characterized by
its sensitivity to atropine, and it has been postulated to mediate
the processing of sensory stimuli before initiating motor activity
(2–5). The absence of type II theta was specific to the loss of the
TASK-3 channels, because the removal of TASK-1 channels left
the oscillations unchanged.
Our finding that type I exploratory theta oscillations are
identical in the wild-type and TASK-3 KO animals has important
implications for the extent to which the pathways and molecular
mechanisms that mediate the two types of theta oscillations
overlap. Clearly, TASK-3 potassium channels are a necessary
component for type II oscillations but play no evident role in
type I oscillations. Although the circuitry responsible for gen-
erating these oscillations is not certain, it is widely believed that
a pathway from the brainstem, ascending through the hypothal-
amus to themedial septum and hippocampus is involved (1, 6–9).
This is consistent with our observation that the type II theta
oscillation can be reversibly blocked by lidocaine injection into
the medial septum.
Given that the recombinant TASK-1 and TASK-3 channels
have similar biophysical properties with respect to anesthetic
sensitivity (15), why are the deficits in oscillatory activity and
sleep patterns specific to the TASK-3 KO strain? This is probably
because of differences in neuronal expression between the two
genes (38); we surmise that the TASK-1 gene is not expressed,
or not expressed highly, in the neurons either driving or sup-
porting the oscillations. In the adult mouse forebrain the
TASK-3 gene has much stronger expression than TASK-1. In
particular, TASK-3 mRNA is abundant in layers 2 to 6 of the
neocortex, CA1 hippocampal pyramidal cells, dentate granule
cells, and the septum (38, 39); the TASK-3 gene is also expressed
in parvalbumin-positive GABAergic interneurons (40) in the
hippocampus, some subtypes of which aid the generation of theta
oscillations (41, 42). The TASK-1 gene, by contrast, is poorly
expressed in the mouse hippocampus (38). One scenario is that,
as a consequence of losing TASK-3 channels, a change in the
biophysical behavior of a specific type of hippocampal interneu-
Fig. 4. The ablationof TASK-3 channels disrupts natural sleep and fragments
both sleep episodes and theta oscillations. (A) TASK-3 KO mice show a much
slower progression into sleep (both into non-REMand REM) at the start of the
natural sleep period (‘‘lights on’’). During the natural wake period (‘‘lights
off’’) the sleep behavior of the two genotypes is broadly similar. (B) The upper
panel shows that therewere no significant differences in sleep fragmentation
during the natural wake period. During the natural sleep period (lower
panel), however, the TASK-3 KO animals show a fragmented sleep pattern
with significantly more (P" 0.001), but significantly shorter (P" 0.005) sleep
episodes. (C) REM sleep episodes during the natural sleep period showed a
clear difference in the fragmentation of the theta oscillations. The Wavelet
power spectra show illustrative examples of 40-s segments of EEG during REM
for wild-type and TASK-3 KO mice. The autocorrelations in (D) reflect this
quantitatively and show that thewild-typemice (n! 5) displaymore coherent
REM theta oscillations (P " 0.05) than do TASK-3 KO mice (n ! 5). The gray
shading represents the SEM envelope, and the arrows indicate the time at
which a peak in the autocorrelation function is no longer significantly differ-
ent from zero.
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ron (e.g., a subtype of parv-positive interneuron) might produce
the selective loss of type II theta with minimal impact on type I
theta. It has recently been shown, for example, that the loss of
TASK-3 channels in cerebellar granule neurons affects their
ability to sustain high-frequency firing of action potentials (43).
Alternatively, TASK-3 channels might govern the regulation of
selective cholinergic input to the hippocampus, so their absence
might disrupt theta oscillations. More work is needed to eluci-
date the cellular mechanism.
Previously, establishing the physiological roles of type II theta
oscillations has been problematic because they are only sustained
when anesthetic is present, or can only be blocked when atropine
is present. Both of these drug treatments will affect neuronal
behavior in ways that do not involve theta oscillations per se.
TASK-3 KO animals should allow us to test hypotheses about
where and when these oscillations might play a role. Whether or
not the theta oscillations that are elicited by various drug
treatments correspond to the theta oscillations that are observed
during specific behavioral states requires further investigation.
Network oscillations and sleep are intimately connected, with
sleep states largely characterized by the frequency and amplitude
of oscillations in the EEG. Transient spindles and K-complexes
appear before sleep onset, and the relative amplitudes of theta
and delta oscillations (together with the EMG) allow REM and
non-REM sleep states to be distinguished. It is too early to be
certain that the absence of type II theta oscillations in the
TASK-3 KO animals is directly responsible for the changes we
observe in sleep behavior. Nonetheless, the differences we see in
both the time to transition into both REM and non-REM sleep,
as well as the fragmentation in the sleep episodes are a strong
indication that modulation of TASK-3 potassium channels is part
of the mechanism used in natural sleep regulation, perhaps via
muscarinic acetylcholine receptors (44). Interestingly, atropine
treatment, which blocks type II theta oscillations, also shortens
REM episodes in both cats (45) and rats (46). The fragmentation
of the theta oscillations during REMepisodes is further evidence
of TASK-3 involvement in sleep mechanisms in general and
theta oscillations in particular.
In summary, we have made the surprising discovery that
TASK-3 channels are required for atropine-sensitive type II
theta oscillations. In contrast, they make no contribution to type
I exploratory theta oscillations. Animals lacking these channels
display a reduced sensitivity to the general anesthetic halothane,
have a significantly slower progression into sleep, and exhibit
fragmented sleep behavior. Because of the many ways in which
TASK-3 channels can bemodulated, it is easy to imagine that this
might lead to the regulation of behavior via the promotion or
reduction of theta oscillations.
Materials and Methods
Mice. All experiments were in accordance with the United Kingdom Animals
(Scientific Procedures) Act of 1986 and approved by the Ethical Review Com-
mittee of Imperial College London. Animals were housed in a humidity- and
temperature-controlled room, under a 12:12-h light-dark cycle. Water and
foodwereprovidedad libitum. TheTASK-1 (39) andTASK-3KO (43)mice, each
with a disruption of the first coding exon, were as described previously.
Anesthetic-Induced Loss of Righting Reflex. An animal was placed in a cylin-
drical glass chamber (900 mL) and, following a 10-min baseline period with
100% oxygen, the anesthetic was introduced, initially at 0.4% for halothane
or 8% for cyclopropane. The anesthetic concentration was then increased
stepwise (steps of 0.1% for halothane and 4% for cyclopropane), and after 10
min equilibration, LORR was assessed by manually rotating the glass cylinder
and scoring a LORR if the animal had all four feet off the ground for 30 s or
more. The observer was blinded to the genotype of the animal. Each animal
was tested once at each anesthetic concentration. Normothermia was main-
tained using a heat lamp placed 45 cm above the glass cylinder. A quantal
concentration-response curve was calculated using themethod ofWaud (47).
EEG Recording. Surgerywas carried out under halothane (0.8–1.5% in oxygen)
anesthesia. Three gold-plated EEG electrodes (Decolletage AG) were inserted
through the skull onto the dura mater, the first in the frontal bone (!1.5 mm
to Bregma, -1.5 mm frommidline), the second in the parietal bone ("1.5 mm
to Bregma, !1.5 mm from midline), and the third in the interparietal bone
over the cerebellum ("2.0 mm from Lambda, 0.0 mm from midline) for the
reference electrode. Three lengths of Teflon-insulated stainless steel wire
(with the distal 3mmof insulation removed) were inserted in the neckmuscle
for EMGrecording.Once all of the electrodeswere inplace, theywere covered
withdental cement (Orthoresin; DeguDentGmbH). The animalswere allowed
at least 7 days to recover from surgery. The EEG and EMG signals were
recordedonaminiaturedata loggingdevice (48) containinga256MBmemory
chip (http://www.vyssotski.ch/neurologger2). This device was sufficiently
small (about 2 g including batteries) to be attached directly to the animal’s
skull. Four data channels (up to 30 h at 10-bit resolution) could be recorded at
a sampling rate of 400 Hz and were bandpass-filtered ("3 db corner fre-
quency) between 1 and 70 Hz followed by high-pass (0.6 Hz, -3db) offline
digital filtering. The recordingdevice allowedEEG-EMGsignals tobe recorded
in free-moving animals, either in an activity monitor or in their home cages,
where data could be recorded during a complete sleep-wake cycle in a natural
and familiar environment.
It should be noted that our EEG measurements were from the cortex, so
that the sleep state of the mice could be determined. Previous work on theta
oscillations has usually been done with rats, often using hippocampal elec-
trodes.However, becauseof the small distancebetween thehippocampusand
the cortex in mice, it is almost certain that oscillations generated in the
hippocampus would be detected by our cortical EEG electrodes.
EEG Analysis. EEG data were analyzed using either conventional FFT power
spectra (Fast Fourier transforms of the autocorrelation function) or Morlet
Wavelet analysis. FFT power spectra were calculated using the program Spike
(Spike 2, v5.14; Cambridge Electronic Design) with the area being normalized
to 100. Where a theta peak was observed, a good fit to the data could be
obtained using a Lorentzian function:
p! p0" ! a0#2#2" # f$ f0$2"
where p is the EEG power, p0 is a baseline, a0 is the height of the Lorenzian, #
is the half-width at half maximum, f is the frequency and f0 is the peak
frequency. The Q-factor, a measure of the sharpness of the peak, was calcu-
lated as f0/(2#).
EEG data were also analyzed using Wavelet transforms (49), which are
appropriatewhen theEEG signal is nonstationary (which is often the case); the
Wavelet power spectrum is the square of theWavelet transform. This method
involves convoluting the EEG signal with a series of ‘‘Daughter’’ wavelets,
which are time-scaled variants of a ‘‘Mother’’ wavelet. In general, thewavelet
transform is defined as:
W#s, %$!
1
#s $ x#t$ &%t$ %s &dt
where s and % represent the scale and local center of the wavelet &(s, %), and
x(t) is the EEG signal as a function of time. We used the most commonly used
Mother wavelet, theMorlet function, which is a complex sinusoid, windowed
by a Gaussian:
&0#'$! (
"1/4ei)0'e"'2/2
where ' is a dimensionless ‘‘time’’ parameter, and )0 is the dimensionless
wavelet central ‘‘frequency’’ that was set to 6 to satisfy the admissibility
criterion (50). The Wavelet power spectra were calculated using Matlab
(MathWorks) using a script based on that of Torrence and Compo (49).
Sleep Scoring. For the sleep experiments, mice were placed in a temperature-
controlled, sound-proof box illuminated within on a 12:12-h light-dark cycle.
Data were recorded both from animals in their home cages as well as from
animals exposed toanovel environment (anactivity test chamber). In these latter
experiments, aswell as the EEG-EMG signals, the coordinates of the animalwere
recorded using two orthogonal sets of 16 infrared beams (Activity test chamber;
Med Associates) and analyzed with Activity Monitor software (Med Associates).
The activity box was thoroughly cleaned with ethanol between experiments.
The sleep state (rapid-eye-movement sleep, REM; nonrapid-eye-movement
sleep, non-REM; or wake, W) was scored automatically using an established
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protocol (51). Briefly, the scoring consisted of filtering the EEG into ‘‘delta’’
(0.5–4 Hz) and ‘‘theta’’ (6–10 Hz) frequency bands and scoring 20-s epochs as
one or other of the three states based on W being periods of high EMG and
intermediate theta/delta ratio, REMbeing periods with high theta/delta ratio
and low EMG and non-REM being periods with high delta waves, low theta/
delta ratio, and low EMG.
Statistics. Unless otherwise stated, Student’s t-test was used to test for signif-
icance. Where shown, errors bars represent the SEM.
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